data_1f3k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f3k _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.6 p . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' ASP . 1.6 mmtp -146.14 142.99 29.02 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 120.802 -1.186 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.2 mp0 -81.04 148.85 29.5 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.416 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.86 133.83 0.56 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.052 0.453 . . . . 0.0 111.121 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.7 t0 82.04 18.38 0.37 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.241 0.544 . . . . 0.0 110.027 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 52.7 mm-40 -106.76 136.88 19.37 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HA ' HG12 ' A' ' 23' ' ' VAL . 44.5 Cg_endo -73.02 137.92 27.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 111.005 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 1.2 p -160.36 177.37 10.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 110.882 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.41 131.5 34.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 109.566 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 7.6 p -89.55 59.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -141.18 -36.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 110.637 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.64 -74.57 0.45 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.663 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.7 pt? -114.39 147.8 38.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 111.218 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.643 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -162.6 -86.52 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.145 178.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.1 t -93.84 140.56 29.53 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.571 0.701 . . . . 0.0 110.67 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.71 -2.4 0.14 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.617 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -131.52 -8.1 3.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.289 -1.507 . . . . 0.0 113.343 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.67 -110.9 0.25 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 116.832 -2.604 . . . . 0.0 114.002 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.627 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -127.55 -150.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.625 -0.927 . . . . 0.0 111.874 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.643 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 t -148.83 76.09 1.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 111.537 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.5 mp -88.32 64.33 7.54 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 105.82 -52.08 0.72 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 106.023 -2.831 . . . . 0.0 106.023 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.3 m -162.11 159.28 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 26.1 t -43.78 115.0 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.949 -1.094 . . . . 0.0 109.917 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.576 ' O ' ' CE3' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -95.05 38.33 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 110.646 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.627 ' CZ2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.99 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.3 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 19.1 mmtt -144.06 144.3 31.56 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.183 -0.948 . . . . 0.0 110.069 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.2 mm-40 -72.11 140.97 49.16 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.02 127.8 1.64 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.611 -0.68 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 8.5 t70 88.49 17.91 0.06 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 120.979 0.419 . . . . 0.0 110.869 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -106.83 147.56 35.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.023 -1.048 . . . . 0.0 109.719 179.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.529 ' HA ' HG12 ' A' ' 23' ' ' VAL . 39.4 Cg_endo -68.28 137.03 38.99 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 124.463 1.77 . . . . 0.0 109.727 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.698 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 5.8 p -161.79 -178.56 6.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.361 -1.335 . . . . 0.0 112.677 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -110.67 145.27 38.26 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.476 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 20' ' ' CYS . 74.7 t -85.88 57.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 109.447 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -130.45 -38.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.117 -0.989 . . . . 0.0 109.963 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.81 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -82.9 102.62 11.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.701 -0.624 . . . . 0.0 111.084 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.728 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 23.3 p30 -160.18 -3.5 0.06 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.243 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 11.5 t 178.14 106.33 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.632 -1.292 . . . . 0.0 109.63 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -59.22 -3.09 0.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 112.352 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.568 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.1 t -128.48 1.76 5.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 112.841 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.47 -125.07 0.83 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 117.687 -2.197 . . . . 0.0 112.645 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.565 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -111.32 -143.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.805 -0.82 . . . . 0.0 110.6 -177.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.728 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 37.1 t -159.81 70.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.84 -1.163 . . . . 0.0 111.332 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.2 mm? -85.81 62.47 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.518 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 110.24 -48.77 0.9 Allowed Glycine 0 N--CA 1.483 1.821 0 N-CA-C 106.471 -2.651 . . . . 0.0 106.471 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 7' ' ' PRO . 3.1 m -162.08 159.86 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.933 -0.745 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 42.8 t -56.73 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.094 -1.004 . . . . 0.0 109.061 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.583 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 7.1 mtp -84.9 52.97 2.56 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.026 -1.046 . . . . 0.0 112.962 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.583 ' CG ' ' C ' ' A' ' 25' ' ' MET . 6.0 m-90 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.099 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 11.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.957 0.408 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtt -137.34 167.17 22.14 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 120.832 -1.168 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.1 mm-40 -95.49 137.53 34.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.059 -1.025 . . . . 0.0 109.616 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 116.64 0.52 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.649 -0.657 . . . . 0.0 110.79 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 18.4 t70 92.24 20.83 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 122.744 0.417 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.6 mt-10 -107.02 161.77 21.83 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.58 138.04 37.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.805 1.424 . . . . 0.0 109.416 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.627 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 11.7 p -150.86 177.82 9.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.161 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -120.82 146.33 46.65 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.999 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.48 56.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.913 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -136.46 -42.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 110.811 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -76.16 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.005 -1.059 . . . . 0.0 111.044 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.8 pp -78.68 111.28 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.685 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.652 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -160.7 -17.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.691 -1.203 . . . . 0.0 113.298 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 12.4 t -172.5 119.23 0.38 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.773 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 40.4 m -60.69 -6.78 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 111.1 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 26' ' ' TRP . 1.6 t -133.07 0.94 3.49 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.856 -1.152 . . . . 0.0 112.266 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.96 -140.17 2.81 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.747 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.616 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -107.38 -147.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 122.341 -0.505 . . . . 0.0 110.304 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.652 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 51.5 t -135.31 83.14 2.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.349 -1.469 . . . . 0.0 111.12 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD22 ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -87.8 51.2 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.524 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 107.28 -41.04 2.3 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 4.5 m -161.04 148.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.949 -0.736 . . . . 0.0 109.142 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 15.3 t -41.11 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.64 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 5.4 mmt -79.49 -165.2 0.75 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 119.896 -1.752 . . . . 0.0 107.826 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CZ2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.503 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.768 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 31.5 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.103 0.477 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 14' ' ' ASP . 7.9 mmtt -153.13 158.24 41.55 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.441 -0.787 . . . . 0.0 108.924 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 26.3 mm-40 -91.89 145.84 24.23 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.01 120.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.838 -0.539 . . . . 0.0 110.428 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.1 t0 86.94 30.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.08 0.467 . . . . 0.0 110.871 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 6.9 mm-40 -114.67 154.61 46.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.081 -1.012 . . . . 0.0 110.069 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.85 120.39 6.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.643 1.339 . . . . 0.0 110.041 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.3 p -140.05 171.56 14.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.077 -1.015 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.58 124.59 48.4 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG12 ' CE1' ' A' ' 11' ' ' PHE . 9.2 p -85.16 54.19 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.041 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.578 ' CE1' HG12 ' A' ' 10' ' ' VAL . 54.3 m-85 -132.0 -17.62 2.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.175 -0.953 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.05 -54.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.929 -1.107 . . . . 0.0 110.875 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.3 pt? -136.82 144.38 43.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.81 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.631 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.94 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' MET . 0.8 OUTLIER -78.72 123.68 27.41 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.681 0.753 . . . . 0.0 109.755 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.69 -20.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.599 -0.688 . . . . 0.0 112.107 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -143.27 14.22 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.488 -1.382 . . . . 0.0 112.226 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -149.81 -126.44 1.43 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.624 -2.227 . . . . 0.0 113.027 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.587 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -130.2 178.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.491 0.662 . . . . 0.0 110.838 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -116.65 65.36 0.71 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 109.557 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 1.9 mt -87.39 62.69 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.26 -50.81 0.76 Allowed Glycine 0 N--CA 1.481 1.658 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.7 m -162.86 -175.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.476 ' HB3' ' CA ' ' A' ' 4' ' ' ALA . 12.1 t -49.85 125.35 11.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.544 ' O ' ' CB ' ' A' ' 26' ' ' TRP . 36.4 mmm -77.16 -174.91 3.4 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 120.242 -1.536 . . . . 0.0 109.301 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.605 ' CD1' HG21 ' A' ' 17' ' ' THR . 1.1 m95 . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.237 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.7 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.015 0.436 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -145.25 156.06 43.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.013 -1.054 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.0 mm100 -88.25 138.35 31.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 109.406 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.56 128.0 1.1 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.452 -0.78 . . . . 0.0 111.184 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 3.3 t0 83.3 19.53 0.21 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.041 -0.412 . . . . 0.0 111.143 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -109.13 165.49 12.54 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 120.866 -1.146 . . . . 0.0 109.697 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 40.1 Cg_endo -70.04 136.75 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.913 1.481 . . . . 0.0 109.618 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 19.2 p -148.81 -170.55 3.65 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.784 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 1.8 m-20 -122.34 131.03 53.7 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.22 55.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.121 -0.987 . . . . 0.0 110.838 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -144.5 -27.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 0.0 111.088 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.557 ' N ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -161.55 -86.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.936 -1.102 . . . . 0.0 110.811 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pp -82.36 117.67 22.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.688 0.756 . . . . 0.0 110.779 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.84 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.761 -1.212 . . . . 0.0 111.889 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -149.51 110.24 4.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.802 -1.186 . . . . 0.0 109.477 -179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -43.99 -17.44 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.638 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -121.52 -21.74 6.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.36 -1.463 . . . . 0.0 112.681 -178.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 17' ' ' THR . . . -151.15 -141.16 3.3 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.144 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.596 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -95.63 -154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 122.086 -0.655 . . . . 0.0 110.479 -179.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -154.88 97.47 1.96 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 111.147 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.9 mm? -90.83 59.81 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.119 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.69 -38.0 3.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' C ' ' SG ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -160.57 149.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.964 . . . . 0.0 109.047 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 48.9 t -39.34 107.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.694 0.759 . . . . 0.0 109.97 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.608 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 1.5 mmt -77.71 -164.08 0.47 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.506 -1.371 . . . . 0.0 108.758 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.37 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.406 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.076 0.465 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 4.3 mmtt -146.09 139.5 26.06 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.249 -0.907 . . . . 0.0 109.981 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 27.3 mm100 -72.17 141.47 49.07 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.283 -0.886 . . . . 0.0 110.016 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.31 136.88 0.61 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.687 -0.633 . . . . 0.0 111.439 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.5 m-20 80.91 10.22 0.99 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.309 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 3' ' ' GLN . 5.7 mm-40 -103.95 143.37 26.51 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.708 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.531 ' HA ' HG13 ' A' ' 23' ' ' VAL . 39.0 Cg_endo -67.07 140.95 55.93 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 124.73 1.911 . . . . 0.0 109.657 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.3 p -160.82 178.06 9.8 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.831 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 95.9 m-20 -101.22 137.87 38.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 0.0 109.872 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 8.7 p -85.49 58.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.511 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.49 -35.07 0.91 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.199 -0.938 . . . . 0.0 110.43 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.05 -80.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -87.53 104.02 16.1 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.813 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.699 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 p30 -160.63 10.62 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.571 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 7.4 t 175.13 106.96 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.967 -1.083 . . . . 0.0 109.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -60.46 -4.26 0.84 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 112.054 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.77 15.02 3.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.576 -1.327 . . . . 0.0 112.692 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.497 ' N ' ' SG ' ' A' ' 15' ' ' CYS . . . 179.09 -130.95 1.61 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 117.915 -2.088 . . . . 0.0 112.296 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.59 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.18 -149.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.827 -0.807 . . . . 0.0 110.106 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.9 t -158.74 78.2 0.77 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.349 -1.469 . . . . 0.0 111.958 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.8 mm? -89.22 47.45 1.49 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.51 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 124.76 -44.81 1.23 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 7' ' ' PRO . 2.8 m -161.9 154.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.82 . . . . 0.0 109.982 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 41.9 t -61.05 99.62 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.033 -1.042 . . . . 0.0 108.862 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.619 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 8.4 mtp -94.33 53.52 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.576 -1.327 . . . . 0.0 113.447 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.619 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.686 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.0 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.051 0.453 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 13.4 mmtt -145.84 144.5 30.28 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.224 -0.922 . . . . 0.0 109.806 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 4' ' ' ALA . 29.2 mm100 -75.07 142.37 43.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.84 128.47 1.2 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.732 -0.605 . . . . 0.0 110.382 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.606 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t0 87.81 19.15 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.139 0.495 . . . . 0.0 110.536 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 23.5 mm-40 -111.41 137.36 21.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.184 -0.947 . . . . 0.0 109.603 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.504 ' HA ' HG13 ' A' ' 23' ' ' VAL . 41.7 Cg_endo -69.81 144.32 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.694 1.365 . . . . 0.0 110.846 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.4 p -160.75 -171.08 2.97 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.569 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.41 145.03 38.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 20' ' ' CYS . 15.5 t -84.96 56.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.23 -37.36 1.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 110.238 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 -79.03 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 111.155 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.2 pp -81.97 109.18 16.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.508 -0.745 . . . . 0.0 111.197 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.677 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -159.98 -12.64 0.05 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.116 -1.034 . . . . 0.0 113.068 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 17' ' ' THR . 50.3 t -173.19 111.98 0.21 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.678 -1.264 . . . . 0.0 110.287 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -56.29 -11.43 1.19 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.488 ' CG2' ' OXT' ' A' ' 26' ' ' TRP . 2.0 t -130.22 0.61 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.785 -1.197 . . . . 0.0 112.393 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -165.59 -152.5 7.17 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.364 -1.874 . . . . 0.0 112.012 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.669 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -97.28 -161.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.122 -0.634 . . . . 0.0 110.857 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.677 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 12.7 t -123.54 80.22 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 111.157 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.1 mp -88.83 55.12 3.24 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' O ' HG12 ' A' ' 23' ' ' VAL . . . 103.75 -43.88 1.59 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -160.86 140.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 5.3 t -41.15 98.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.694 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.7 mtt -76.15 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.725 -1.859 . . . . 0.0 107.43 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.694 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.899 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.72 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.237 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -142.29 143.89 33.02 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.162 -0.961 . . . . 0.0 109.432 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.8 mm-40 -79.18 142.05 36.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.25 127.85 1.36 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.752 -0.593 . . . . 0.0 111.063 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 83.44 19.61 0.2 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 61.8 mm-40 -107.88 154.43 41.04 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.224 -0.922 . . . . 0.0 109.283 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 41.7 Cg_endo -71.25 114.06 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.779 1.41 . . . . 0.0 109.736 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.0 p -132.65 172.16 12.89 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.707 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 12.3 m-20 -91.24 126.25 36.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 109.975 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 10' ' ' VAL . 14.2 p -88.93 61.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 110.074 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 0.8 OUTLIER -149.16 -35.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.025 -1.047 . . . . 0.0 110.56 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.575 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 29.1 t -132.32 -86.79 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -113.73 136.87 52.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.547 -0.721 . . . . 0.0 109.087 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.674 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -162.03 -21.4 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.423 -1.311 . . . . 0.0 113.031 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 25' ' ' MET . 20.7 t -141.23 108.66 5.56 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.359 -1.463 . . . . 0.0 111.106 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.93 -19.08 0.35 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.803 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.561 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -108.88 -26.13 10.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.062 . . . . 0.0 112.312 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.543 ' N ' HG21 ' A' ' 17' ' ' THR . . . -160.57 -104.85 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 117.953 -2.07 . . . . 0.0 112.959 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.524 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -131.51 -164.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -1.076 . . . . 0.0 111.74 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 8.0 t -129.0 73.39 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.502 -0.749 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.8 mm? -88.15 51.71 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 124.32 -44.73 1.25 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 1.8 m -162.91 171.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 49.7 t -45.45 121.05 2.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.95 -1.094 . . . . 0.0 108.399 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.673 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -82.83 171.7 13.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.843 -1.161 . . . . 0.0 110.71 -178.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.673 ' CD2' ' HB3' ' A' ' 25' ' ' MET . 17.4 p90 . . . . . 0 N--CA 1.502 2.156 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.137 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.029 0.442 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -111.66 136.19 51.21 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.7 mm100 -73.09 133.06 44.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.622 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 137.87 0.46 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.698 -0.626 . . . . 0.0 110.635 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.0 t70 87.76 4.84 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.992 0.425 . . . . 0.0 110.127 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -100.22 143.84 27.28 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HA ' HG12 ' A' ' 23' ' ' VAL . 44.4 Cg_endo -73.28 143.67 35.69 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.313 1.691 . . . . 0.0 109.679 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.598 ' CB ' ' HA ' ' A' ' 14' ' ' ASP . 1.7 p -161.2 179.95 7.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.383 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.7 OUTLIER -102.9 144.87 30.65 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 20' ' ' CYS . 23.2 m -83.83 54.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.472 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -127.81 -32.86 2.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.109 -0.995 . . . . 0.0 109.806 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.6 t -161.05 -83.49 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.617 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pt? -79.06 120.17 23.23 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.54 0.686 . . . . 0.0 110.812 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.686 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -38.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.828 -1.17 . . . . 0.0 111.938 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 17' ' ' THR . 44.3 t -151.03 117.23 5.62 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.35 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -8.83 0.53 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 111.411 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -134.22 -0.15 3.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.727 -1.233 . . . . 0.0 113.25 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.08 -110.13 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 116.98 -2.533 . . . . 0.0 113.999 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.64 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -135.07 -152.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.567 -0.96 . . . . 0.0 111.742 -175.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.686 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -145.19 77.63 1.53 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.975 -1.078 . . . . 0.0 111.957 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 21' ' ' LEU . 4.8 mt -90.81 52.52 2.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 114.04 -47.67 1.02 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.604 -2.598 . . . . 0.0 106.604 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 5.9 m -161.04 147.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.856 -0.79 . . . . 0.0 108.915 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 4' ' ' ALA . 3.9 t -52.14 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.812 -1.18 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.575 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 5.8 mtp -82.87 52.03 2.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.968 -1.083 . . . . 0.0 111.823 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CH2' HG13 ' A' ' 19' ' ' ILE . 8.5 m-90 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.998 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.552 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 29.2 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.071 0.462 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -146.24 144.71 30.06 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.155 -0.966 . . . . 0.0 109.923 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 36.7 mm-40 -75.22 142.32 43.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.674 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.52 139.43 0.4 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.653 -0.654 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.0 m-20 84.21 4.97 0.7 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 120.963 0.411 . . . . 0.0 110.247 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 14.0 mm-40 -96.84 137.38 21.37 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 121.037 -1.039 . . . . 0.0 110.059 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HA ' HG12 ' A' ' 23' ' ' VAL . 43.1 Cg_endo -72.11 140.31 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.155 1.608 . . . . 0.0 110.11 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.1 p -161.12 -174.66 4.46 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.727 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -106.52 148.01 28.71 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 20' ' ' CYS . 24.5 m -85.36 56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.085 -1.009 . . . . 0.0 109.453 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.6 -38.36 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.158 -0.964 . . . . 0.0 110.694 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.36 -73.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 111.636 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.4 pp -86.12 107.81 18.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.306 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.628 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -160.78 -18.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.743 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 17' ' ' THR . 35.8 t -173.03 114.53 0.25 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.672 -1.268 . . . . 0.0 110.23 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -57.7 -6.82 0.56 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 112.064 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.472 HG21 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -135.69 3.89 3.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.515 -1.366 . . . . 0.0 112.993 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.76 -132.92 1.43 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 117.321 -2.371 . . . . 0.0 113.025 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.585 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.68 -150.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 122.058 -0.672 . . . . 0.0 110.902 -177.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.628 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 32.1 t -148.09 76.94 1.39 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.587 -1.321 . . . . 0.0 111.482 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -88.47 51.53 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.513 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.44 -45.28 1.31 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 4.3 m -161.8 158.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.998 -0.707 . . . . 0.0 109.459 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 12.4 t -61.37 101.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 108.658 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.63 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -95.36 50.58 1.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.716 -1.24 . . . . 0.0 113.673 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.855 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.554 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.4 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.969 0.414 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -144.23 147.19 33.27 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 5.8 mm-40 -76.27 137.92 40.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.186 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.611 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.74 121.57 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 111.138 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 11.3 t0 89.2 23.25 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.078 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mt-10 -112.51 157.63 39.66 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.389 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.6 Cg_endo -69.66 141.86 46.81 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.778 1.41 . . . . 0.0 109.513 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.6 p -155.83 174.85 14.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.88 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 1.1 m-20 -102.91 137.63 40.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -83.65 55.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.295 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -141.57 -34.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.864 -1.148 . . . . 0.0 110.971 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.83 -80.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.079 . . . . 0.0 110.735 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -79.53 116.15 19.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 109.88 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.723 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.11 -23.61 0.06 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.771 -1.172 . . . . 0.0 112.618 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -164.21 117.16 1.38 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.056 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -54.32 -10.38 0.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 111.331 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -132.2 2.49 3.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.739 -1.225 . . . . 0.0 112.315 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 26' ' ' TRP . . . -166.49 -146.36 4.81 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 117.943 -2.075 . . . . 0.0 112.772 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.618 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -103.39 -156.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 122.222 -0.576 . . . . 0.0 110.745 -178.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.5 t -132.1 75.01 1.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.634 -1.291 . . . . 0.0 110.833 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 21' ' ' LEU . 6.5 mt -88.48 51.77 2.27 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 117.78 -49.63 0.85 Allowed Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.0 m -161.96 150.05 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.866 -0.785 . . . . 0.0 109.048 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 4.8 t -43.49 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.722 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 3.1 mmm -78.05 -161.76 0.28 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 119.818 -1.802 . . . . 0.0 107.087 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.722 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.0 0.428 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -140.25 158.05 44.63 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.952 -1.093 . . . . 0.0 110.133 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.3 mm-40 -88.28 139.86 30.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.626 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.99 120.49 0.86 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.647 . . . . 0.0 111.015 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t70 92.01 19.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.74 0.416 . . . . 0.0 111.755 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HB3' ' CG ' ' A' ' 2' ' ' LYS . 1.4 mp0 -110.67 152.08 43.23 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 120.747 -1.221 . . . . 0.0 109.359 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.504 ' HA ' HG13 ' A' ' 23' ' ' VAL . 40.5 Cg_endo -68.78 141.85 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.757 1.398 . . . . 0.0 110.465 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.672 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 6.1 p -158.22 178.66 9.94 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.238 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -103.52 145.74 29.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.211 0.529 . . . . 0.0 109.662 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 20' ' ' CYS . 3.5 t -86.15 54.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.78 -41.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.773 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.61 -76.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 111.557 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.508 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -78.94 105.77 10.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.733 -0.605 . . . . 0.0 110.703 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.672 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 2.9 p30 -161.04 -24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.874 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' A' ' 17' ' ' THR . 11.8 t -161.28 109.79 1.54 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.872 -1.143 . . . . 0.0 110.211 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.556 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.44 -11.81 2.18 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.665 -0.647 . . . . 0.0 110.855 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 26' ' ' TRP . 3.4 t -120.98 -7.66 9.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 112.128 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.88 -139.27 2.59 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.525 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.61 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -105.64 -149.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.123 -0.634 . . . . 0.0 110.669 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 49.2 t -139.65 77.06 1.59 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.426 -1.421 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.6 mm? -86.89 48.57 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.59 -43.89 1.56 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.3 m -161.67 146.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.811 -0.817 . . . . 0.0 109.482 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 39.1 t -41.54 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.641 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 4.8 mmm -78.42 -164.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 119.969 -1.707 . . . . 0.0 107.39 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.619 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.757 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.539 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.042 0.448 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -134.58 145.16 48.41 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.961 -1.087 . . . . 0.0 110.531 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.7 mm100 -81.27 135.47 35.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 109.653 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.75 128.04 1.54 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 111.341 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t0 83.76 15.2 0.29 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.252 0.549 . . . . 0.0 110.397 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 60.9 mm-40 -104.37 145.23 30.28 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.537 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HA ' HG11 ' A' ' 23' ' ' VAL . 39.9 Cg_endo -67.32 133.9 31.87 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.555 1.818 . . . . 0.0 109.417 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -160.59 169.86 22.05 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.241 -178.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 7.7 m-20 -96.06 142.25 28.48 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 7.9 p -85.66 59.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 0.0 109.385 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -24.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.203 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 31.2 t -161.0 -87.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.65 -1.281 . . . . 0.0 110.25 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -79.61 93.4 5.48 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -135.99 -17.83 1.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.584 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 17' ' ' THR . 40.9 t -176.69 106.64 0.07 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.921 -1.112 . . . . 0.0 109.809 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -40.83 -21.17 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.889 -0.507 . . . . 0.0 111.935 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.595 ' CG2' ' CB ' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -111.04 -24.41 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.742 -1.224 . . . . 0.0 112.98 -178.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' N ' HG22 ' A' ' 17' ' ' THR . . . -152.7 -111.03 0.45 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 117.98 -2.057 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.577 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -124.59 -152.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.81 -0.818 . . . . 0.0 110.904 -176.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.8 t -157.7 88.39 0.98 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.089 -1.007 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -88.17 51.99 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.548 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 123.01 -42.75 1.55 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.263 -2.735 . . . . 0.0 106.263 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 21.4 m -160.72 158.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 1.7 t -63.94 94.63 0.1 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.952 -1.093 . . . . 0.0 109.368 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.3 mtp -86.47 52.8 2.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.76 -1.212 . . . . 0.0 110.719 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.599 ' CG ' ' O ' ' A' ' 25' ' ' MET . 15.0 m-90 . . . . . 0 C--N 1.295 -1.783 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.407 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 16' ' ' CYS . 19.6 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' ASP . 22.2 mmtt -149.27 161.2 42.51 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.804 -1.185 . . . . 0.0 109.951 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -97.25 142.13 29.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.389 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.09 121.48 0.8 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 111.467 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 85.59 26.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.122 -0.361 . . . . 0.0 111.771 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -114.65 162.04 25.69 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.695 -1.253 . . . . 0.0 109.956 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 40.3 Cg_endo -69.22 117.22 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.818 1.431 . . . . 0.0 109.606 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.591 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.9 p -124.42 168.47 12.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 111.96 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.23 119.33 27.36 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.589 HG23 ' CE2' ' A' ' 11' ' ' PHE . 11.2 m -86.08 52.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.591 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.589 ' CE2' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.6 -36.06 0.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.774 -1.204 . . . . 0.0 110.929 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.18 -82.94 0.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.123 -0.986 . . . . 0.0 110.605 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.3 pt? -106.02 152.56 23.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.5 -0.75 . . . . 0.0 110.386 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.697 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -161.99 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.131 -0.98 . . . . 0.0 111.37 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 1.1 t -81.31 134.28 35.56 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.743 0.782 . . . . 0.0 110.333 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 1' ' ' CYS . 60.0 m -51.74 -12.96 0.22 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.701 -0.625 . . . . 0.0 112.201 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.63 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -134.07 -1.57 2.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.437 -1.414 . . . . 0.0 113.234 -178.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.31 -109.59 0.31 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 116.748 -2.644 . . . . 0.0 114.105 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.521 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.64 -161.82 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.752 0.786 . . . . 0.0 111.831 -175.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.697 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 44.4 t -135.55 80.27 1.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.663 . . . . 0.0 110.379 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 6.1 mp -88.75 52.27 2.38 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.51 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.27 -43.75 1.6 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.21 157.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.731 -0.864 . . . . 0.0 109.858 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 2' ' ' LYS . 37.8 t -39.83 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.7 . . . . 0.0 109.564 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.615 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -78.2 -162.46 0.34 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.296 -1.503 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.389 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.05 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 16' ' ' CYS . 27.9 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.282 0.563 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.8 mmtm -155.37 166.83 32.35 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.286 -0.884 . . . . 0.0 109.234 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -102.21 143.8 31.54 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.01 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.608 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.54 119.46 0.62 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.83 -0.544 . . . . 0.0 110.891 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.7 t0 88.15 27.26 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -112.93 159.87 32.95 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.429 -1.419 . . . . 0.0 110.632 178.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 43.3 Cg_endo -70.63 109.33 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.545 1.287 . . . . 0.0 109.942 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.1 p -128.24 170.0 13.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.38 124.62 34.62 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.293 0.568 . . . . 0.0 109.66 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 10' ' ' VAL . 7.7 p -90.45 58.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.871 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -147.76 -34.08 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.187 . . . . 0.0 110.994 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.62 -76.81 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.9 pt? -122.48 153.59 38.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.632 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -161.6 -85.51 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.349 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -76.19 134.97 39.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.563 0.697 . . . . 0.0 109.464 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -49.24 -12.75 0.06 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.662 -0.649 . . . . 0.0 112.106 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.565 HG21 ' CD1' ' A' ' 26' ' ' TRP . 1.2 t -145.83 40.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.457 -1.402 . . . . 0.0 113.007 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . 171.24 -110.06 0.34 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 117.357 -2.354 . . . . 0.0 113.671 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.524 HD11 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -137.31 -164.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.128 -1.219 . . . . 0.0 112.33 -175.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.632 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 23.2 t -131.67 76.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 109.793 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 6.4 mp -86.97 63.32 7.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 108.84 -43.75 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 106.876 -2.489 . . . . 0.0 106.876 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 5' ' ' ASP . 13.7 m -161.49 -176.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 4.7 t -47.48 120.35 3.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.617 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -78.31 -169.09 1.51 Allowed 'General case' 0 C--N 1.288 -2.079 0 O-C-N 119.976 -1.702 . . . . 0.0 108.903 -178.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 25' ' ' MET . 1.4 m95 . . . . . 0 C--N 1.283 -2.295 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 12.3 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.908 0.385 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -147.91 154.24 40.12 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.995 -1.066 . . . . 0.0 110.092 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -86.25 139.51 30.96 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.728 179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.63 119.94 0.77 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.381 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 23.0 t0 90.87 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 122.782 0.433 . . . . 0.0 111.416 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -117.57 156.23 49.57 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.977 -1.077 . . . . 0.0 109.151 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 42.8 Cg_endo -70.49 123.41 9.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.769 1.405 . . . . 0.0 110.43 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.624 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.8 p -134.96 172.56 12.83 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.11 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 20.1 t0 -79.41 124.72 28.71 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.499 0.666 . . . . 0.0 110.215 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 20' ' ' CYS . 3.9 m -90.53 57.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -158.1 -28.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.779 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.96 -83.48 0.31 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.914 -1.116 . . . . 0.0 110.033 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.509 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.3 pt? -110.65 148.39 32.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.972 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.669 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.27 -86.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.004 -1.06 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -77.49 125.35 29.19 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.425 0.631 . . . . 0.0 111.015 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.85 -10.75 1.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.536 -0.728 . . . . 0.0 110.846 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.468 HG23 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -127.93 -5.42 5.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.0 112.219 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.5 -142.72 3.47 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.203 -1.951 . . . . 0.0 112.123 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.62 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -102.21 -149.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.224 -0.574 . . . . 0.0 109.765 -179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.669 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 46.4 t -153.83 81.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.295 -1.503 . . . . 0.0 111.688 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.3 mm? -89.85 43.74 1.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.503 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 130.25 -46.43 1.08 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m -160.7 146.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.5 -1.0 . . . . 0.0 109.734 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 2.0 t -45.61 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 110.482 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.636 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 2.7 mmt -78.01 -162.97 0.37 Allowed 'General case' 0 C--N 1.292 -1.907 0 O-C-N 120.172 -1.58 . . . . 0.0 106.88 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.636 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.662 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.532 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.3 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.188 0.518 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -160.22 143.21 13.56 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.8 143.18 49.61 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.525 0.679 . . . . 0.0 111.052 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.13 134.88 1.02 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.576 -0.703 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.4 m-20 84.77 4.77 0.62 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.021 -0.424 . . . . 0.0 110.844 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CG ' ' HG2' ' A' ' 2' ' ' LYS . 13.1 tp10 -96.16 143.07 25.48 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 120.901 -1.124 . . . . 0.0 109.076 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 38.8 Cg_endo -68.25 141.57 52.44 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.651 1.342 . . . . 0.0 110.014 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 p -160.81 -168.92 2.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.334 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.16 133.94 52.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' CA ' ' HB3' ' A' ' 20' ' ' CYS . 6.3 p -85.81 60.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.123 -0.986 . . . . 0.0 110.202 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -139.0 -40.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.89 -77.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.327 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -119.21 132.35 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 110.121 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.651 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.84 -34.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.5 t -144.63 114.43 7.28 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.247 -0.908 . . . . 0.0 109.285 -178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.532 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -50.75 -13.0 0.12 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.518 -0.738 . . . . 0.0 111.874 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' OXT' ' A' ' 26' ' ' TRP . 1.3 t -135.95 11.61 3.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.442 -1.411 . . . . 0.0 112.53 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.563 ' HA3' ' CZ3' ' A' ' 26' ' ' TRP . . . -171.03 -164.11 26.19 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.266 -1.921 . . . . 0.0 111.996 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -84.68 -160.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 122.108 -0.642 . . . . 0.0 111.125 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 42.7 t -135.33 82.32 1.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.013 -1.055 . . . . 0.0 110.656 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -88.35 48.07 1.59 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 117.72 -41.25 2.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.4 143.4 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.855 . . . . 0.0 109.796 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 12.9 t -39.79 108.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.684 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 2.8 mmt -83.4 -166.69 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.232 -1.543 . . . . 0.0 108.223 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.715 ' CH2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.836 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 25.4 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 14' ' ' ASP . 18.0 mmtt -153.87 154.91 34.75 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.992 -1.067 . . . . 0.0 110.006 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 4' ' ' ALA . 8.9 mm-40 -86.49 144.92 27.02 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.155 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.556 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.23 129.35 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.735 -0.603 . . . . 0.0 110.718 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.1 t70 79.97 26.05 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.736 -0.603 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.524 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 1.7 mm-40 -107.03 143.35 26.92 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.01 112.1 3.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.611 1.322 . . . . 0.0 109.943 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -124.74 168.19 13.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.493 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 15.6 m-20 -97.62 134.03 41.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.6 -0.688 . . . . 0.0 110.026 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 33.8 m -85.42 57.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 10' ' ' VAL . 13.9 m-85 -133.66 -24.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 111.105 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.16 -73.17 0.07 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.925 -1.109 . . . . 0.0 110.998 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.9 pt? -110.35 147.36 34.1 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.802 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.719 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.96 -85.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 111.161 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 2.8 t -86.29 126.2 34.14 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.924 0.868 . . . . 0.0 110.529 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 61.6 m -47.6 -14.56 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.645 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -131.7 -11.6 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.33 -1.482 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.13 -128.41 1.77 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.575 -2.25 . . . . 0.0 113.109 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -110.37 -166.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.603 0.716 . . . . 0.0 111.6 -176.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.9 t -131.75 75.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.643 -0.661 . . . . 0.0 110.575 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.55 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.0 mt -88.29 62.43 6.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 111.82 -45.01 1.38 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 6.1 m -161.22 179.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 50.9 t -65.21 103.74 0.82 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 108.772 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.606 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.5 -163.29 0.31 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 120.339 -1.476 . . . . 0.0 108.593 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.645 ' CD1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.369 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.702 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 29.7 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.864 0.364 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtp -153.21 144.12 22.87 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.088 -1.007 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 18.8 mm100 -69.92 140.64 53.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 5' ' ' ASP . . . -38.93 143.15 0.17 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.44 -0.787 . . . . 0.0 111.619 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER 72.93 9.52 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.044 0.45 . . . . 0.0 110.582 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 10.8 tt0 -106.2 146.74 33.56 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.77 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 37.4 Cg_endo -64.04 132.38 34.19 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.375 1.197 . . . . 0.0 110.52 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.7 p -144.2 177.63 8.46 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.264 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -79.4 121.84 25.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.499 -0.751 . . . . 0.0 110.671 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 20' ' ' CYS . 11.7 m -90.98 62.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.605 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.69 -32.42 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.296 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.0 -86.32 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -110.72 142.34 42.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.141 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.655 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -164.24 -62.27 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.439 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 25' ' ' MET . 19.8 t -87.19 113.02 22.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.643 0.735 . . . . 0.0 111.064 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 2' ' ' LYS . 67.7 m -44.53 -19.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.841 -0.537 . . . . 0.0 111.442 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.613 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -129.99 -12.22 4.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.764 -1.21 . . . . 0.0 112.922 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 15' ' ' CYS . . . -149.51 -122.14 1.14 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.009 -2.043 . . . . 0.0 112.276 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.581 ' N ' ' CD1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -121.75 -176.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.895 . . . . 0.0 110.751 -178.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 22.6 t -129.7 76.04 1.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.293 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' CE ' ' A' ' 25' ' ' MET . 4.2 mm? -92.19 45.2 1.2 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.54 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 136.01 -44.72 1.14 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.05 163.17 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.985 -0.715 . . . . 0.0 109.393 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 42.6 t -47.94 121.28 4.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.869 -1.145 . . . . 0.0 108.441 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.607 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -87.13 135.7 33.2 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 111.009 -178.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.613 ' CD1' HG22 ' A' ' 17' ' ' THR . 4.8 p90 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.001 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 16' ' ' CYS . 27.5 p . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.141 0.496 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -150.96 132.86 15.08 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.219 -0.926 . . . . 0.0 110.227 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.87 137.89 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.28 140.12 0.46 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.539 -0.726 . . . . 0.0 111.547 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 5.1 m-20 81.65 5.3 1.27 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.042 0.449 . . . . 0.0 110.756 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mm-40 -107.55 149.44 38.87 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.45 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.1 Cg_endo -69.43 130.56 19.97 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.94 1.495 . . . . 0.0 110.651 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -139.5 177.37 7.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.702 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.96 114.57 22.97 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.672 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' CA ' ' HB3' ' A' ' 20' ' ' CYS . 10.6 p -85.11 56.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -143.84 -37.47 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -75.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.968 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -123.44 153.03 41.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.658 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.85 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.308 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 6.4 t -73.66 118.1 16.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.866 -0.521 . . . . 0.0 109.875 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -38.76 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.674 -0.641 . . . . 0.0 111.336 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.63 ' CG2' ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.66 -13.6 2.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.845 -1.159 . . . . 0.0 111.808 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.525 ' HA3' ' CE2' ' A' ' 26' ' ' TRP . . . -121.3 -127.13 3.37 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.431 -1.842 . . . . 0.0 112.654 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.511 ' CD1' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -137.33 -175.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.747 -0.854 . . . . 0.0 110.447 -177.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.1 t -117.44 59.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.057 -1.027 . . . . 0.0 110.793 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.47 ' N ' HD13 ' A' ' 21' ' ' LEU . 4.8 mp -88.71 49.6 1.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 131.48 -54.81 0.78 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 106.384 -2.686 . . . . 0.0 106.384 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 4.1 m -161.73 165.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 8.6 t -46.51 116.48 1.31 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.994 -1.066 . . . . 0.0 108.294 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TRP . 3.7 mtp -81.95 139.25 34.7 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.446 -0.784 . . . . 0.0 110.203 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CD1' ' CG2' ' A' ' 17' ' ' THR . 4.9 p90 . . . . . 0 C--N 1.291 -1.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.6 p . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' ASP . 1.6 mmtp -146.14 142.99 29.02 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 120.802 -1.186 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.2 mp0 -81.04 148.85 29.5 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.416 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.86 133.83 0.56 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.052 0.453 . . . . 0.0 111.121 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.7 t0 82.04 18.38 0.37 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.241 0.544 . . . . 0.0 110.027 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 52.7 mm-40 -106.76 136.88 19.37 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HA ' HG12 ' A' ' 23' ' ' VAL . 44.5 Cg_endo -73.02 137.92 27.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 111.005 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 1.2 p -160.36 177.37 10.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 110.882 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.41 131.5 34.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 109.566 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 7.6 p -89.55 59.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -141.18 -36.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 110.637 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.64 -74.57 0.45 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.663 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.7 pt? -114.39 147.8 38.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 111.218 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.643 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -162.6 -86.52 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.145 178.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.1 t -93.84 140.56 29.53 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.571 0.701 . . . . 0.0 110.67 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.71 -2.4 0.14 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.617 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -131.52 -8.1 3.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.289 -1.507 . . . . 0.0 113.343 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.67 -110.9 0.25 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 116.832 -2.604 . . . . 0.0 114.002 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.627 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -127.55 -150.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.625 -0.927 . . . . 0.0 111.874 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.643 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 t -148.83 76.09 1.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 111.537 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.5 mp -88.32 64.33 7.54 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 105.82 -52.08 0.72 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 106.023 -2.831 . . . . 0.0 106.023 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.3 m -162.11 159.28 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 26.1 t -43.78 115.0 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.949 -1.094 . . . . 0.0 109.917 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.576 ' O ' ' CE3' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -95.05 38.33 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 110.646 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.627 ' CZ2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.99 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.3 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 19.1 mmtt -144.06 144.3 31.56 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.183 -0.948 . . . . 0.0 110.069 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.2 mm-40 -72.11 140.97 49.16 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.02 127.8 1.64 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.611 -0.68 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 8.5 t70 88.49 17.91 0.06 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 120.979 0.419 . . . . 0.0 110.869 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -106.83 147.56 35.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.023 -1.048 . . . . 0.0 109.719 179.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' HA ' HG12 ' A' ' 23' ' ' VAL . 39.4 Cg_endo -68.28 137.03 38.99 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 124.463 1.77 . . . . 0.0 109.727 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.698 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 5.8 p -161.79 -178.56 6.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.361 -1.335 . . . . 0.0 112.677 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -110.67 145.27 38.26 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.476 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 20' ' ' CYS . 74.7 t -85.88 57.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 109.447 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -130.45 -38.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.117 -0.989 . . . . 0.0 109.963 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.81 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -82.9 102.62 11.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.701 -0.624 . . . . 0.0 111.084 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.728 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 23.3 p30 -160.18 -3.5 0.06 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.243 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 11.5 t 178.14 106.33 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.632 -1.292 . . . . 0.0 109.63 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -59.22 -3.09 0.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 112.352 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.568 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.1 t -128.48 1.76 5.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 112.841 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.47 -125.07 0.83 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 117.687 -2.197 . . . . 0.0 112.645 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.565 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -111.32 -143.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.805 -0.82 . . . . 0.0 110.6 -177.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.728 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 37.1 t -159.81 70.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.84 -1.163 . . . . 0.0 111.332 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.2 mm? -85.81 62.47 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.518 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 110.24 -48.77 0.9 Allowed Glycine 0 N--CA 1.483 1.821 0 N-CA-C 106.471 -2.651 . . . . 0.0 106.471 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 7' ' ' PRO . 3.1 m -162.08 159.86 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.933 -0.745 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 42.8 t -56.73 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.094 -1.004 . . . . 0.0 109.061 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.583 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 7.1 mtp -84.9 52.97 2.56 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.026 -1.046 . . . . 0.0 112.962 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.583 ' CG ' ' C ' ' A' ' 25' ' ' MET . 6.0 m-90 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.099 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 11.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.957 0.408 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtt -137.34 167.17 22.14 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 120.832 -1.168 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.1 mm-40 -95.49 137.53 34.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.059 -1.025 . . . . 0.0 109.616 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 116.64 0.52 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.649 -0.657 . . . . 0.0 110.79 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 18.4 t70 92.24 20.83 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 122.744 0.417 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.6 mt-10 -107.02 161.77 21.83 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.58 138.04 37.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.805 1.424 . . . . 0.0 109.416 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.627 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 11.7 p -150.86 177.82 9.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.161 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -120.82 146.33 46.65 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.999 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.48 56.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.913 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -136.46 -42.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 110.811 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -76.16 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.005 -1.059 . . . . 0.0 111.044 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.8 pp -78.68 111.28 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.685 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.652 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -160.7 -17.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.691 -1.203 . . . . 0.0 113.298 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 12.4 t -172.5 119.23 0.38 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.773 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 40.4 m -60.69 -6.78 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 111.1 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 26' ' ' TRP . 1.6 t -133.07 0.94 3.49 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.856 -1.152 . . . . 0.0 112.266 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.96 -140.17 2.81 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.747 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.616 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -107.38 -147.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 122.341 -0.505 . . . . 0.0 110.304 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.652 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 51.5 t -135.31 83.14 2.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.349 -1.469 . . . . 0.0 111.12 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD22 ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -87.8 51.2 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.524 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 107.28 -41.04 2.3 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 4.5 m -161.04 148.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.949 -0.736 . . . . 0.0 109.142 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 15.3 t -41.11 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.64 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 5.4 mmt -79.49 -165.2 0.75 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 119.896 -1.752 . . . . 0.0 107.826 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CZ2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.503 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.768 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 31.5 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.103 0.477 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 14' ' ' ASP . 7.9 mmtt -153.13 158.24 41.55 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.441 -0.787 . . . . 0.0 108.924 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 26.3 mm-40 -91.89 145.84 24.23 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.01 120.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.838 -0.539 . . . . 0.0 110.428 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.1 t0 86.94 30.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.08 0.467 . . . . 0.0 110.871 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 6.9 mm-40 -114.67 154.61 46.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.081 -1.012 . . . . 0.0 110.069 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.85 120.39 6.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.643 1.339 . . . . 0.0 110.041 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.3 p -140.05 171.56 14.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.077 -1.015 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.58 124.59 48.4 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG12 ' CE1' ' A' ' 11' ' ' PHE . 9.2 p -85.16 54.19 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.041 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.578 ' CE1' HG12 ' A' ' 10' ' ' VAL . 54.3 m-85 -132.0 -17.62 2.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.175 -0.953 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.05 -54.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.929 -1.107 . . . . 0.0 110.875 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.3 pt? -136.82 144.38 43.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.81 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.631 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.94 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' MET . 0.8 OUTLIER -78.72 123.68 27.41 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.681 0.753 . . . . 0.0 109.755 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.69 -20.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.599 -0.688 . . . . 0.0 112.107 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -143.27 14.22 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.488 -1.382 . . . . 0.0 112.226 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -149.81 -126.44 1.43 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.624 -2.227 . . . . 0.0 113.027 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.587 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -130.2 178.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.491 0.662 . . . . 0.0 110.838 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -116.65 65.36 0.71 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 109.557 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 1.9 mt -87.39 62.69 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.26 -50.81 0.76 Allowed Glycine 0 N--CA 1.481 1.658 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.7 m -162.86 -175.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.476 ' HB3' ' CA ' ' A' ' 4' ' ' ALA . 12.1 t -49.85 125.35 11.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.544 ' O ' ' CB ' ' A' ' 26' ' ' TRP . 36.4 mmm -77.16 -174.91 3.4 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 120.242 -1.536 . . . . 0.0 109.301 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.605 ' CD1' HG21 ' A' ' 17' ' ' THR . 1.1 m95 . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.237 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.7 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.015 0.436 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -145.25 156.06 43.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.013 -1.054 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.0 mm100 -88.25 138.35 31.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 109.406 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.56 128.0 1.1 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.452 -0.78 . . . . 0.0 111.184 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 3.3 t0 83.3 19.53 0.21 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.041 -0.412 . . . . 0.0 111.143 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -109.13 165.49 12.54 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 120.866 -1.146 . . . . 0.0 109.697 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 40.1 Cg_endo -70.04 136.75 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.913 1.481 . . . . 0.0 109.618 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 19.2 p -148.81 -170.55 3.65 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.784 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 1.8 m-20 -122.34 131.03 53.7 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.22 55.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.121 -0.987 . . . . 0.0 110.838 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -144.5 -27.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 0.0 111.088 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.557 ' N ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -161.55 -86.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.936 -1.102 . . . . 0.0 110.811 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pp -82.36 117.67 22.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.688 0.756 . . . . 0.0 110.779 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.84 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.761 -1.212 . . . . 0.0 111.889 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -149.51 110.24 4.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.802 -1.186 . . . . 0.0 109.477 -179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -43.99 -17.44 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.638 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -121.52 -21.74 6.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.36 -1.463 . . . . 0.0 112.681 -178.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 17' ' ' THR . . . -151.15 -141.16 3.3 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.144 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.596 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -95.63 -154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 122.086 -0.655 . . . . 0.0 110.479 -179.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -154.88 97.47 1.96 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 111.147 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.9 mm? -90.83 59.81 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.119 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.69 -38.0 3.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' C ' ' SG ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -160.57 149.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.964 . . . . 0.0 109.047 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 48.9 t -39.34 107.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.694 0.759 . . . . 0.0 109.97 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.608 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 1.5 mmt -77.71 -164.08 0.47 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.506 -1.371 . . . . 0.0 108.758 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.37 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.406 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.076 0.465 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 4.3 mmtt -146.09 139.5 26.06 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.249 -0.907 . . . . 0.0 109.981 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 27.3 mm100 -72.17 141.47 49.07 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.283 -0.886 . . . . 0.0 110.016 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.31 136.88 0.61 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.687 -0.633 . . . . 0.0 111.439 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.5 m-20 80.91 10.22 0.99 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.309 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 3' ' ' GLN . 5.7 mm-40 -103.95 143.37 26.51 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.708 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.531 ' HA ' HG13 ' A' ' 23' ' ' VAL . 39.0 Cg_endo -67.07 140.95 55.93 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 124.73 1.911 . . . . 0.0 109.657 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.3 p -160.82 178.06 9.8 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.831 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 95.9 m-20 -101.22 137.87 38.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 0.0 109.872 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 8.7 p -85.49 58.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.511 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.49 -35.07 0.91 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.199 -0.938 . . . . 0.0 110.43 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.05 -80.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -87.53 104.02 16.1 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.813 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.699 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 p30 -160.63 10.62 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.571 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 7.4 t 175.13 106.96 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.967 -1.083 . . . . 0.0 109.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -60.46 -4.26 0.84 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 112.054 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.77 15.02 3.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.576 -1.327 . . . . 0.0 112.692 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.497 ' N ' ' SG ' ' A' ' 15' ' ' CYS . . . 179.09 -130.95 1.61 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 117.915 -2.088 . . . . 0.0 112.296 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.59 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.18 -149.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.827 -0.807 . . . . 0.0 110.106 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.9 t -158.74 78.2 0.77 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.349 -1.469 . . . . 0.0 111.958 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.8 mm? -89.22 47.45 1.49 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.51 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 124.76 -44.81 1.23 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 7' ' ' PRO . 2.8 m -161.9 154.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.82 . . . . 0.0 109.982 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 41.9 t -61.05 99.62 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.033 -1.042 . . . . 0.0 108.862 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.619 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 8.4 mtp -94.33 53.52 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.576 -1.327 . . . . 0.0 113.447 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.619 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.686 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.0 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.051 0.453 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 13.4 mmtt -145.84 144.5 30.28 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.224 -0.922 . . . . 0.0 109.806 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 4' ' ' ALA . 29.2 mm100 -75.07 142.37 43.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.84 128.47 1.2 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.732 -0.605 . . . . 0.0 110.382 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.606 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t0 87.81 19.15 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.139 0.495 . . . . 0.0 110.536 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 23.5 mm-40 -111.41 137.36 21.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.184 -0.947 . . . . 0.0 109.603 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.504 ' HA ' HG13 ' A' ' 23' ' ' VAL . 41.7 Cg_endo -69.81 144.32 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.694 1.365 . . . . 0.0 110.846 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.4 p -160.75 -171.08 2.97 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.569 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.41 145.03 38.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 20' ' ' CYS . 15.5 t -84.96 56.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.23 -37.36 1.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 110.238 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 -79.03 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 111.155 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.2 pp -81.97 109.18 16.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.508 -0.745 . . . . 0.0 111.197 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.677 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -159.98 -12.64 0.05 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.116 -1.034 . . . . 0.0 113.068 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 17' ' ' THR . 50.3 t -173.19 111.98 0.21 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.678 -1.264 . . . . 0.0 110.287 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -56.29 -11.43 1.19 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.488 ' CG2' ' OXT' ' A' ' 26' ' ' TRP . 2.0 t -130.22 0.61 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.785 -1.197 . . . . 0.0 112.393 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -165.59 -152.5 7.17 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.364 -1.874 . . . . 0.0 112.012 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.669 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -97.28 -161.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.122 -0.634 . . . . 0.0 110.857 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.677 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 12.7 t -123.54 80.22 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 111.157 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.1 mp -88.83 55.12 3.24 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' O ' HG12 ' A' ' 23' ' ' VAL . . . 103.75 -43.88 1.59 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -160.86 140.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 5.3 t -41.15 98.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.694 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.7 mtt -76.15 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.725 -1.859 . . . . 0.0 107.43 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.694 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.899 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.72 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.237 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -142.29 143.89 33.02 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.162 -0.961 . . . . 0.0 109.432 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.8 mm-40 -79.18 142.05 36.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.25 127.85 1.36 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.752 -0.593 . . . . 0.0 111.063 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 83.44 19.61 0.2 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 61.8 mm-40 -107.88 154.43 41.04 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.224 -0.922 . . . . 0.0 109.283 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 41.7 Cg_endo -71.25 114.06 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.779 1.41 . . . . 0.0 109.736 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.0 p -132.65 172.16 12.89 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.707 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 12.3 m-20 -91.24 126.25 36.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 109.975 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 10' ' ' VAL . 14.2 p -88.93 61.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 110.074 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 0.8 OUTLIER -149.16 -35.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.025 -1.047 . . . . 0.0 110.56 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.575 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 29.1 t -132.32 -86.79 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -113.73 136.87 52.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.547 -0.721 . . . . 0.0 109.087 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.674 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -162.03 -21.4 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.423 -1.311 . . . . 0.0 113.031 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 25' ' ' MET . 20.7 t -141.23 108.66 5.56 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.359 -1.463 . . . . 0.0 111.106 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.93 -19.08 0.35 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.803 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.561 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -108.88 -26.13 10.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.062 . . . . 0.0 112.312 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.543 ' N ' HG21 ' A' ' 17' ' ' THR . . . -160.57 -104.85 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 117.953 -2.07 . . . . 0.0 112.959 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.524 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -131.51 -164.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -1.076 . . . . 0.0 111.74 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 8.0 t -129.0 73.39 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.502 -0.749 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.8 mm? -88.15 51.71 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 124.32 -44.73 1.25 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 1.8 m -162.91 171.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 49.7 t -45.45 121.05 2.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.95 -1.094 . . . . 0.0 108.399 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.673 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -82.83 171.7 13.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.843 -1.161 . . . . 0.0 110.71 -178.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.673 ' CD2' ' HB3' ' A' ' 25' ' ' MET . 17.4 p90 . . . . . 0 N--CA 1.502 2.156 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.137 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.029 0.442 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -111.66 136.19 51.21 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.7 mm100 -73.09 133.06 44.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.622 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 137.87 0.46 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.698 -0.626 . . . . 0.0 110.635 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.0 t70 87.76 4.84 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.992 0.425 . . . . 0.0 110.127 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -100.22 143.84 27.28 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HA ' HG12 ' A' ' 23' ' ' VAL . 44.4 Cg_endo -73.28 143.67 35.69 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.313 1.691 . . . . 0.0 109.679 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.598 ' CB ' ' HA ' ' A' ' 14' ' ' ASP . 1.7 p -161.2 179.95 7.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.383 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.7 OUTLIER -102.9 144.87 30.65 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 20' ' ' CYS . 23.2 m -83.83 54.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.472 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -127.81 -32.86 2.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.109 -0.995 . . . . 0.0 109.806 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.6 t -161.05 -83.49 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.617 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pt? -79.06 120.17 23.23 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.54 0.686 . . . . 0.0 110.812 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.686 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -38.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.828 -1.17 . . . . 0.0 111.938 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 17' ' ' THR . 44.3 t -151.03 117.23 5.62 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.35 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -8.83 0.53 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 111.411 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -134.22 -0.15 3.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.727 -1.233 . . . . 0.0 113.25 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.08 -110.13 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 116.98 -2.533 . . . . 0.0 113.999 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.64 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -135.07 -152.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.567 -0.96 . . . . 0.0 111.742 -175.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.686 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -145.19 77.63 1.53 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.975 -1.078 . . . . 0.0 111.957 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 21' ' ' LEU . 4.8 mt -90.81 52.52 2.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 114.04 -47.67 1.02 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.604 -2.598 . . . . 0.0 106.604 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 5.9 m -161.04 147.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.856 -0.79 . . . . 0.0 108.915 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 4' ' ' ALA . 3.9 t -52.14 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.812 -1.18 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.575 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 5.8 mtp -82.87 52.03 2.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.968 -1.083 . . . . 0.0 111.823 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CH2' HG13 ' A' ' 19' ' ' ILE . 8.5 m-90 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.998 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.552 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 29.2 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.071 0.462 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -146.24 144.71 30.06 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.155 -0.966 . . . . 0.0 109.923 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 36.7 mm-40 -75.22 142.32 43.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.674 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.52 139.43 0.4 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.653 -0.654 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.0 m-20 84.21 4.97 0.7 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 120.963 0.411 . . . . 0.0 110.247 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 14.0 mm-40 -96.84 137.38 21.37 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 121.037 -1.039 . . . . 0.0 110.059 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HA ' HG12 ' A' ' 23' ' ' VAL . 43.1 Cg_endo -72.11 140.31 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.155 1.608 . . . . 0.0 110.11 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.1 p -161.12 -174.66 4.46 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.727 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -106.52 148.01 28.71 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 20' ' ' CYS . 24.5 m -85.36 56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.085 -1.009 . . . . 0.0 109.453 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.6 -38.36 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.158 -0.964 . . . . 0.0 110.694 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.36 -73.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 111.636 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.4 pp -86.12 107.81 18.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.306 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.628 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -160.78 -18.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.743 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 17' ' ' THR . 35.8 t -173.03 114.53 0.25 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.672 -1.268 . . . . 0.0 110.23 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -57.7 -6.82 0.56 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 112.064 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 HG21 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -135.69 3.89 3.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.515 -1.366 . . . . 0.0 112.993 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.76 -132.92 1.43 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 117.321 -2.371 . . . . 0.0 113.025 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.585 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.68 -150.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 122.058 -0.672 . . . . 0.0 110.902 -177.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.628 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 32.1 t -148.09 76.94 1.39 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.587 -1.321 . . . . 0.0 111.482 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -88.47 51.53 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.513 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.44 -45.28 1.31 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 4.3 m -161.8 158.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.998 -0.707 . . . . 0.0 109.459 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 12.4 t -61.37 101.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 108.658 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.63 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -95.36 50.58 1.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.716 -1.24 . . . . 0.0 113.673 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.855 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.554 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.4 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.969 0.414 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -144.23 147.19 33.27 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 5.8 mm-40 -76.27 137.92 40.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.186 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.611 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.74 121.57 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 111.138 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 11.3 t0 89.2 23.25 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.078 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mt-10 -112.51 157.63 39.66 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.389 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.6 Cg_endo -69.66 141.86 46.81 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.778 1.41 . . . . 0.0 109.513 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.6 p -155.83 174.85 14.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.88 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 1.1 m-20 -102.91 137.63 40.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -83.65 55.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.295 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -141.57 -34.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.864 -1.148 . . . . 0.0 110.971 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.83 -80.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.079 . . . . 0.0 110.735 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -79.53 116.15 19.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 109.88 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.723 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.11 -23.61 0.06 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.771 -1.172 . . . . 0.0 112.618 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -164.21 117.16 1.38 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.056 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -54.32 -10.38 0.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 111.331 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -132.2 2.49 3.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.739 -1.225 . . . . 0.0 112.315 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 26' ' ' TRP . . . -166.49 -146.36 4.81 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 117.943 -2.075 . . . . 0.0 112.772 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.618 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -103.39 -156.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 122.222 -0.576 . . . . 0.0 110.745 -178.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.5 t -132.1 75.01 1.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.634 -1.291 . . . . 0.0 110.833 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 21' ' ' LEU . 6.5 mt -88.48 51.77 2.27 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 117.78 -49.63 0.85 Allowed Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.0 m -161.96 150.05 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.866 -0.785 . . . . 0.0 109.048 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 4.8 t -43.49 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.722 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 3.1 mmm -78.05 -161.76 0.28 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 119.818 -1.802 . . . . 0.0 107.087 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.722 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.0 0.428 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -140.25 158.05 44.63 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.952 -1.093 . . . . 0.0 110.133 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.3 mm-40 -88.28 139.86 30.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.626 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.99 120.49 0.86 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.647 . . . . 0.0 111.015 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t70 92.01 19.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.74 0.416 . . . . 0.0 111.755 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HB3' ' CG ' ' A' ' 2' ' ' LYS . 1.4 mp0 -110.67 152.08 43.23 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 120.747 -1.221 . . . . 0.0 109.359 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.504 ' HA ' HG13 ' A' ' 23' ' ' VAL . 40.5 Cg_endo -68.78 141.85 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.757 1.398 . . . . 0.0 110.465 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.672 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 6.1 p -158.22 178.66 9.94 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.238 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -103.52 145.74 29.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.211 0.529 . . . . 0.0 109.662 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 20' ' ' CYS . 3.5 t -86.15 54.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.78 -41.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.773 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.61 -76.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 111.557 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.508 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -78.94 105.77 10.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.733 -0.605 . . . . 0.0 110.703 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.672 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 2.9 p30 -161.04 -24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.874 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' A' ' 17' ' ' THR . 11.8 t -161.28 109.79 1.54 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.872 -1.143 . . . . 0.0 110.211 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.556 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.44 -11.81 2.18 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.665 -0.647 . . . . 0.0 110.855 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 26' ' ' TRP . 3.4 t -120.98 -7.66 9.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 112.128 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.88 -139.27 2.59 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.525 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.61 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -105.64 -149.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.123 -0.634 . . . . 0.0 110.669 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 49.2 t -139.65 77.06 1.59 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.426 -1.421 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.6 mm? -86.89 48.57 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.59 -43.89 1.56 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.3 m -161.67 146.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.811 -0.817 . . . . 0.0 109.482 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 39.1 t -41.54 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.641 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 4.8 mmm -78.42 -164.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 119.969 -1.707 . . . . 0.0 107.39 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.619 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.757 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.539 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.042 0.448 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -134.58 145.16 48.41 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.961 -1.087 . . . . 0.0 110.531 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.7 mm100 -81.27 135.47 35.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 109.653 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.75 128.04 1.54 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 111.341 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t0 83.76 15.2 0.29 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.252 0.549 . . . . 0.0 110.397 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 60.9 mm-40 -104.37 145.23 30.28 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.537 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HA ' HG11 ' A' ' 23' ' ' VAL . 39.9 Cg_endo -67.32 133.9 31.87 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.555 1.818 . . . . 0.0 109.417 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -160.59 169.86 22.05 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.241 -178.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 7.7 m-20 -96.06 142.25 28.48 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 7.9 p -85.66 59.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 0.0 109.385 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -24.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.203 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 31.2 t -161.0 -87.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.65 -1.281 . . . . 0.0 110.25 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -79.61 93.4 5.48 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -135.99 -17.83 1.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.584 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 17' ' ' THR . 40.9 t -176.69 106.64 0.07 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.921 -1.112 . . . . 0.0 109.809 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -40.83 -21.17 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.889 -0.507 . . . . 0.0 111.935 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.595 ' CG2' ' CB ' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -111.04 -24.41 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.742 -1.224 . . . . 0.0 112.98 -178.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' N ' HG22 ' A' ' 17' ' ' THR . . . -152.7 -111.03 0.45 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 117.98 -2.057 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.577 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -124.59 -152.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.81 -0.818 . . . . 0.0 110.904 -176.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.8 t -157.7 88.39 0.98 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.089 -1.007 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -88.17 51.99 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.548 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 123.01 -42.75 1.55 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.263 -2.735 . . . . 0.0 106.263 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 21.4 m -160.72 158.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 1.7 t -63.94 94.63 0.1 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.952 -1.093 . . . . 0.0 109.368 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.3 mtp -86.47 52.8 2.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.76 -1.212 . . . . 0.0 110.719 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.599 ' CG ' ' O ' ' A' ' 25' ' ' MET . 15.0 m-90 . . . . . 0 C--N 1.295 -1.783 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.407 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 16' ' ' CYS . 19.6 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' ASP . 22.2 mmtt -149.27 161.2 42.51 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.804 -1.185 . . . . 0.0 109.951 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -97.25 142.13 29.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.389 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.09 121.48 0.8 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 111.467 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 85.59 26.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.122 -0.361 . . . . 0.0 111.771 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -114.65 162.04 25.69 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.695 -1.253 . . . . 0.0 109.956 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 40.3 Cg_endo -69.22 117.22 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.818 1.431 . . . . 0.0 109.606 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.591 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.9 p -124.42 168.47 12.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 111.96 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.23 119.33 27.36 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.589 HG23 ' CE2' ' A' ' 11' ' ' PHE . 11.2 m -86.08 52.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.591 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.589 ' CE2' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.6 -36.06 0.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.774 -1.204 . . . . 0.0 110.929 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.18 -82.94 0.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.123 -0.986 . . . . 0.0 110.605 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.3 pt? -106.02 152.56 23.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.5 -0.75 . . . . 0.0 110.386 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.697 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -161.99 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.131 -0.98 . . . . 0.0 111.37 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 1.1 t -81.31 134.28 35.56 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.743 0.782 . . . . 0.0 110.333 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 1' ' ' CYS . 60.0 m -51.74 -12.96 0.22 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.701 -0.625 . . . . 0.0 112.201 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.63 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -134.07 -1.57 2.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.437 -1.414 . . . . 0.0 113.234 -178.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.31 -109.59 0.31 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 116.748 -2.644 . . . . 0.0 114.105 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.521 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.64 -161.82 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.752 0.786 . . . . 0.0 111.831 -175.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.697 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 44.4 t -135.55 80.27 1.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.663 . . . . 0.0 110.379 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 6.1 mp -88.75 52.27 2.38 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.51 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.27 -43.75 1.6 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.21 157.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.731 -0.864 . . . . 0.0 109.858 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 2' ' ' LYS . 37.8 t -39.83 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.7 . . . . 0.0 109.564 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.615 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -78.2 -162.46 0.34 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.296 -1.503 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.389 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.05 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 16' ' ' CYS . 27.9 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.282 0.563 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.8 mmtm -155.37 166.83 32.35 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.286 -0.884 . . . . 0.0 109.234 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -102.21 143.8 31.54 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.01 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.608 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.54 119.46 0.62 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.83 -0.544 . . . . 0.0 110.891 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.7 t0 88.15 27.26 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -112.93 159.87 32.95 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.429 -1.419 . . . . 0.0 110.632 178.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 43.3 Cg_endo -70.63 109.33 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.545 1.287 . . . . 0.0 109.942 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.1 p -128.24 170.0 13.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.38 124.62 34.62 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.293 0.568 . . . . 0.0 109.66 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 10' ' ' VAL . 7.7 p -90.45 58.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.871 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -147.76 -34.08 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.187 . . . . 0.0 110.994 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.62 -76.81 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.9 pt? -122.48 153.59 38.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.632 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -161.6 -85.51 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.349 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -76.19 134.97 39.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.563 0.697 . . . . 0.0 109.464 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -49.24 -12.75 0.06 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.662 -0.649 . . . . 0.0 112.106 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.565 HG21 ' CD1' ' A' ' 26' ' ' TRP . 1.2 t -145.83 40.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.457 -1.402 . . . . 0.0 113.007 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . 171.24 -110.06 0.34 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 117.357 -2.354 . . . . 0.0 113.671 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.524 HD11 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -137.31 -164.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.128 -1.219 . . . . 0.0 112.33 -175.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.632 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 23.2 t -131.67 76.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 109.793 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 6.4 mp -86.97 63.32 7.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 108.84 -43.75 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 106.876 -2.489 . . . . 0.0 106.876 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 5' ' ' ASP . 13.7 m -161.49 -176.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 4.7 t -47.48 120.35 3.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.617 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -78.31 -169.09 1.51 Allowed 'General case' 0 C--N 1.288 -2.079 0 O-C-N 119.976 -1.702 . . . . 0.0 108.903 -178.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 25' ' ' MET . 1.4 m95 . . . . . 0 C--N 1.283 -2.295 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 12.3 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.908 0.385 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -147.91 154.24 40.12 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.995 -1.066 . . . . 0.0 110.092 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -86.25 139.51 30.96 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.728 179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.63 119.94 0.77 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.381 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 23.0 t0 90.87 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 122.782 0.433 . . . . 0.0 111.416 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -117.57 156.23 49.57 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.977 -1.077 . . . . 0.0 109.151 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 42.8 Cg_endo -70.49 123.41 9.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.769 1.405 . . . . 0.0 110.43 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.624 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.8 p -134.96 172.56 12.83 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.11 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 20.1 t0 -79.41 124.72 28.71 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.499 0.666 . . . . 0.0 110.215 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 20' ' ' CYS . 3.9 m -90.53 57.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -158.1 -28.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.779 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.96 -83.48 0.31 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.914 -1.116 . . . . 0.0 110.033 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.509 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.3 pt? -110.65 148.39 32.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.972 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.669 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.27 -86.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.004 -1.06 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -77.49 125.35 29.19 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.425 0.631 . . . . 0.0 111.015 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.85 -10.75 1.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.536 -0.728 . . . . 0.0 110.846 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 HG23 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -127.93 -5.42 5.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.0 112.219 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.5 -142.72 3.47 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.203 -1.951 . . . . 0.0 112.123 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.62 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -102.21 -149.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.224 -0.574 . . . . 0.0 109.765 -179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.669 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 46.4 t -153.83 81.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.295 -1.503 . . . . 0.0 111.688 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.3 mm? -89.85 43.74 1.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.503 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 130.25 -46.43 1.08 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m -160.7 146.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.5 -1.0 . . . . 0.0 109.734 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 2.0 t -45.61 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 110.482 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.636 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 2.7 mmt -78.01 -162.97 0.37 Allowed 'General case' 0 C--N 1.292 -1.907 0 O-C-N 120.172 -1.58 . . . . 0.0 106.88 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.636 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.662 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.532 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.3 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.188 0.518 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -160.22 143.21 13.56 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.8 143.18 49.61 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.525 0.679 . . . . 0.0 111.052 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.13 134.88 1.02 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.576 -0.703 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.4 m-20 84.77 4.77 0.62 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.021 -0.424 . . . . 0.0 110.844 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CG ' ' HG2' ' A' ' 2' ' ' LYS . 13.1 tp10 -96.16 143.07 25.48 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 120.901 -1.124 . . . . 0.0 109.076 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 38.8 Cg_endo -68.25 141.57 52.44 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.651 1.342 . . . . 0.0 110.014 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 p -160.81 -168.92 2.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.334 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.16 133.94 52.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' CA ' ' HB3' ' A' ' 20' ' ' CYS . 6.3 p -85.81 60.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.123 -0.986 . . . . 0.0 110.202 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -139.0 -40.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.89 -77.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.327 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -119.21 132.35 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 110.121 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.651 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.84 -34.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.5 t -144.63 114.43 7.28 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.247 -0.908 . . . . 0.0 109.285 -178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.532 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -50.75 -13.0 0.12 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.518 -0.738 . . . . 0.0 111.874 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' OXT' ' A' ' 26' ' ' TRP . 1.3 t -135.95 11.61 3.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.442 -1.411 . . . . 0.0 112.53 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.563 ' HA3' ' CZ3' ' A' ' 26' ' ' TRP . . . -171.03 -164.11 26.19 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.266 -1.921 . . . . 0.0 111.996 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -84.68 -160.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 122.108 -0.642 . . . . 0.0 111.125 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 42.7 t -135.33 82.32 1.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.013 -1.055 . . . . 0.0 110.656 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -88.35 48.07 1.59 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 117.72 -41.25 2.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.4 143.4 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.855 . . . . 0.0 109.796 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 12.9 t -39.79 108.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.684 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 2.8 mmt -83.4 -166.69 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.232 -1.543 . . . . 0.0 108.223 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.715 ' CH2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.836 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 25.4 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 14' ' ' ASP . 18.0 mmtt -153.87 154.91 34.75 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.992 -1.067 . . . . 0.0 110.006 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 4' ' ' ALA . 8.9 mm-40 -86.49 144.92 27.02 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.155 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.556 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.23 129.35 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.735 -0.603 . . . . 0.0 110.718 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.1 t70 79.97 26.05 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.736 -0.603 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.524 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 1.7 mm-40 -107.03 143.35 26.92 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.01 112.1 3.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.611 1.322 . . . . 0.0 109.943 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -124.74 168.19 13.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.493 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 15.6 m-20 -97.62 134.03 41.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.6 -0.688 . . . . 0.0 110.026 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 33.8 m -85.42 57.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 10' ' ' VAL . 13.9 m-85 -133.66 -24.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 111.105 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.16 -73.17 0.07 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.925 -1.109 . . . . 0.0 110.998 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.9 pt? -110.35 147.36 34.1 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.802 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.719 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.96 -85.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 111.161 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 2.8 t -86.29 126.2 34.14 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.924 0.868 . . . . 0.0 110.529 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 61.6 m -47.6 -14.56 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.645 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -131.7 -11.6 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.33 -1.482 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.13 -128.41 1.77 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.575 -2.25 . . . . 0.0 113.109 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -110.37 -166.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.603 0.716 . . . . 0.0 111.6 -176.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.9 t -131.75 75.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.643 -0.661 . . . . 0.0 110.575 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.55 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.0 mt -88.29 62.43 6.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 111.82 -45.01 1.38 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 6.1 m -161.22 179.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 50.9 t -65.21 103.74 0.82 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 108.772 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.606 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.5 -163.29 0.31 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 120.339 -1.476 . . . . 0.0 108.593 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.645 ' CD1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.369 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.702 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 29.7 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.864 0.364 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtp -153.21 144.12 22.87 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.088 -1.007 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 18.8 mm100 -69.92 140.64 53.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 5' ' ' ASP . . . -38.93 143.15 0.17 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.44 -0.787 . . . . 0.0 111.619 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER 72.93 9.52 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.044 0.45 . . . . 0.0 110.582 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 10.8 tt0 -106.2 146.74 33.56 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.77 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 37.4 Cg_endo -64.04 132.38 34.19 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.375 1.197 . . . . 0.0 110.52 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.7 p -144.2 177.63 8.46 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.264 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -79.4 121.84 25.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.499 -0.751 . . . . 0.0 110.671 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 20' ' ' CYS . 11.7 m -90.98 62.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.605 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.69 -32.42 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.296 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.0 -86.32 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -110.72 142.34 42.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.141 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.655 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -164.24 -62.27 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.439 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 25' ' ' MET . 19.8 t -87.19 113.02 22.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.643 0.735 . . . . 0.0 111.064 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 2' ' ' LYS . 67.7 m -44.53 -19.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.841 -0.537 . . . . 0.0 111.442 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.613 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -129.99 -12.22 4.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.764 -1.21 . . . . 0.0 112.922 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 15' ' ' CYS . . . -149.51 -122.14 1.14 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.009 -2.043 . . . . 0.0 112.276 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.581 ' N ' ' CD1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -121.75 -176.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.895 . . . . 0.0 110.751 -178.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.653 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 22.6 t -129.7 76.04 1.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.293 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' CE ' ' A' ' 25' ' ' MET . 4.2 mm? -92.19 45.2 1.2 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.54 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 136.01 -44.72 1.14 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.05 163.17 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.985 -0.715 . . . . 0.0 109.393 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 42.6 t -47.94 121.28 4.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.869 -1.145 . . . . 0.0 108.441 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.607 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -87.13 135.7 33.2 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 111.009 -178.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.613 ' CD1' HG22 ' A' ' 17' ' ' THR . 4.8 p90 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.001 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 16' ' ' CYS . 27.5 p . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.141 0.496 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -150.96 132.86 15.08 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.219 -0.926 . . . . 0.0 110.227 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.87 137.89 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.28 140.12 0.46 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.539 -0.726 . . . . 0.0 111.547 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 5.1 m-20 81.65 5.3 1.27 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.042 0.449 . . . . 0.0 110.756 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mm-40 -107.55 149.44 38.87 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.45 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.1 Cg_endo -69.43 130.56 19.97 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.94 1.495 . . . . 0.0 110.651 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -139.5 177.37 7.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.702 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.96 114.57 22.97 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.672 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' CA ' ' HB3' ' A' ' 20' ' ' CYS . 10.6 p -85.11 56.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -143.84 -37.47 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -75.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.968 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -123.44 153.03 41.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.658 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.85 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.308 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 6.4 t -73.66 118.1 16.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.866 -0.521 . . . . 0.0 109.875 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -38.76 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.674 -0.641 . . . . 0.0 111.336 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.63 ' CG2' ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.66 -13.6 2.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.845 -1.159 . . . . 0.0 111.808 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.525 ' HA3' ' CE2' ' A' ' 26' ' ' TRP . . . -121.3 -127.13 3.37 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.431 -1.842 . . . . 0.0 112.654 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.511 ' CD1' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -137.33 -175.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.747 -0.854 . . . . 0.0 110.447 -177.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.1 t -117.44 59.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.057 -1.027 . . . . 0.0 110.793 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.47 ' N ' HD13 ' A' ' 21' ' ' LEU . 4.8 mp -88.71 49.6 1.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 23' ' ' VAL . . . 131.48 -54.81 0.78 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 106.384 -2.686 . . . . 0.0 106.384 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 22' ' ' GLY . 4.1 m -161.73 165.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 8.6 t -46.51 116.48 1.31 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.994 -1.066 . . . . 0.0 108.294 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TRP . 3.7 mtp -81.95 139.25 34.7 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.446 -0.784 . . . . 0.0 110.203 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CD1' ' CG2' ' A' ' 17' ' ' THR . 4.9 p90 . . . . . 0 C--N 1.291 -1.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.6 p . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 1.6 mmtp -146.14 142.99 29.02 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 120.802 -1.186 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.2 mp0 -81.04 148.85 29.5 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.416 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.86 133.83 0.56 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.052 0.453 . . . . 0.0 111.121 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.7 t0 82.04 18.38 0.37 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.241 0.544 . . . . 0.0 110.027 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 52.7 mm-40 -106.76 136.88 19.37 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.02 137.92 27.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 111.005 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 1.2 p -160.36 177.37 10.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 110.882 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.41 131.5 34.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 109.566 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.6 p -89.55 59.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -141.18 -36.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 110.637 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.64 -74.57 0.45 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.663 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.7 pt? -114.39 147.8 38.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 111.218 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.657 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -162.6 -86.52 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.145 178.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.1 t -93.84 140.56 29.53 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.571 0.701 . . . . 0.0 110.67 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.71 -2.4 0.14 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.645 HG22 ' HD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -131.52 -8.1 3.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.289 -1.507 . . . . 0.0 113.343 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.511 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -162.67 -110.9 0.25 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 116.832 -2.604 . . . . 0.0 114.002 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.642 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -127.55 -150.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.625 -0.927 . . . . 0.0 111.874 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 t -148.83 76.09 1.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 111.537 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 5.5 mp -88.32 64.33 7.54 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.766 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 105.82 -52.08 0.72 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 106.023 -2.831 . . . . 0.0 106.023 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -162.11 159.28 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 26.1 t -43.78 115.0 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.949 -1.094 . . . . 0.0 109.917 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.576 ' O ' ' CE3' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -95.05 38.33 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 110.646 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.645 ' HD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.99 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.3 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 19.1 mmtt -144.06 144.3 31.56 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.183 -0.948 . . . . 0.0 110.069 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.2 mm-40 -72.11 140.97 49.16 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.02 127.8 1.64 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.611 -0.68 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 8.5 t70 88.49 17.91 0.06 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 120.979 0.419 . . . . 0.0 110.869 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.659 ' C ' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -106.83 147.56 35.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.023 -1.048 . . . . 0.0 109.719 179.121 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.28 137.03 38.99 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 124.463 1.77 . . . . 0.0 109.727 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.722 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 5.8 p -161.79 -178.56 6.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.361 -1.335 . . . . 0.0 112.677 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -110.67 145.27 38.26 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.476 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 10' ' ' VAL . 74.7 t -85.88 57.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 109.447 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -130.45 -38.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.117 -0.989 . . . . 0.0 109.963 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.81 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -82.9 102.62 11.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.701 -0.624 . . . . 0.0 111.084 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.754 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 23.3 p30 -160.18 -3.5 0.06 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.243 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.5 t 178.14 106.33 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.632 -1.292 . . . . 0.0 109.63 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -59.22 -3.09 0.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 112.352 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.596 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.1 t -128.48 1.76 5.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 112.841 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.47 -125.07 0.83 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 117.687 -2.197 . . . . 0.0 112.645 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.565 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -111.32 -143.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.805 -0.82 . . . . 0.0 110.6 -177.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 37.1 t -159.81 70.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.84 -1.163 . . . . 0.0 111.332 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.796 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.2 mm? -85.81 62.47 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 110.24 -48.77 0.9 Allowed Glycine 0 N--CA 1.483 1.821 0 N-CA-C 106.471 -2.651 . . . . 0.0 106.471 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.08 159.86 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.933 -0.745 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 42.8 t -56.73 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.094 -1.004 . . . . 0.0 109.061 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.583 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 7.1 mtp -84.9 52.97 2.56 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.026 -1.046 . . . . 0.0 112.962 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.0 m-90 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.099 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.583 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 11.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.957 0.408 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.603 ' HG3' ' HA ' ' A' ' 14' ' ' ASP . 12.4 mmtt -137.34 167.17 22.14 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 120.832 -1.168 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.9 mm-40 -95.49 137.53 34.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.059 -1.025 . . . . 0.0 109.616 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 116.64 0.52 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.649 -0.657 . . . . 0.0 110.79 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 18.4 t70 92.24 20.83 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 122.744 0.417 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.6 mt-10 -107.02 161.77 21.83 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.58 138.04 37.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.805 1.424 . . . . 0.0 109.416 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 11.7 p -150.86 177.82 9.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.161 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -120.82 146.33 46.65 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.999 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.48 56.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.913 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -136.46 -42.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 110.811 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -76.16 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.005 -1.059 . . . . 0.0 111.044 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.536 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 1.8 pp -78.68 111.28 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.685 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.675 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -160.7 -17.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.691 -1.203 . . . . 0.0 113.298 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 12.4 t -172.5 119.23 0.38 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.773 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 40.4 m -60.69 -6.78 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 111.1 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.956 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.6 t -133.07 0.94 3.49 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.856 -1.152 . . . . 0.0 112.266 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.96 -140.17 2.81 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.747 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.633 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -107.38 -147.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 122.341 -0.505 . . . . 0.0 110.304 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 51.5 t -135.31 83.14 2.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.349 -1.469 . . . . 0.0 111.12 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.597 HD23 ' HZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -87.8 51.2 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.756 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 107.28 -41.04 2.3 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.5 m -161.04 148.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.949 -0.736 . . . . 0.0 109.142 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 15.3 t -41.11 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 5.4 mmt -79.49 -165.2 0.75 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 119.896 -1.752 . . . . 0.0 107.826 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.956 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.503 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.768 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 31.5 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.103 0.477 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 14' ' ' ASP . 7.9 mmtt -153.13 158.24 41.55 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.441 -0.787 . . . . 0.0 108.924 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.6 mm100 -91.89 145.84 24.23 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.01 120.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.838 -0.539 . . . . 0.0 110.428 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.1 t0 86.94 30.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.08 0.467 . . . . 0.0 110.871 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 6.9 mm-40 -114.67 154.61 46.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.081 -1.012 . . . . 0.0 110.069 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.85 120.39 6.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.643 1.339 . . . . 0.0 110.041 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.3 p -140.05 171.56 14.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.077 -1.015 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.58 124.59 48.4 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 10' ' ' VAL . 9.2 p -85.16 54.19 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.041 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 54.3 m-85 -132.0 -17.62 2.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.175 -0.953 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.05 -54.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.929 -1.107 . . . . 0.0 110.875 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.813 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.3 pt? -136.82 144.38 43.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.81 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.94 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' MET . 0.8 OUTLIER -78.72 123.68 27.41 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.681 0.753 . . . . 0.0 109.755 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.69 -20.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.599 -0.688 . . . . 0.0 112.107 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -143.27 14.22 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.488 -1.382 . . . . 0.0 112.226 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.599 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -149.81 -126.44 1.43 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.624 -2.227 . . . . 0.0 113.027 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.658 HD11 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -130.2 178.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.491 0.662 . . . . 0.0 110.838 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -116.65 65.36 0.71 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 109.557 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 21' ' ' LEU . 1.9 mt -87.39 62.69 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.765 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.26 -50.81 0.76 Allowed Glycine 0 N--CA 1.481 1.658 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.7 m -162.86 -175.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 12.1 t -49.85 125.35 11.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.555 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 36.4 mmm -77.16 -174.91 3.4 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 120.242 -1.536 . . . . 0.0 109.301 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.658 ' CH2' HD11 ' A' ' 19' ' ' ILE . 1.1 m95 . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.237 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.7 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.015 0.436 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -145.25 156.06 43.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.013 -1.054 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 40.1 mm-40 -88.25 138.35 31.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 109.406 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.56 128.0 1.1 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.452 -0.78 . . . . 0.0 111.184 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 3.3 t0 83.3 19.53 0.21 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.041 -0.412 . . . . 0.0 111.143 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -109.13 165.49 12.54 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 120.866 -1.146 . . . . 0.0 109.697 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.462 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 40.1 Cg_endo -70.04 136.75 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.913 1.481 . . . . 0.0 109.618 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 19.2 p -148.81 -170.55 3.65 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.784 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 1.8 m-20 -122.34 131.03 53.7 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 20' ' ' CYS . 24.8 m -84.22 55.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.121 -0.987 . . . . 0.0 110.838 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -144.5 -27.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 0.0 111.088 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.557 ' N ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -161.55 -86.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.936 -1.102 . . . . 0.0 110.811 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pp -82.36 117.67 22.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.688 0.756 . . . . 0.0 110.779 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.84 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.761 -1.212 . . . . 0.0 111.889 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -149.51 110.24 4.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.802 -1.186 . . . . 0.0 109.477 -179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -43.99 -17.44 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.662 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -121.52 -21.74 6.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.36 -1.463 . . . . 0.0 112.681 -178.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -151.15 -141.16 3.3 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.144 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.771 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -95.63 -154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 122.086 -0.655 . . . . 0.0 110.479 -179.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -154.88 97.47 1.96 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 111.147 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 21' ' ' LEU . 2.9 mm? -90.83 59.81 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.119 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 113.69 -38.0 3.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -160.57 149.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.964 . . . . 0.0 109.047 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 48.9 t -39.34 107.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.694 0.759 . . . . 0.0 109.97 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.624 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.5 mmt -77.71 -164.08 0.47 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.506 -1.371 . . . . 0.0 108.758 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.662 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.37 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.406 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.076 0.465 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 4.3 mmtt -146.09 139.5 26.06 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.249 -0.907 . . . . 0.0 109.981 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.531 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 27.3 mm100 -72.17 141.47 49.07 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.283 -0.886 . . . . 0.0 110.016 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.31 136.88 0.61 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.687 -0.633 . . . . 0.0 111.439 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.5 m-20 80.91 10.22 0.99 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.309 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.626 ' C ' HG12 ' A' ' 23' ' ' VAL . 5.7 mm-40 -103.95 143.37 26.51 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.708 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 39.0 Cg_endo -67.07 140.95 55.93 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 124.73 1.911 . . . . 0.0 109.657 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.3 p -160.82 178.06 9.8 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.831 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 95.9 m-20 -101.22 137.87 38.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 0.0 109.872 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.7 p -85.49 58.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.511 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.49 -35.07 0.91 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.199 -0.938 . . . . 0.0 110.43 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -161.05 -80.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -178.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -87.53 104.02 16.1 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.813 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.718 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 p30 -160.63 10.62 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.571 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 7.4 t 175.13 106.96 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.967 -1.083 . . . . 0.0 109.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -60.46 -4.26 0.84 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 112.054 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -133.77 15.02 3.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.576 -1.327 . . . . 0.0 112.692 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.497 ' N ' ' SG ' ' A' ' 15' ' ' CYS . . . 179.09 -130.95 1.61 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 117.915 -2.088 . . . . 0.0 112.296 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.602 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.18 -149.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.827 -0.807 . . . . 0.0 110.106 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.9 t -158.74 78.2 0.77 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.349 -1.469 . . . . 0.0 111.958 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.734 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -89.22 47.45 1.49 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.784 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.76 -44.81 1.23 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -161.9 154.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.82 . . . . 0.0 109.982 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 41.9 t -61.05 99.62 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.033 -1.042 . . . . 0.0 108.862 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.619 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 8.4 mtp -94.33 53.52 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.576 -1.327 . . . . 0.0 113.447 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.619 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.686 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.0 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.051 0.453 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 13.4 mmtt -145.84 144.5 30.28 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.224 -0.922 . . . . 0.0 109.806 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 4' ' ' ALA . 29.2 mm100 -75.07 142.37 43.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.84 128.47 1.2 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.732 -0.605 . . . . 0.0 110.382 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.606 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t0 87.81 19.15 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.139 0.495 . . . . 0.0 110.536 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.518 ' C ' HG12 ' A' ' 23' ' ' VAL . 23.5 mm-40 -111.41 137.36 21.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.184 -0.947 . . . . 0.0 109.603 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' N ' HG12 ' A' ' 23' ' ' VAL . 41.7 Cg_endo -69.81 144.32 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.694 1.365 . . . . 0.0 110.846 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.4 p -160.75 -171.08 2.97 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.569 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.41 145.03 38.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 20' ' ' CYS . 15.5 t -84.96 56.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.23 -37.36 1.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 110.238 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 -79.03 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 111.155 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 1.2 pp -81.97 109.18 16.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.508 -0.745 . . . . 0.0 111.197 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -159.98 -12.64 0.05 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.116 -1.034 . . . . 0.0 113.068 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 50.3 t -173.19 111.98 0.21 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.678 -1.264 . . . . 0.0 110.287 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -56.29 -11.43 1.19 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.718 HG21 ' OXT' ' A' ' 26' ' ' TRP . 2.0 t -130.22 0.61 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.785 -1.197 . . . . 0.0 112.393 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -165.59 -152.5 7.17 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.364 -1.874 . . . . 0.0 112.012 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.68 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -97.28 -161.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.122 -0.634 . . . . 0.0 110.857 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 12.7 t -123.54 80.22 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 111.157 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 5.1 mp -88.83 55.12 3.24 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 103.75 -43.88 1.59 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.7 OUTLIER -160.86 140.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 5.3 t -41.15 98.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.7 mtt -76.15 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.725 -1.859 . . . . 0.0 107.43 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.718 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.899 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.72 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.237 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -142.29 143.89 33.02 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.162 -0.961 . . . . 0.0 109.432 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 2.8 mm-40 -79.18 142.05 36.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.25 127.85 1.36 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.752 -0.593 . . . . 0.0 111.063 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 83.44 19.61 0.2 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 61.8 mm-40 -107.88 154.43 41.04 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.224 -0.922 . . . . 0.0 109.283 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 41.7 Cg_endo -71.25 114.06 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.779 1.41 . . . . 0.0 109.736 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.695 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.0 p -132.65 172.16 12.89 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.707 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 12.3 m-20 -91.24 126.25 36.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 109.975 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 10' ' ' VAL . 14.2 p -88.93 61.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 110.074 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 0.8 OUTLIER -149.16 -35.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.025 -1.047 . . . . 0.0 110.56 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 13' ' ' LEU . 29.1 t -132.32 -86.79 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -113.73 136.87 52.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.547 -0.721 . . . . 0.0 109.087 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.695 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -162.03 -21.4 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.423 -1.311 . . . . 0.0 113.031 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.737 ' SG ' HG22 ' A' ' 17' ' ' THR . 20.7 t -141.23 108.66 5.56 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.359 -1.463 . . . . 0.0 111.106 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.93 -19.08 0.35 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.803 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.844 HG21 ' C ' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -108.88 -26.13 10.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.062 . . . . 0.0 112.312 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.424 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -160.57 -104.85 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 117.953 -2.07 . . . . 0.0 112.959 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.529 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.51 -164.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -1.076 . . . . 0.0 111.74 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 8.0 t -129.0 73.39 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.502 -0.749 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -88.15 51.71 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.793 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.32 -44.73 1.25 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 22' ' ' GLY . 1.8 m -162.91 171.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 49.7 t -45.45 121.05 2.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.95 -1.094 . . . . 0.0 108.399 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -82.83 171.7 13.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.843 -1.161 . . . . 0.0 110.71 -178.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.844 ' C ' HG21 ' A' ' 17' ' ' THR . 17.4 p90 . . . . . 0 N--CA 1.502 2.156 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.137 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.029 0.442 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -111.66 136.19 51.21 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 74.3 mm-40 -73.09 133.06 44.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.622 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 137.87 0.46 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.698 -0.626 . . . . 0.0 110.635 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.0 t70 87.76 4.84 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.992 0.425 . . . . 0.0 110.127 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -100.22 143.84 27.28 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.28 143.67 35.69 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.313 1.691 . . . . 0.0 109.679 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' CB ' ' HA ' ' A' ' 14' ' ' ASP . 1.7 p -161.2 179.95 7.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.383 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.7 OUTLIER -102.9 144.87 30.65 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 10' ' ' VAL . 23.2 m -83.83 54.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.472 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -127.81 -32.86 2.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.109 -0.995 . . . . 0.0 109.806 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.6 t -161.05 -83.49 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pt? -79.06 120.17 23.23 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.54 0.686 . . . . 0.0 110.812 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.709 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -38.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.828 -1.17 . . . . 0.0 111.938 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 17' ' ' THR . 44.3 t -151.03 117.23 5.62 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.35 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -8.83 0.53 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 111.411 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -134.22 -0.15 3.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.727 -1.233 . . . . 0.0 113.25 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.08 -110.13 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 116.98 -2.533 . . . . 0.0 113.999 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.635 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -135.07 -152.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.567 -0.96 . . . . 0.0 111.742 -175.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -145.19 77.63 1.53 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.975 -1.078 . . . . 0.0 111.957 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 21' ' ' LEU . 4.8 mt -90.81 52.52 2.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.709 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 114.04 -47.67 1.02 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.604 -2.598 . . . . 0.0 106.604 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -161.04 147.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.856 -0.79 . . . . 0.0 108.915 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.449 ' SG ' ' HA ' ' A' ' 4' ' ' ALA . 3.9 t -52.14 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.812 -1.18 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.575 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 5.8 mtp -82.87 52.03 2.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.968 -1.083 . . . . 0.0 111.823 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.635 ' CH2' HG13 ' A' ' 19' ' ' ILE . 8.5 m-90 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.998 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 29.2 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.071 0.462 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -146.24 144.71 30.06 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.155 -0.966 . . . . 0.0 109.923 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 36.7 mm-40 -75.22 142.32 43.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.674 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.52 139.43 0.4 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.653 -0.654 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.0 m-20 84.21 4.97 0.7 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 120.963 0.411 . . . . 0.0 110.247 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 mm-40 -96.84 137.38 21.37 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 121.037 -1.039 . . . . 0.0 110.059 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.11 140.31 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.155 1.608 . . . . 0.0 110.11 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.1 p -161.12 -174.66 4.46 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.727 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -106.52 148.01 28.71 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 10' ' ' VAL . 24.5 m -85.36 56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.085 -1.009 . . . . 0.0 109.453 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.6 -38.36 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.158 -0.964 . . . . 0.0 110.694 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.36 -73.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 111.636 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 pp -86.12 107.81 18.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.306 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.7 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -160.78 -18.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.743 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' ' HE3' ' A' ' 26' ' ' TRP . 35.8 t -173.03 114.53 0.25 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.672 -1.268 . . . . 0.0 110.23 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -57.7 -6.82 0.56 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 112.064 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -135.69 3.89 3.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.515 -1.366 . . . . 0.0 112.993 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.76 -132.92 1.43 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 117.321 -2.371 . . . . 0.0 113.025 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.594 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.68 -150.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 122.058 -0.672 . . . . 0.0 110.902 -177.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 32.1 t -148.09 76.94 1.39 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.587 -1.321 . . . . 0.0 111.482 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.0 mm? -88.47 51.53 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.75 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.44 -45.28 1.31 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.3 m -161.8 158.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.998 -0.707 . . . . 0.0 109.459 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.559 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 12.4 t -61.37 101.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 108.658 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.63 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -95.36 50.58 1.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.716 -1.24 . . . . 0.0 113.673 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.855 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.4 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.969 0.414 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -144.23 147.19 33.27 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.6 mm100 -76.27 137.92 40.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.186 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -38.74 121.57 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 111.138 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 11.3 t0 89.2 23.25 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.078 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mt-10 -112.51 157.63 39.66 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.389 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.6 Cg_endo -69.66 141.86 46.81 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.778 1.41 . . . . 0.0 109.513 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.6 p -155.83 174.85 14.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.88 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 1.1 m-20 -102.91 137.63 40.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 20' ' ' CYS . 29.4 m -83.65 55.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.295 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -141.57 -34.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.864 -1.148 . . . . 0.0 110.971 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.83 -80.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.079 . . . . 0.0 110.735 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -79.53 116.15 19.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 109.88 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.11 -23.61 0.06 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.771 -1.172 . . . . 0.0 112.618 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 17' ' ' THR . 46.5 t -164.21 117.16 1.38 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.056 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -54.32 -10.38 0.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 111.331 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.4 t -132.2 2.49 3.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.739 -1.225 . . . . 0.0 112.315 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 26' ' ' TRP . . . -166.49 -146.36 4.81 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 117.943 -2.075 . . . . 0.0 112.772 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.643 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -103.39 -156.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 122.222 -0.576 . . . . 0.0 110.745 -178.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.891 ' O ' HG12 ' A' ' 10' ' ' VAL . 49.5 t -132.1 75.01 1.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.634 -1.291 . . . . 0.0 110.833 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 21' ' ' LEU . 6.5 mt -88.48 51.77 2.27 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.791 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.78 -49.63 0.85 Allowed Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.0 m -161.96 150.05 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.866 -0.785 . . . . 0.0 109.048 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 4.8 t -43.49 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.761 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 3.1 mmm -78.05 -161.76 0.28 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 119.818 -1.802 . . . . 0.0 107.087 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.903 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.574 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.0 0.428 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -140.25 158.05 44.63 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.952 -1.093 . . . . 0.0 110.133 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.4 mm100 -88.28 139.86 30.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.626 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.99 120.49 0.86 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.647 . . . . 0.0 111.015 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t70 92.01 19.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.74 0.416 . . . . 0.0 111.755 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 1.4 mp0 -110.67 152.08 43.23 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 120.747 -1.221 . . . . 0.0 109.359 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.78 141.85 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.757 1.398 . . . . 0.0 110.465 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 6.1 p -158.22 178.66 9.94 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.238 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -103.52 145.74 29.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.211 0.529 . . . . 0.0 109.662 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 20' ' ' CYS . 3.5 t -86.15 54.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.78 -41.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.773 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.61 -76.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 111.557 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -78.94 105.77 10.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.733 -0.605 . . . . 0.0 110.703 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 2.9 p30 -161.04 -24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.874 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.8 t -161.28 109.79 1.54 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.872 -1.143 . . . . 0.0 110.211 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.44 -11.81 2.18 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.665 -0.647 . . . . 0.0 110.855 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.758 HG21 ' OXT' ' A' ' 26' ' ' TRP . 3.4 t -120.98 -7.66 9.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 112.128 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.88 -139.27 2.59 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.525 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.627 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -105.64 -149.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.123 -0.634 . . . . 0.0 110.669 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 49.2 t -139.65 77.06 1.59 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.426 -1.421 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.719 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.89 48.57 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.59 -43.89 1.56 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -161.67 146.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.811 -0.817 . . . . 0.0 109.482 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 39.1 t -41.54 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.684 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 4.8 mmm -78.42 -164.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 119.969 -1.707 . . . . 0.0 107.39 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.758 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.619 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.757 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.042 0.448 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -134.58 145.16 48.41 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.961 -1.087 . . . . 0.0 110.531 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 48.1 mm-40 -81.27 135.47 35.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 109.653 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.75 128.04 1.54 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 111.341 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t0 83.76 15.2 0.29 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.252 0.549 . . . . 0.0 110.397 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 60.9 mm-40 -104.37 145.23 30.28 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.537 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 39.9 Cg_endo -67.32 133.9 31.87 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.555 1.818 . . . . 0.0 109.417 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -160.59 169.86 22.05 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.241 -178.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 7.7 m-20 -96.06 142.25 28.48 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.9 p -85.66 59.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 0.0 109.385 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -24.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.203 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 31.2 t -161.0 -87.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.65 -1.281 . . . . 0.0 110.25 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -79.61 93.4 5.48 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.723 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -135.99 -17.83 1.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.584 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.717 ' SG ' HG22 ' A' ' 17' ' ' THR . 40.9 t -176.69 106.64 0.07 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.921 -1.112 . . . . 0.0 109.809 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -40.83 -21.17 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.889 -0.507 . . . . 0.0 111.935 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.717 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -111.04 -24.41 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.742 -1.224 . . . . 0.0 112.98 -178.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.7 -111.03 0.45 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 117.98 -2.057 . . . . 0.0 113.176 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.572 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -124.59 -152.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.81 -0.818 . . . . 0.0 110.904 -176.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.8 t -157.7 88.39 0.98 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.089 -1.007 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 4.0 mm? -88.17 51.99 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.661 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 123.01 -42.75 1.55 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.263 -2.735 . . . . 0.0 106.263 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 22' ' ' GLY . 21.4 m -160.72 158.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 1.7 t -63.94 94.63 0.1 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.952 -1.093 . . . . 0.0 109.368 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.3 mtp -86.47 52.8 2.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.76 -1.212 . . . . 0.0 110.719 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 15.0 m-90 . . . . . 0 C--N 1.295 -1.783 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.407 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 19.6 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' ASP . 22.2 mmtt -149.27 161.2 42.51 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.804 -1.185 . . . . 0.0 109.951 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -97.25 142.13 29.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.389 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.09 121.48 0.8 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 111.467 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 85.59 26.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.122 -0.361 . . . . 0.0 111.771 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -114.65 162.04 25.69 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.695 -1.253 . . . . 0.0 109.956 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 40.3 Cg_endo -69.22 117.22 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.818 1.431 . . . . 0.0 109.606 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.9 p -124.42 168.47 12.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 111.96 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.23 119.33 27.36 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' CZ ' ' A' ' 11' ' ' PHE . 11.2 m -86.08 52.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.591 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.6 -36.06 0.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.774 -1.204 . . . . 0.0 110.929 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.18 -82.94 0.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.123 -0.986 . . . . 0.0 110.605 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.75 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.3 pt? -106.02 152.56 23.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.5 -0.75 . . . . 0.0 110.386 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.719 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -161.99 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.131 -0.98 . . . . 0.0 111.37 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 1.1 t -81.31 134.28 35.56 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.743 0.782 . . . . 0.0 110.333 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 60.0 m -51.74 -12.96 0.22 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.701 -0.625 . . . . 0.0 112.201 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.666 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -134.07 -1.57 2.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.437 -1.414 . . . . 0.0 113.234 -178.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.31 -109.59 0.31 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 116.748 -2.644 . . . . 0.0 114.105 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.682 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.64 -161.82 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.752 0.786 . . . . 0.0 111.831 -175.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 44.4 t -135.55 80.27 1.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.663 . . . . 0.0 110.379 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 6.1 mp -88.75 52.27 2.38 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.748 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.27 -43.75 1.6 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.21 157.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.731 -0.864 . . . . 0.0 109.858 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 2' ' ' LYS . 37.8 t -39.83 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.7 . . . . 0.0 109.564 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.626 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -78.2 -162.46 0.34 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.296 -1.503 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.682 ' CH2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.389 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.05 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.9 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.282 0.563 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 12.8 mmtm -155.37 166.83 32.35 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.286 -0.884 . . . . 0.0 109.234 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -102.21 143.8 31.54 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.01 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.608 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.54 119.46 0.62 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.83 -0.544 . . . . 0.0 110.891 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.7 t0 88.15 27.26 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -112.93 159.87 32.95 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.429 -1.419 . . . . 0.0 110.632 178.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 43.3 Cg_endo -70.63 109.33 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.545 1.287 . . . . 0.0 109.942 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.1 p -128.24 170.0 13.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.38 124.62 34.62 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.293 0.568 . . . . 0.0 109.66 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -90.45 58.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.871 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -147.76 -34.08 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.187 . . . . 0.0 110.994 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.62 -76.81 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.9 pt? -122.48 153.59 38.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.645 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -161.6 -85.51 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.349 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -76.19 134.97 39.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.563 0.697 . . . . 0.0 109.464 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -49.24 -12.75 0.06 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.662 -0.649 . . . . 0.0 112.106 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 17' ' ' THR . 1.2 t -145.83 40.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.457 -1.402 . . . . 0.0 113.007 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . 171.24 -110.06 0.34 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 117.357 -2.354 . . . . 0.0 113.671 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -137.31 -164.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.128 -1.219 . . . . 0.0 112.33 -175.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.668 ' H ' HG22 ' A' ' 19' ' ' ILE . 23.2 t -131.67 76.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 109.793 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.725 HD22 ' HE3' ' A' ' 25' ' ' MET . 6.4 mp -86.97 63.32 7.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.706 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 108.84 -43.75 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 106.876 -2.489 . . . . 0.0 106.876 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 22' ' ' GLY . 13.7 m -161.49 -176.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 4' ' ' ALA . 4.7 t -47.48 120.35 3.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.725 ' HE3' HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -78.31 -169.09 1.51 Allowed 'General case' 0 C--N 1.288 -2.079 0 O-C-N 119.976 -1.702 . . . . 0.0 108.903 -178.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 19' ' ' ILE . 1.4 m95 . . . . . 0 C--N 1.283 -2.295 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.3 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.908 0.385 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -147.91 154.24 40.12 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.995 -1.066 . . . . 0.0 110.092 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -86.25 139.51 30.96 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.728 179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -37.63 119.94 0.77 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.381 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 23.0 t0 90.87 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 122.782 0.433 . . . . 0.0 111.416 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -117.57 156.23 49.57 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.977 -1.077 . . . . 0.0 109.151 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 42.8 Cg_endo -70.49 123.41 9.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.769 1.405 . . . . 0.0 110.43 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.8 p -134.96 172.56 12.83 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.11 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 20.1 t0 -79.41 124.72 28.71 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.499 0.666 . . . . 0.0 110.215 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 20' ' ' CYS . 3.9 m -90.53 57.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -158.1 -28.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.779 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.96 -83.48 0.31 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.914 -1.116 . . . . 0.0 110.033 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.75 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.3 pt? -110.65 148.39 32.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.972 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.702 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.27 -86.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.004 -1.06 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 17' ' ' THR . 49.5 t -77.49 125.35 29.19 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.425 0.631 . . . . 0.0 111.015 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.85 -10.75 1.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.536 -0.728 . . . . 0.0 110.846 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -127.93 -5.42 5.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.0 112.219 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.5 -142.72 3.47 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.203 -1.951 . . . . 0.0 112.123 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -102.21 -149.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.224 -0.574 . . . . 0.0 109.765 -179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.855 ' O ' HG12 ' A' ' 10' ' ' VAL . 46.4 t -153.83 81.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.295 -1.503 . . . . 0.0 111.688 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.734 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.3 mm? -89.85 43.74 1.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 130.25 -46.43 1.08 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -160.7 146.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.5 -1.0 . . . . 0.0 109.734 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 2.0 t -45.61 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 110.482 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 2.7 mmt -78.01 -162.97 0.37 Allowed 'General case' 0 C--N 1.292 -1.907 0 O-C-N 120.172 -1.58 . . . . 0.0 106.88 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.673 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.662 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.3 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.188 0.518 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -160.22 143.21 13.56 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mp0 -71.8 143.18 49.61 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.525 0.679 . . . . 0.0 111.052 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.13 134.88 1.02 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.576 -0.703 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.4 m-20 84.77 4.77 0.62 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.021 -0.424 . . . . 0.0 110.844 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.552 ' CG ' ' HG2' ' A' ' 2' ' ' LYS . 13.1 tp10 -96.16 143.07 25.48 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 120.901 -1.124 . . . . 0.0 109.076 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 38.8 Cg_endo -68.25 141.57 52.44 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.651 1.342 . . . . 0.0 110.014 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 p -160.81 -168.92 2.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.334 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.16 133.94 52.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' VAL . 6.3 p -85.81 60.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.123 -0.986 . . . . 0.0 110.202 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -139.0 -40.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.89 -77.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.327 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -119.21 132.35 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 110.121 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.679 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.84 -34.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.5 t -144.63 114.43 7.28 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.247 -0.908 . . . . 0.0 109.285 -178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -50.75 -13.0 0.12 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.518 -0.738 . . . . 0.0 111.874 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -135.95 11.61 3.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.442 -1.411 . . . . 0.0 112.53 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.554 ' HA3' ' CZ3' ' A' ' 26' ' ' TRP . . . -171.03 -164.11 26.19 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.266 -1.921 . . . . 0.0 111.996 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.728 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -84.68 -160.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 122.108 -0.642 . . . . 0.0 111.125 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 42.7 t -135.33 82.32 1.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.013 -1.055 . . . . 0.0 110.656 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -88.35 48.07 1.59 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.764 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.72 -41.25 2.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.4 143.4 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.855 . . . . 0.0 109.796 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 12.9 t -39.79 108.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.726 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 2.8 mmt -83.4 -166.69 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.232 -1.543 . . . . 0.0 108.223 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.728 ' CH2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.836 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 25.4 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 14' ' ' ASP . 18.0 mmtt -153.87 154.91 34.75 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.992 -1.067 . . . . 0.0 110.006 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 8.9 mm-40 -86.49 144.92 27.02 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.155 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.556 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.23 129.35 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.735 -0.603 . . . . 0.0 110.718 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.1 t70 79.97 26.05 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.736 -0.603 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 1.7 mm-40 -107.03 143.35 26.92 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.01 112.1 3.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.611 1.322 . . . . 0.0 109.943 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -124.74 168.19 13.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 15.6 m-20 -97.62 134.03 41.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.6 -0.688 . . . . 0.0 110.026 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 20' ' ' CYS . 33.8 m -85.42 57.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 10' ' ' VAL . 13.9 m-85 -133.66 -24.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 111.105 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.16 -73.17 0.07 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.925 -1.109 . . . . 0.0 110.998 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.9 pt? -110.35 147.36 34.1 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.802 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.743 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.96 -85.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 111.161 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 2.8 t -86.29 126.2 34.14 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.924 0.868 . . . . 0.0 110.529 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 61.6 m -47.6 -14.56 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.687 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -131.7 -11.6 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.33 -1.482 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.766 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -148.13 -128.41 1.77 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.575 -2.25 . . . . 0.0 113.109 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -110.37 -166.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.603 0.716 . . . . 0.0 111.6 -176.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.743 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.9 t -131.75 75.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.643 -0.661 . . . . 0.0 110.575 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.0 mt -88.29 62.43 6.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.746 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 111.82 -45.01 1.38 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 22' ' ' GLY . 6.1 m -161.22 179.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 50.9 t -65.21 103.74 0.82 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 108.772 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.634 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.5 -163.29 0.31 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 120.339 -1.476 . . . . 0.0 108.593 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.687 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.369 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.702 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 29.7 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.864 0.364 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtp -153.21 144.12 22.87 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.088 -1.007 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 18.8 mm100 -69.92 140.64 53.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 5' ' ' ASP . . . -38.93 143.15 0.17 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.44 -0.787 . . . . 0.0 111.619 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER 72.93 9.52 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.044 0.45 . . . . 0.0 110.582 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 10.8 tt0 -106.2 146.74 33.56 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.77 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 37.4 Cg_endo -64.04 132.38 34.19 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.375 1.197 . . . . 0.0 110.52 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.7 p -144.2 177.63 8.46 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.264 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -79.4 121.84 25.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.499 -0.751 . . . . 0.0 110.671 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 20' ' ' CYS . 11.7 m -90.98 62.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.605 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.69 -32.42 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.296 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.0 -86.32 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -110.72 142.34 42.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.141 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -62.27 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.439 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 19.8 t -87.19 113.02 22.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.643 0.735 . . . . 0.0 111.064 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 2' ' ' LYS . 67.7 m -44.53 -19.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.841 -0.537 . . . . 0.0 111.442 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -129.99 -12.22 4.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.764 -1.21 . . . . 0.0 112.922 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.78 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -149.51 -122.14 1.14 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.009 -2.043 . . . . 0.0 112.276 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.78 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.75 -176.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.895 . . . . 0.0 110.751 -178.176 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.916 ' O ' HG12 ' A' ' 10' ' ' VAL . 22.6 t -129.7 76.04 1.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.293 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.569 ' HB2' ' CE ' ' A' ' 25' ' ' MET . 4.2 mm? -92.19 45.2 1.2 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.808 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 136.01 -44.72 1.14 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.05 163.17 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.985 -0.715 . . . . 0.0 109.393 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 42.6 t -47.94 121.28 4.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.869 -1.145 . . . . 0.0 108.441 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -87.13 135.7 33.2 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 111.009 -178.271 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.614 ' CE3' ' HB3' ' A' ' 25' ' ' MET . 4.8 p90 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.001 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' CA ' ' A' ' 16' ' ' CYS . 27.5 p . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.141 0.496 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -150.96 132.86 15.08 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.219 -0.926 . . . . 0.0 110.227 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mp0 -71.87 137.89 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.28 140.12 0.46 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.539 -0.726 . . . . 0.0 111.547 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 5.1 m-20 81.65 5.3 1.27 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.042 0.449 . . . . 0.0 110.756 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mm-40 -107.55 149.44 38.87 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.1 Cg_endo -69.43 130.56 19.97 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.94 1.495 . . . . 0.0 110.651 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -139.5 177.37 7.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.702 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.96 114.57 22.97 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.672 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 10' ' ' VAL . 10.6 p -85.11 56.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -143.84 -37.47 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -75.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.968 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -123.44 153.03 41.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.673 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.85 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.308 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 6.4 t -73.66 118.1 16.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.866 -0.521 . . . . 0.0 109.875 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -38.76 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.674 -0.641 . . . . 0.0 111.336 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.74 HG23 ' HE1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.66 -13.6 2.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.845 -1.159 . . . . 0.0 111.808 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.944 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -121.3 -127.13 3.37 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.431 -1.842 . . . . 0.0 112.654 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.944 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -137.33 -175.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.747 -0.854 . . . . 0.0 110.447 -177.281 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.1 t -117.44 59.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.057 -1.027 . . . . 0.0 110.793 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 4.8 mp -88.71 49.6 1.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 131.48 -54.81 0.78 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 106.384 -2.686 . . . . 0.0 106.384 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.1 m -161.73 165.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 8.6 t -46.51 116.48 1.31 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.994 -1.066 . . . . 0.0 108.294 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TRP . 3.7 mtp -81.95 139.25 34.7 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.446 -0.784 . . . . 0.0 110.203 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.74 ' HE1' HG23 ' A' ' 17' ' ' THR . 4.9 p90 . . . . . 0 C--N 1.291 -1.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.6 p . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 1.6 mmtp -146.14 142.99 29.02 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 120.802 -1.186 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.2 mp0 -81.04 148.85 29.5 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.416 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.86 133.83 0.56 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.052 0.453 . . . . 0.0 111.121 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.7 t0 82.04 18.38 0.37 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.241 0.544 . . . . 0.0 110.027 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 52.7 mm-40 -106.76 136.88 19.37 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.02 137.92 27.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 111.005 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 1.2 p -160.36 177.37 10.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 110.882 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.41 131.5 34.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 109.566 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.6 p -89.55 59.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -141.18 -36.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 110.637 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.64 -74.57 0.45 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.663 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.7 pt? -114.39 147.8 38.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 111.218 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.657 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -162.6 -86.52 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.145 178.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.1 t -93.84 140.56 29.53 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.571 0.701 . . . . 0.0 110.67 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.71 -2.4 0.14 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.645 HG22 ' HD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -131.52 -8.1 3.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.289 -1.507 . . . . 0.0 113.343 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.511 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -162.67 -110.9 0.25 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 116.832 -2.604 . . . . 0.0 114.002 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -127.55 -150.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.625 -0.927 . . . . 0.0 111.874 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 t -148.83 76.09 1.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 111.537 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 5.5 mp -88.32 64.33 7.54 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.766 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 105.82 -52.08 0.72 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 106.023 -2.831 . . . . 0.0 106.023 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -162.11 159.28 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 26.1 t -43.78 115.0 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.949 -1.094 . . . . 0.0 109.917 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.576 ' O ' ' CE3' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -95.05 38.33 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 110.646 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.645 ' HD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.99 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.3 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 19.1 mmtt -144.06 144.3 31.56 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.183 -0.948 . . . . 0.0 110.069 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.2 mm-40 -72.11 140.97 49.16 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.02 127.8 1.64 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.611 -0.68 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 8.5 t70 88.49 17.91 0.06 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 120.979 0.419 . . . . 0.0 110.869 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.659 ' C ' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -106.83 147.56 35.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.023 -1.048 . . . . 0.0 109.719 179.121 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.28 137.03 38.99 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 124.463 1.77 . . . . 0.0 109.727 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.722 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 5.8 p -161.79 -178.56 6.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.361 -1.335 . . . . 0.0 112.677 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -110.67 145.27 38.26 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.476 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 10' ' ' VAL . 74.7 t -85.88 57.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 109.447 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -130.45 -38.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.117 -0.989 . . . . 0.0 109.963 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.81 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -82.9 102.62 11.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.701 -0.624 . . . . 0.0 111.084 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.754 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 23.3 p30 -160.18 -3.5 0.06 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.243 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.5 t 178.14 106.33 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.632 -1.292 . . . . 0.0 109.63 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -59.22 -3.09 0.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 112.352 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.596 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.1 t -128.48 1.76 5.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 112.841 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.47 -125.07 0.83 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 117.687 -2.197 . . . . 0.0 112.645 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.565 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -111.32 -143.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.805 -0.82 . . . . 0.0 110.6 -177.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 37.1 t -159.81 70.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.84 -1.163 . . . . 0.0 111.332 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.796 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.2 mm? -85.81 62.47 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 110.24 -48.77 0.9 Allowed Glycine 0 N--CA 1.483 1.821 0 N-CA-C 106.471 -2.651 . . . . 0.0 106.471 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.08 159.86 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.933 -0.745 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 42.8 t -56.73 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.094 -1.004 . . . . 0.0 109.061 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.583 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 7.1 mtp -84.9 52.97 2.56 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.026 -1.046 . . . . 0.0 112.962 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.0 m-90 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.099 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 11.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.957 0.408 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.603 ' HG3' ' HA ' ' A' ' 14' ' ' ASP . 12.4 mmtt -137.34 167.17 22.14 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 120.832 -1.168 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.9 mm-40 -95.49 137.53 34.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.059 -1.025 . . . . 0.0 109.616 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 116.64 0.52 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.649 -0.657 . . . . 0.0 110.79 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 18.4 t70 92.24 20.83 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 122.744 0.417 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.6 mt-10 -107.02 161.77 21.83 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.58 138.04 37.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.805 1.424 . . . . 0.0 109.416 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 11.7 p -150.86 177.82 9.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.161 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -120.82 146.33 46.65 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.999 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.48 56.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.913 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -136.46 -42.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 110.811 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -76.16 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.005 -1.059 . . . . 0.0 111.044 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.536 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 1.8 pp -78.68 111.28 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.685 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.675 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -160.7 -17.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.691 -1.203 . . . . 0.0 113.298 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 12.4 t -172.5 119.23 0.38 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.773 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 40.4 m -60.69 -6.78 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 111.1 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.956 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.6 t -133.07 0.94 3.49 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.856 -1.152 . . . . 0.0 112.266 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.96 -140.17 2.81 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.747 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.633 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -107.38 -147.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 122.341 -0.505 . . . . 0.0 110.304 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 51.5 t -135.31 83.14 2.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.349 -1.469 . . . . 0.0 111.12 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.597 HD23 ' HZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -87.8 51.2 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.756 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 107.28 -41.04 2.3 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.5 m -161.04 148.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.949 -0.736 . . . . 0.0 109.142 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 15.3 t -41.11 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 5.4 mmt -79.49 -165.2 0.75 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 119.896 -1.752 . . . . 0.0 107.826 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.956 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.503 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.768 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 31.5 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.103 0.477 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 14' ' ' ASP . 7.9 mmtt -153.13 158.24 41.55 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.441 -0.787 . . . . 0.0 108.924 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.6 mm100 -91.89 145.84 24.23 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.01 120.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.838 -0.539 . . . . 0.0 110.428 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.1 t0 86.94 30.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.08 0.467 . . . . 0.0 110.871 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 6.9 mm-40 -114.67 154.61 46.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.081 -1.012 . . . . 0.0 110.069 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.85 120.39 6.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.643 1.339 . . . . 0.0 110.041 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.3 p -140.05 171.56 14.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.077 -1.015 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.58 124.59 48.4 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 10' ' ' VAL . 9.2 p -85.16 54.19 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.041 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 54.3 m-85 -132.0 -17.62 2.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.175 -0.953 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.05 -54.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.929 -1.107 . . . . 0.0 110.875 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.813 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.3 pt? -136.82 144.38 43.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.81 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.94 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' MET . 0.8 OUTLIER -78.72 123.68 27.41 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.681 0.753 . . . . 0.0 109.755 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.69 -20.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.599 -0.688 . . . . 0.0 112.107 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -143.27 14.22 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.488 -1.382 . . . . 0.0 112.226 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.599 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -149.81 -126.44 1.43 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.624 -2.227 . . . . 0.0 113.027 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.658 HD11 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -130.2 178.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.491 0.662 . . . . 0.0 110.838 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -116.65 65.36 0.71 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 109.557 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 21' ' ' LEU . 1.9 mt -87.39 62.69 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.765 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.26 -50.81 0.76 Allowed Glycine 0 N--CA 1.481 1.658 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.7 m -162.86 -175.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 12.1 t -49.85 125.35 11.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.555 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 36.4 mmm -77.16 -174.91 3.4 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 120.242 -1.536 . . . . 0.0 109.301 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.658 ' CH2' HD11 ' A' ' 19' ' ' ILE . 1.1 m95 . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.237 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.7 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.015 0.436 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -145.25 156.06 43.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.013 -1.054 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 40.1 mm-40 -88.25 138.35 31.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 109.406 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.56 128.0 1.1 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.452 -0.78 . . . . 0.0 111.184 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 3.3 t0 83.3 19.53 0.21 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.041 -0.412 . . . . 0.0 111.143 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -109.13 165.49 12.54 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 120.866 -1.146 . . . . 0.0 109.697 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.462 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 40.1 Cg_endo -70.04 136.75 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.913 1.481 . . . . 0.0 109.618 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 19.2 p -148.81 -170.55 3.65 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.784 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 1.8 m-20 -122.34 131.03 53.7 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 20' ' ' CYS . 24.8 m -84.22 55.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.121 -0.987 . . . . 0.0 110.838 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -144.5 -27.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 0.0 111.088 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.557 ' N ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -161.55 -86.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.936 -1.102 . . . . 0.0 110.811 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pp -82.36 117.67 22.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.688 0.756 . . . . 0.0 110.779 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.84 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.761 -1.212 . . . . 0.0 111.889 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -149.51 110.24 4.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.802 -1.186 . . . . 0.0 109.477 -179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -43.99 -17.44 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.662 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -121.52 -21.74 6.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.36 -1.463 . . . . 0.0 112.681 -178.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -151.15 -141.16 3.3 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.144 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.771 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -95.63 -154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 122.086 -0.655 . . . . 0.0 110.479 -179.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -154.88 97.47 1.96 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 111.147 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 21' ' ' LEU . 2.9 mm? -90.83 59.81 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.119 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 113.69 -38.0 3.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -160.57 149.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.964 . . . . 0.0 109.047 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 48.9 t -39.34 107.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.694 0.759 . . . . 0.0 109.97 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.624 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.5 mmt -77.71 -164.08 0.47 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.506 -1.371 . . . . 0.0 108.758 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.662 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.37 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.406 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.076 0.465 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 4.3 mmtt -146.09 139.5 26.06 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.249 -0.907 . . . . 0.0 109.981 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.531 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 27.3 mm100 -72.17 141.47 49.07 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.283 -0.886 . . . . 0.0 110.016 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.31 136.88 0.61 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.687 -0.633 . . . . 0.0 111.439 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.5 m-20 80.91 10.22 0.99 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.309 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.626 ' C ' HG12 ' A' ' 23' ' ' VAL . 5.7 mm-40 -103.95 143.37 26.51 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.708 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 39.0 Cg_endo -67.07 140.95 55.93 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 124.73 1.911 . . . . 0.0 109.657 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.3 p -160.82 178.06 9.8 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.831 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 95.9 m-20 -101.22 137.87 38.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 0.0 109.872 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.7 p -85.49 58.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.511 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.49 -35.07 0.91 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.199 -0.938 . . . . 0.0 110.43 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -161.05 -80.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -178.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -87.53 104.02 16.1 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.813 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.718 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 p30 -160.63 10.62 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.571 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 7.4 t 175.13 106.96 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.967 -1.083 . . . . 0.0 109.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -60.46 -4.26 0.84 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 112.054 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -133.77 15.02 3.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.576 -1.327 . . . . 0.0 112.692 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.497 ' N ' ' SG ' ' A' ' 15' ' ' CYS . . . 179.09 -130.95 1.61 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 117.915 -2.088 . . . . 0.0 112.296 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.602 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.18 -149.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.827 -0.807 . . . . 0.0 110.106 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.9 t -158.74 78.2 0.77 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.349 -1.469 . . . . 0.0 111.958 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.734 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -89.22 47.45 1.49 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.784 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.76 -44.81 1.23 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -161.9 154.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.82 . . . . 0.0 109.982 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 41.9 t -61.05 99.62 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.033 -1.042 . . . . 0.0 108.862 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.619 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 8.4 mtp -94.33 53.52 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.576 -1.327 . . . . 0.0 113.447 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.619 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.686 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.0 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.051 0.453 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 13.4 mmtt -145.84 144.5 30.28 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.224 -0.922 . . . . 0.0 109.806 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 4' ' ' ALA . 29.2 mm100 -75.07 142.37 43.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.84 128.47 1.2 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.732 -0.605 . . . . 0.0 110.382 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.606 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t0 87.81 19.15 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.139 0.495 . . . . 0.0 110.536 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' C ' HG12 ' A' ' 23' ' ' VAL . 23.5 mm-40 -111.41 137.36 21.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.184 -0.947 . . . . 0.0 109.603 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' N ' HG12 ' A' ' 23' ' ' VAL . 41.7 Cg_endo -69.81 144.32 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.694 1.365 . . . . 0.0 110.846 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.4 p -160.75 -171.08 2.97 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.569 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.41 145.03 38.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 20' ' ' CYS . 15.5 t -84.96 56.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.23 -37.36 1.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 110.238 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 -79.03 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 111.155 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 1.2 pp -81.97 109.18 16.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.508 -0.745 . . . . 0.0 111.197 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -159.98 -12.64 0.05 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.116 -1.034 . . . . 0.0 113.068 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 50.3 t -173.19 111.98 0.21 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.678 -1.264 . . . . 0.0 110.287 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -56.29 -11.43 1.19 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.718 HG21 ' OXT' ' A' ' 26' ' ' TRP . 2.0 t -130.22 0.61 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.785 -1.197 . . . . 0.0 112.393 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -165.59 -152.5 7.17 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.364 -1.874 . . . . 0.0 112.012 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.68 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -97.28 -161.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.122 -0.634 . . . . 0.0 110.857 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 12.7 t -123.54 80.22 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 111.157 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 5.1 mp -88.83 55.12 3.24 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 103.75 -43.88 1.59 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.7 OUTLIER -160.86 140.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 5.3 t -41.15 98.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.7 mtt -76.15 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.725 -1.859 . . . . 0.0 107.43 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.718 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.899 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.72 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.237 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -142.29 143.89 33.02 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.162 -0.961 . . . . 0.0 109.432 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 2.8 mm-40 -79.18 142.05 36.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.25 127.85 1.36 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.752 -0.593 . . . . 0.0 111.063 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 83.44 19.61 0.2 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 61.8 mm-40 -107.88 154.43 41.04 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.224 -0.922 . . . . 0.0 109.283 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 41.7 Cg_endo -71.25 114.06 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.779 1.41 . . . . 0.0 109.736 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.695 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.0 p -132.65 172.16 12.89 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.707 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 12.3 m-20 -91.24 126.25 36.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 109.975 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 10' ' ' VAL . 14.2 p -88.93 61.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 110.074 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 0.8 OUTLIER -149.16 -35.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.025 -1.047 . . . . 0.0 110.56 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 13' ' ' LEU . 29.1 t -132.32 -86.79 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -113.73 136.87 52.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.547 -0.721 . . . . 0.0 109.087 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.695 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -162.03 -21.4 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.423 -1.311 . . . . 0.0 113.031 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.737 ' SG ' HG22 ' A' ' 17' ' ' THR . 20.7 t -141.23 108.66 5.56 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.359 -1.463 . . . . 0.0 111.106 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.93 -19.08 0.35 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.803 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.844 HG21 ' C ' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -108.88 -26.13 10.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.062 . . . . 0.0 112.312 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.424 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -160.57 -104.85 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 117.953 -2.07 . . . . 0.0 112.959 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.529 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.51 -164.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -1.076 . . . . 0.0 111.74 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 8.0 t -129.0 73.39 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.502 -0.749 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -88.15 51.71 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.793 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.32 -44.73 1.25 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 22' ' ' GLY . 1.8 m -162.91 171.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 49.7 t -45.45 121.05 2.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.95 -1.094 . . . . 0.0 108.399 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -82.83 171.7 13.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.843 -1.161 . . . . 0.0 110.71 -178.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.844 ' C ' HG21 ' A' ' 17' ' ' THR . 17.4 p90 . . . . . 0 N--CA 1.502 2.156 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.137 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.029 0.442 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -111.66 136.19 51.21 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 74.3 mm-40 -73.09 133.06 44.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.622 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 137.87 0.46 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.698 -0.626 . . . . 0.0 110.635 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.0 t70 87.76 4.84 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.992 0.425 . . . . 0.0 110.127 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -100.22 143.84 27.28 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.28 143.67 35.69 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.313 1.691 . . . . 0.0 109.679 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' CB ' ' HA ' ' A' ' 14' ' ' ASP . 1.7 p -161.2 179.95 7.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.383 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.7 OUTLIER -102.9 144.87 30.65 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 10' ' ' VAL . 23.2 m -83.83 54.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.472 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -127.81 -32.86 2.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.109 -0.995 . . . . 0.0 109.806 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.6 t -161.05 -83.49 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pt? -79.06 120.17 23.23 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.54 0.686 . . . . 0.0 110.812 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.709 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -38.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.828 -1.17 . . . . 0.0 111.938 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 17' ' ' THR . 44.3 t -151.03 117.23 5.62 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.35 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -8.83 0.53 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 111.411 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -134.22 -0.15 3.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.727 -1.233 . . . . 0.0 113.25 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.08 -110.13 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 116.98 -2.533 . . . . 0.0 113.999 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.635 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -135.07 -152.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.567 -0.96 . . . . 0.0 111.742 -175.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -145.19 77.63 1.53 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.975 -1.078 . . . . 0.0 111.957 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 21' ' ' LEU . 4.8 mt -90.81 52.52 2.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.709 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 114.04 -47.67 1.02 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.604 -2.598 . . . . 0.0 106.604 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -161.04 147.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.856 -0.79 . . . . 0.0 108.915 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.449 ' SG ' ' HA ' ' A' ' 4' ' ' ALA . 3.9 t -52.14 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.812 -1.18 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.575 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 5.8 mtp -82.87 52.03 2.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.968 -1.083 . . . . 0.0 111.823 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.635 ' CH2' HG13 ' A' ' 19' ' ' ILE . 8.5 m-90 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.998 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 29.2 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.071 0.462 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -146.24 144.71 30.06 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.155 -0.966 . . . . 0.0 109.923 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 36.7 mm-40 -75.22 142.32 43.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.674 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.52 139.43 0.4 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.653 -0.654 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.0 m-20 84.21 4.97 0.7 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 120.963 0.411 . . . . 0.0 110.247 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 mm-40 -96.84 137.38 21.37 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 121.037 -1.039 . . . . 0.0 110.059 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.11 140.31 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.155 1.608 . . . . 0.0 110.11 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.1 p -161.12 -174.66 4.46 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.727 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -106.52 148.01 28.71 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 10' ' ' VAL . 24.5 m -85.36 56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.085 -1.009 . . . . 0.0 109.453 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.6 -38.36 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.158 -0.964 . . . . 0.0 110.694 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.36 -73.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 111.636 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 pp -86.12 107.81 18.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.306 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.7 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -160.78 -18.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.743 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' ' HE3' ' A' ' 26' ' ' TRP . 35.8 t -173.03 114.53 0.25 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.672 -1.268 . . . . 0.0 110.23 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -57.7 -6.82 0.56 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 112.064 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -135.69 3.89 3.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.515 -1.366 . . . . 0.0 112.993 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.76 -132.92 1.43 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 117.321 -2.371 . . . . 0.0 113.025 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.594 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.68 -150.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 122.058 -0.672 . . . . 0.0 110.902 -177.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 32.1 t -148.09 76.94 1.39 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.587 -1.321 . . . . 0.0 111.482 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.0 mm? -88.47 51.53 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.75 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.44 -45.28 1.31 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.3 m -161.8 158.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.998 -0.707 . . . . 0.0 109.459 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.559 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 12.4 t -61.37 101.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 108.658 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.63 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -95.36 50.58 1.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.716 -1.24 . . . . 0.0 113.673 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.855 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.4 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.969 0.414 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -144.23 147.19 33.27 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.6 mm100 -76.27 137.92 40.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.186 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -38.74 121.57 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 111.138 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 11.3 t0 89.2 23.25 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.078 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mt-10 -112.51 157.63 39.66 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.389 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.6 Cg_endo -69.66 141.86 46.81 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.778 1.41 . . . . 0.0 109.513 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.6 p -155.83 174.85 14.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.88 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 1.1 m-20 -102.91 137.63 40.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 20' ' ' CYS . 29.4 m -83.65 55.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.295 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -141.57 -34.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.864 -1.148 . . . . 0.0 110.971 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.83 -80.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.079 . . . . 0.0 110.735 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -79.53 116.15 19.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 109.88 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.11 -23.61 0.06 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.771 -1.172 . . . . 0.0 112.618 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 17' ' ' THR . 46.5 t -164.21 117.16 1.38 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.056 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -54.32 -10.38 0.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 111.331 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.4 t -132.2 2.49 3.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.739 -1.225 . . . . 0.0 112.315 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 26' ' ' TRP . . . -166.49 -146.36 4.81 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 117.943 -2.075 . . . . 0.0 112.772 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.643 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -103.39 -156.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 122.222 -0.576 . . . . 0.0 110.745 -178.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.891 ' O ' HG12 ' A' ' 10' ' ' VAL . 49.5 t -132.1 75.01 1.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.634 -1.291 . . . . 0.0 110.833 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 21' ' ' LEU . 6.5 mt -88.48 51.77 2.27 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.791 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.78 -49.63 0.85 Allowed Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.0 m -161.96 150.05 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.866 -0.785 . . . . 0.0 109.048 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 4.8 t -43.49 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.761 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 3.1 mmm -78.05 -161.76 0.28 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 119.818 -1.802 . . . . 0.0 107.087 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.903 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.574 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.0 0.428 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -140.25 158.05 44.63 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.952 -1.093 . . . . 0.0 110.133 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.4 mm100 -88.28 139.86 30.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.626 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.99 120.49 0.86 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.647 . . . . 0.0 111.015 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t70 92.01 19.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.74 0.416 . . . . 0.0 111.755 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 1.4 mp0 -110.67 152.08 43.23 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 120.747 -1.221 . . . . 0.0 109.359 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.78 141.85 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.757 1.398 . . . . 0.0 110.465 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 6.1 p -158.22 178.66 9.94 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.238 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -103.52 145.74 29.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.211 0.529 . . . . 0.0 109.662 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 20' ' ' CYS . 3.5 t -86.15 54.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.78 -41.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.773 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.61 -76.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 111.557 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -78.94 105.77 10.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.733 -0.605 . . . . 0.0 110.703 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 2.9 p30 -161.04 -24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.874 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.8 t -161.28 109.79 1.54 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.872 -1.143 . . . . 0.0 110.211 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.44 -11.81 2.18 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.665 -0.647 . . . . 0.0 110.855 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.758 HG21 ' OXT' ' A' ' 26' ' ' TRP . 3.4 t -120.98 -7.66 9.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 112.128 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.88 -139.27 2.59 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.525 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.627 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -105.64 -149.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.123 -0.634 . . . . 0.0 110.669 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 49.2 t -139.65 77.06 1.59 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.426 -1.421 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.719 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.89 48.57 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.59 -43.89 1.56 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -161.67 146.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.811 -0.817 . . . . 0.0 109.482 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 39.1 t -41.54 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.684 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 4.8 mmm -78.42 -164.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 119.969 -1.707 . . . . 0.0 107.39 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.758 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.619 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.757 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.042 0.448 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -134.58 145.16 48.41 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.961 -1.087 . . . . 0.0 110.531 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 48.1 mm-40 -81.27 135.47 35.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 109.653 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.75 128.04 1.54 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 111.341 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t0 83.76 15.2 0.29 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.252 0.549 . . . . 0.0 110.397 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 60.9 mm-40 -104.37 145.23 30.28 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.537 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 39.9 Cg_endo -67.32 133.9 31.87 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.555 1.818 . . . . 0.0 109.417 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -160.59 169.86 22.05 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.241 -178.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 7.7 m-20 -96.06 142.25 28.48 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.9 p -85.66 59.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 0.0 109.385 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -24.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.203 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 31.2 t -161.0 -87.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.65 -1.281 . . . . 0.0 110.25 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -79.61 93.4 5.48 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.723 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -135.99 -17.83 1.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.584 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.717 ' SG ' HG22 ' A' ' 17' ' ' THR . 40.9 t -176.69 106.64 0.07 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.921 -1.112 . . . . 0.0 109.809 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -40.83 -21.17 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.889 -0.507 . . . . 0.0 111.935 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.717 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -111.04 -24.41 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.742 -1.224 . . . . 0.0 112.98 -178.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.7 -111.03 0.45 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 117.98 -2.057 . . . . 0.0 113.176 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.572 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -124.59 -152.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.81 -0.818 . . . . 0.0 110.904 -176.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.8 t -157.7 88.39 0.98 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.089 -1.007 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 4.0 mm? -88.17 51.99 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.661 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 123.01 -42.75 1.55 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.263 -2.735 . . . . 0.0 106.263 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 22' ' ' GLY . 21.4 m -160.72 158.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 1.7 t -63.94 94.63 0.1 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.952 -1.093 . . . . 0.0 109.368 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.3 mtp -86.47 52.8 2.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.76 -1.212 . . . . 0.0 110.719 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 15.0 m-90 . . . . . 0 C--N 1.295 -1.783 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.407 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 19.6 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' ASP . 22.2 mmtt -149.27 161.2 42.51 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.804 -1.185 . . . . 0.0 109.951 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -97.25 142.13 29.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.389 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.09 121.48 0.8 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 111.467 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 85.59 26.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.122 -0.361 . . . . 0.0 111.771 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -114.65 162.04 25.69 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.695 -1.253 . . . . 0.0 109.956 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 40.3 Cg_endo -69.22 117.22 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.818 1.431 . . . . 0.0 109.606 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.9 p -124.42 168.47 12.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 111.96 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.23 119.33 27.36 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' CZ ' ' A' ' 11' ' ' PHE . 11.2 m -86.08 52.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.591 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.6 -36.06 0.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.774 -1.204 . . . . 0.0 110.929 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.18 -82.94 0.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.123 -0.986 . . . . 0.0 110.605 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.75 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.3 pt? -106.02 152.56 23.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.5 -0.75 . . . . 0.0 110.386 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.719 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -161.99 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.131 -0.98 . . . . 0.0 111.37 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 1.1 t -81.31 134.28 35.56 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.743 0.782 . . . . 0.0 110.333 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 60.0 m -51.74 -12.96 0.22 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.701 -0.625 . . . . 0.0 112.201 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.666 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -134.07 -1.57 2.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.437 -1.414 . . . . 0.0 113.234 -178.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.31 -109.59 0.31 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 116.748 -2.644 . . . . 0.0 114.105 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.682 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.64 -161.82 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.752 0.786 . . . . 0.0 111.831 -175.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 44.4 t -135.55 80.27 1.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.663 . . . . 0.0 110.379 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 6.1 mp -88.75 52.27 2.38 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.748 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.27 -43.75 1.6 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.21 157.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.731 -0.864 . . . . 0.0 109.858 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 2' ' ' LYS . 37.8 t -39.83 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.7 . . . . 0.0 109.564 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.626 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -78.2 -162.46 0.34 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.296 -1.503 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.682 ' CH2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.389 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.05 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.9 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.282 0.563 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 12.8 mmtm -155.37 166.83 32.35 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.286 -0.884 . . . . 0.0 109.234 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -102.21 143.8 31.54 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.01 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.608 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.54 119.46 0.62 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.83 -0.544 . . . . 0.0 110.891 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.7 t0 88.15 27.26 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -112.93 159.87 32.95 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.429 -1.419 . . . . 0.0 110.632 178.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 43.3 Cg_endo -70.63 109.33 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.545 1.287 . . . . 0.0 109.942 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.1 p -128.24 170.0 13.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.38 124.62 34.62 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.293 0.568 . . . . 0.0 109.66 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -90.45 58.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.871 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -147.76 -34.08 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.187 . . . . 0.0 110.994 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.62 -76.81 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.9 pt? -122.48 153.59 38.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.645 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -161.6 -85.51 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.349 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -76.19 134.97 39.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.563 0.697 . . . . 0.0 109.464 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -49.24 -12.75 0.06 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.662 -0.649 . . . . 0.0 112.106 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 17' ' ' THR . 1.2 t -145.83 40.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.457 -1.402 . . . . 0.0 113.007 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . 171.24 -110.06 0.34 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 117.357 -2.354 . . . . 0.0 113.671 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -137.31 -164.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.128 -1.219 . . . . 0.0 112.33 -175.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.668 ' H ' HG22 ' A' ' 19' ' ' ILE . 23.2 t -131.67 76.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 109.793 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.725 HD22 ' HE3' ' A' ' 25' ' ' MET . 6.4 mp -86.97 63.32 7.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.706 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 108.84 -43.75 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 106.876 -2.489 . . . . 0.0 106.876 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 22' ' ' GLY . 13.7 m -161.49 -176.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 4' ' ' ALA . 4.7 t -47.48 120.35 3.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.725 ' HE3' HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -78.31 -169.09 1.51 Allowed 'General case' 0 C--N 1.288 -2.079 0 O-C-N 119.976 -1.702 . . . . 0.0 108.903 -178.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 19' ' ' ILE . 1.4 m95 . . . . . 0 C--N 1.283 -2.295 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.3 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.908 0.385 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -147.91 154.24 40.12 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.995 -1.066 . . . . 0.0 110.092 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -86.25 139.51 30.96 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.728 179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -37.63 119.94 0.77 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.381 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 23.0 t0 90.87 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 122.782 0.433 . . . . 0.0 111.416 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -117.57 156.23 49.57 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.977 -1.077 . . . . 0.0 109.151 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 42.8 Cg_endo -70.49 123.41 9.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.769 1.405 . . . . 0.0 110.43 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.8 p -134.96 172.56 12.83 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.11 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 20.1 t0 -79.41 124.72 28.71 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.499 0.666 . . . . 0.0 110.215 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 20' ' ' CYS . 3.9 m -90.53 57.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -158.1 -28.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.779 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.96 -83.48 0.31 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.914 -1.116 . . . . 0.0 110.033 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.75 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.3 pt? -110.65 148.39 32.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.972 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.702 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.27 -86.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.004 -1.06 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 17' ' ' THR . 49.5 t -77.49 125.35 29.19 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.425 0.631 . . . . 0.0 111.015 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.85 -10.75 1.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.536 -0.728 . . . . 0.0 110.846 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -127.93 -5.42 5.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.0 112.219 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.5 -142.72 3.47 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.203 -1.951 . . . . 0.0 112.123 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -102.21 -149.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.224 -0.574 . . . . 0.0 109.765 -179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.855 ' O ' HG12 ' A' ' 10' ' ' VAL . 46.4 t -153.83 81.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.295 -1.503 . . . . 0.0 111.688 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.734 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.3 mm? -89.85 43.74 1.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 130.25 -46.43 1.08 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -160.7 146.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.5 -1.0 . . . . 0.0 109.734 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 2.0 t -45.61 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 110.482 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 2.7 mmt -78.01 -162.97 0.37 Allowed 'General case' 0 C--N 1.292 -1.907 0 O-C-N 120.172 -1.58 . . . . 0.0 106.88 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.673 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.662 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.3 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.188 0.518 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -160.22 143.21 13.56 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mp0 -71.8 143.18 49.61 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.525 0.679 . . . . 0.0 111.052 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.13 134.88 1.02 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.576 -0.703 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.4 m-20 84.77 4.77 0.62 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.021 -0.424 . . . . 0.0 110.844 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.552 ' CG ' ' HG2' ' A' ' 2' ' ' LYS . 13.1 tp10 -96.16 143.07 25.48 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 120.901 -1.124 . . . . 0.0 109.076 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 38.8 Cg_endo -68.25 141.57 52.44 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.651 1.342 . . . . 0.0 110.014 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 p -160.81 -168.92 2.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.334 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.16 133.94 52.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' VAL . 6.3 p -85.81 60.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.123 -0.986 . . . . 0.0 110.202 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -139.0 -40.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.89 -77.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.327 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -119.21 132.35 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 110.121 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.679 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.84 -34.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.5 t -144.63 114.43 7.28 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.247 -0.908 . . . . 0.0 109.285 -178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -50.75 -13.0 0.12 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.518 -0.738 . . . . 0.0 111.874 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -135.95 11.61 3.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.442 -1.411 . . . . 0.0 112.53 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.554 ' HA3' ' CZ3' ' A' ' 26' ' ' TRP . . . -171.03 -164.11 26.19 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.266 -1.921 . . . . 0.0 111.996 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.728 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -84.68 -160.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 122.108 -0.642 . . . . 0.0 111.125 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 42.7 t -135.33 82.32 1.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.013 -1.055 . . . . 0.0 110.656 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -88.35 48.07 1.59 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.764 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.72 -41.25 2.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.4 143.4 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.855 . . . . 0.0 109.796 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 12.9 t -39.79 108.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.726 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 2.8 mmt -83.4 -166.69 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.232 -1.543 . . . . 0.0 108.223 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.728 ' CH2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.836 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 25.4 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 14' ' ' ASP . 18.0 mmtt -153.87 154.91 34.75 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.992 -1.067 . . . . 0.0 110.006 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 8.9 mm-40 -86.49 144.92 27.02 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.155 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.556 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.23 129.35 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.735 -0.603 . . . . 0.0 110.718 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.1 t70 79.97 26.05 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.736 -0.603 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 1.7 mm-40 -107.03 143.35 26.92 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.01 112.1 3.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.611 1.322 . . . . 0.0 109.943 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -124.74 168.19 13.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 15.6 m-20 -97.62 134.03 41.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.6 -0.688 . . . . 0.0 110.026 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 20' ' ' CYS . 33.8 m -85.42 57.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 10' ' ' VAL . 13.9 m-85 -133.66 -24.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 111.105 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.16 -73.17 0.07 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.925 -1.109 . . . . 0.0 110.998 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.9 pt? -110.35 147.36 34.1 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.802 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.743 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.96 -85.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 111.161 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 2.8 t -86.29 126.2 34.14 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.924 0.868 . . . . 0.0 110.529 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 61.6 m -47.6 -14.56 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.687 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -131.7 -11.6 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.33 -1.482 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.766 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -148.13 -128.41 1.77 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.575 -2.25 . . . . 0.0 113.109 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -110.37 -166.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.603 0.716 . . . . 0.0 111.6 -176.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.743 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.9 t -131.75 75.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.643 -0.661 . . . . 0.0 110.575 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.0 mt -88.29 62.43 6.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.746 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 111.82 -45.01 1.38 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 22' ' ' GLY . 6.1 m -161.22 179.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 50.9 t -65.21 103.74 0.82 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 108.772 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.634 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.5 -163.29 0.31 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 120.339 -1.476 . . . . 0.0 108.593 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.687 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.369 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.702 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 29.7 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.864 0.364 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtp -153.21 144.12 22.87 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.088 -1.007 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 18.8 mm100 -69.92 140.64 53.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 5' ' ' ASP . . . -38.93 143.15 0.17 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.44 -0.787 . . . . 0.0 111.619 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER 72.93 9.52 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.044 0.45 . . . . 0.0 110.582 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 10.8 tt0 -106.2 146.74 33.56 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.77 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 37.4 Cg_endo -64.04 132.38 34.19 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.375 1.197 . . . . 0.0 110.52 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.7 p -144.2 177.63 8.46 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.264 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -79.4 121.84 25.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.499 -0.751 . . . . 0.0 110.671 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 20' ' ' CYS . 11.7 m -90.98 62.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.605 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.69 -32.42 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.296 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.0 -86.32 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -110.72 142.34 42.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.141 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -62.27 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.439 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 19.8 t -87.19 113.02 22.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.643 0.735 . . . . 0.0 111.064 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 2' ' ' LYS . 67.7 m -44.53 -19.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.841 -0.537 . . . . 0.0 111.442 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -129.99 -12.22 4.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.764 -1.21 . . . . 0.0 112.922 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.78 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -149.51 -122.14 1.14 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.009 -2.043 . . . . 0.0 112.276 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.78 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.75 -176.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.895 . . . . 0.0 110.751 -178.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.916 ' O ' HG12 ' A' ' 10' ' ' VAL . 22.6 t -129.7 76.04 1.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.293 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.569 ' HB2' ' CE ' ' A' ' 25' ' ' MET . 4.2 mm? -92.19 45.2 1.2 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.808 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 136.01 -44.72 1.14 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.05 163.17 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.985 -0.715 . . . . 0.0 109.393 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 42.6 t -47.94 121.28 4.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.869 -1.145 . . . . 0.0 108.441 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -87.13 135.7 33.2 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 111.009 -178.271 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.614 ' CE3' ' HB3' ' A' ' 25' ' ' MET . 4.8 p90 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.001 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' CA ' ' A' ' 16' ' ' CYS . 27.5 p . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.141 0.496 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -150.96 132.86 15.08 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.219 -0.926 . . . . 0.0 110.227 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mp0 -71.87 137.89 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.28 140.12 0.46 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.539 -0.726 . . . . 0.0 111.547 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 5.1 m-20 81.65 5.3 1.27 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.042 0.449 . . . . 0.0 110.756 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mm-40 -107.55 149.44 38.87 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.1 Cg_endo -69.43 130.56 19.97 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.94 1.495 . . . . 0.0 110.651 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -139.5 177.37 7.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.702 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.96 114.57 22.97 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.672 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 10' ' ' VAL . 10.6 p -85.11 56.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -143.84 -37.47 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -75.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.968 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -123.44 153.03 41.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.673 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.85 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.308 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 6.4 t -73.66 118.1 16.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.866 -0.521 . . . . 0.0 109.875 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -38.76 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.674 -0.641 . . . . 0.0 111.336 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.74 HG23 ' HE1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.66 -13.6 2.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.845 -1.159 . . . . 0.0 111.808 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.944 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -121.3 -127.13 3.37 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.431 -1.842 . . . . 0.0 112.654 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.944 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -137.33 -175.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.747 -0.854 . . . . 0.0 110.447 -177.281 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.1 t -117.44 59.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.057 -1.027 . . . . 0.0 110.793 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 4.8 mp -88.71 49.6 1.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 131.48 -54.81 0.78 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 106.384 -2.686 . . . . 0.0 106.384 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.1 m -161.73 165.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 8.6 t -46.51 116.48 1.31 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.994 -1.066 . . . . 0.0 108.294 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TRP . 3.7 mtp -81.95 139.25 34.7 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.446 -0.784 . . . . 0.0 110.203 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.74 ' HE1' HG23 ' A' ' 17' ' ' THR . 4.9 p90 . . . . . 0 C--N 1.291 -1.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.6 p . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 1.6 mmtp -146.14 142.99 29.02 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 120.802 -1.186 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.2 mp0 -81.04 148.85 29.5 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.416 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.86 133.83 0.56 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.052 0.453 . . . . 0.0 111.121 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.7 t0 82.04 18.38 0.37 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.241 0.544 . . . . 0.0 110.027 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 52.7 mm-40 -106.76 136.88 19.37 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.02 137.92 27.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 111.005 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 1.2 p -160.36 177.37 10.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 110.882 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.41 131.5 34.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 109.566 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.6 p -89.55 59.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -141.18 -36.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 110.637 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.64 -74.57 0.45 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.663 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.758 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.7 pt? -114.39 147.8 38.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 111.218 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.657 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -162.6 -86.52 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.145 178.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.1 t -93.84 140.56 29.53 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.571 0.701 . . . . 0.0 110.67 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.71 -2.4 0.14 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.645 HG22 ' HD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -131.52 -8.1 3.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.289 -1.507 . . . . 0.0 113.343 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.511 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -162.67 -110.9 0.25 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 116.832 -2.604 . . . . 0.0 114.002 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.642 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -127.55 -150.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.625 -0.927 . . . . 0.0 111.874 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 t -148.83 76.09 1.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 111.537 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.5 mp -88.32 64.33 7.54 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.766 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 105.82 -52.08 0.72 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 106.023 -2.831 . . . . 0.0 106.023 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -162.11 159.28 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 26.1 t -43.78 115.0 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.949 -1.094 . . . . 0.0 109.917 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.576 ' O ' ' CE3' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -95.05 38.33 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 110.646 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.645 ' HD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.99 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.3 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 19.1 mmtt -144.06 144.3 31.56 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.183 -0.948 . . . . 0.0 110.069 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.2 mm-40 -72.11 140.97 49.16 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.02 127.8 1.64 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.611 -0.68 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 8.5 t70 88.49 17.91 0.06 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 120.979 0.419 . . . . 0.0 110.869 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.659 ' C ' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -106.83 147.56 35.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.023 -1.048 . . . . 0.0 109.719 179.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.28 137.03 38.99 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 124.463 1.77 . . . . 0.0 109.727 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.722 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 5.8 p -161.79 -178.56 6.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.361 -1.335 . . . . 0.0 112.677 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -110.67 145.27 38.26 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.476 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 10' ' ' VAL . 74.7 t -85.88 57.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 109.447 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -130.45 -38.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.117 -0.989 . . . . 0.0 109.963 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.81 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -82.9 102.62 11.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.701 -0.624 . . . . 0.0 111.084 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.754 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 23.3 p30 -160.18 -3.5 0.06 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.243 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.5 t 178.14 106.33 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.632 -1.292 . . . . 0.0 109.63 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -59.22 -3.09 0.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 112.352 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.596 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.1 t -128.48 1.76 5.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 112.841 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.47 -125.07 0.83 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 117.687 -2.197 . . . . 0.0 112.645 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.565 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -111.32 -143.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.805 -0.82 . . . . 0.0 110.6 -177.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 37.1 t -159.81 70.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.84 -1.163 . . . . 0.0 111.332 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.796 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.2 mm? -85.81 62.47 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 110.24 -48.77 0.9 Allowed Glycine 0 N--CA 1.483 1.821 0 N-CA-C 106.471 -2.651 . . . . 0.0 106.471 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.08 159.86 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.933 -0.745 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 42.8 t -56.73 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.094 -1.004 . . . . 0.0 109.061 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.583 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 7.1 mtp -84.9 52.97 2.56 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.026 -1.046 . . . . 0.0 112.962 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.0 m-90 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.099 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.583 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 11.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.957 0.408 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.603 ' HG3' ' HA ' ' A' ' 14' ' ' ASP . 12.4 mmtt -137.34 167.17 22.14 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 120.832 -1.168 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.1 mm-40 -95.49 137.53 34.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.059 -1.025 . . . . 0.0 109.616 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 116.64 0.52 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.649 -0.657 . . . . 0.0 110.79 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 18.4 t70 92.24 20.83 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 122.744 0.417 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.6 mt-10 -107.02 161.77 21.83 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.58 138.04 37.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.805 1.424 . . . . 0.0 109.416 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 11.7 p -150.86 177.82 9.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.161 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -120.82 146.33 46.65 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.999 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.48 56.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.913 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -136.46 -42.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 110.811 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -76.16 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.005 -1.059 . . . . 0.0 111.044 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.8 pp -78.68 111.28 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.685 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.675 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -160.7 -17.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.691 -1.203 . . . . 0.0 113.298 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 12.4 t -172.5 119.23 0.38 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.773 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 40.4 m -60.69 -6.78 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 111.1 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.956 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.6 t -133.07 0.94 3.49 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.856 -1.152 . . . . 0.0 112.266 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.96 -140.17 2.81 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.747 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.633 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -107.38 -147.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 122.341 -0.505 . . . . 0.0 110.304 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 51.5 t -135.31 83.14 2.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.349 -1.469 . . . . 0.0 111.12 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.597 HD23 ' HZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -87.8 51.2 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.756 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 107.28 -41.04 2.3 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.5 m -161.04 148.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.949 -0.736 . . . . 0.0 109.142 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 15.3 t -41.11 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 5.4 mmt -79.49 -165.2 0.75 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 119.896 -1.752 . . . . 0.0 107.826 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.956 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.503 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.768 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 31.5 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.103 0.477 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 14' ' ' ASP . 7.9 mmtt -153.13 158.24 41.55 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.441 -0.787 . . . . 0.0 108.924 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 26.3 mm-40 -91.89 145.84 24.23 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.01 120.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.838 -0.539 . . . . 0.0 110.428 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.1 t0 86.94 30.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.08 0.467 . . . . 0.0 110.871 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 6.9 mm-40 -114.67 154.61 46.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.081 -1.012 . . . . 0.0 110.069 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.85 120.39 6.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.643 1.339 . . . . 0.0 110.041 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.3 p -140.05 171.56 14.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.077 -1.015 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.58 124.59 48.4 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 10' ' ' VAL . 9.2 p -85.16 54.19 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.041 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 54.3 m-85 -132.0 -17.62 2.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.175 -0.953 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.05 -54.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.929 -1.107 . . . . 0.0 110.875 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.813 HD23 ' H ' ' A' ' 13' ' ' LEU . 2.3 pt? -136.82 144.38 43.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.81 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.94 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' MET . 0.8 OUTLIER -78.72 123.68 27.41 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.681 0.753 . . . . 0.0 109.755 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.69 -20.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.599 -0.688 . . . . 0.0 112.107 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -143.27 14.22 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.488 -1.382 . . . . 0.0 112.226 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.599 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -149.81 -126.44 1.43 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.624 -2.227 . . . . 0.0 113.027 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.658 HD11 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -130.2 178.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.491 0.662 . . . . 0.0 110.838 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -116.65 65.36 0.71 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 109.557 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 21' ' ' LEU . 1.9 mt -87.39 62.69 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.765 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.26 -50.81 0.76 Allowed Glycine 0 N--CA 1.481 1.658 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.7 m -162.86 -175.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 12.1 t -49.85 125.35 11.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.555 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 36.4 mmm -77.16 -174.91 3.4 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 120.242 -1.536 . . . . 0.0 109.301 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.658 ' CH2' HD11 ' A' ' 19' ' ' ILE . 1.1 m95 . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.237 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.7 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.015 0.436 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -145.25 156.06 43.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.013 -1.054 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.0 mm100 -88.25 138.35 31.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 109.406 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.56 128.0 1.1 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.452 -0.78 . . . . 0.0 111.184 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 3.3 t0 83.3 19.53 0.21 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.041 -0.412 . . . . 0.0 111.143 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -109.13 165.49 12.54 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 120.866 -1.146 . . . . 0.0 109.697 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.462 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 40.1 Cg_endo -70.04 136.75 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.913 1.481 . . . . 0.0 109.618 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 19.2 p -148.81 -170.55 3.65 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.784 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 1.8 m-20 -122.34 131.03 53.7 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 20' ' ' CYS . 24.8 m -84.22 55.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.121 -0.987 . . . . 0.0 110.838 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -144.5 -27.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 0.0 111.088 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.557 ' N ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -161.55 -86.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.936 -1.102 . . . . 0.0 110.811 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pp -82.36 117.67 22.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.688 0.756 . . . . 0.0 110.779 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.84 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.761 -1.212 . . . . 0.0 111.889 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -149.51 110.24 4.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.802 -1.186 . . . . 0.0 109.477 -179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -43.99 -17.44 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.662 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -121.52 -21.74 6.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.36 -1.463 . . . . 0.0 112.681 -178.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -151.15 -141.16 3.3 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.144 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.771 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -95.63 -154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 122.086 -0.655 . . . . 0.0 110.479 -179.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -154.88 97.47 1.96 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 111.147 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.824 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.9 mm? -90.83 59.81 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.119 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 113.69 -38.0 3.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -160.57 149.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.964 . . . . 0.0 109.047 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 48.9 t -39.34 107.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.694 0.759 . . . . 0.0 109.97 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.624 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.5 mmt -77.71 -164.08 0.47 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.506 -1.371 . . . . 0.0 108.758 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.662 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.37 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.406 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.076 0.465 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 4.3 mmtt -146.09 139.5 26.06 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.249 -0.907 . . . . 0.0 109.981 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.531 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 27.3 mm100 -72.17 141.47 49.07 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.283 -0.886 . . . . 0.0 110.016 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.31 136.88 0.61 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.687 -0.633 . . . . 0.0 111.439 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.5 m-20 80.91 10.22 0.99 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.309 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.626 ' C ' HG12 ' A' ' 23' ' ' VAL . 5.7 mm-40 -103.95 143.37 26.51 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.708 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 39.0 Cg_endo -67.07 140.95 55.93 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 124.73 1.911 . . . . 0.0 109.657 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.3 p -160.82 178.06 9.8 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.831 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 95.9 m-20 -101.22 137.87 38.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 0.0 109.872 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.7 p -85.49 58.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.511 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.49 -35.07 0.91 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.199 -0.938 . . . . 0.0 110.43 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -161.05 -80.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -178.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -87.53 104.02 16.1 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.813 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.718 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 p30 -160.63 10.62 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.571 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 7.4 t 175.13 106.96 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.967 -1.083 . . . . 0.0 109.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -60.46 -4.26 0.84 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 112.054 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -133.77 15.02 3.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.576 -1.327 . . . . 0.0 112.692 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.497 ' N ' ' SG ' ' A' ' 15' ' ' CYS . . . 179.09 -130.95 1.61 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 117.915 -2.088 . . . . 0.0 112.296 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.602 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.18 -149.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.827 -0.807 . . . . 0.0 110.106 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.9 t -158.74 78.2 0.77 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.349 -1.469 . . . . 0.0 111.958 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.734 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -89.22 47.45 1.49 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.784 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.76 -44.81 1.23 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -161.9 154.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.82 . . . . 0.0 109.982 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 41.9 t -61.05 99.62 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.033 -1.042 . . . . 0.0 108.862 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.619 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 8.4 mtp -94.33 53.52 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.576 -1.327 . . . . 0.0 113.447 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.619 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.686 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.0 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.051 0.453 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 13.4 mmtt -145.84 144.5 30.28 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.224 -0.922 . . . . 0.0 109.806 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 4' ' ' ALA . 29.2 mm100 -75.07 142.37 43.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.84 128.47 1.2 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.732 -0.605 . . . . 0.0 110.382 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.606 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t0 87.81 19.15 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.139 0.495 . . . . 0.0 110.536 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.518 ' C ' HG12 ' A' ' 23' ' ' VAL . 23.5 mm-40 -111.41 137.36 21.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.184 -0.947 . . . . 0.0 109.603 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' N ' HG12 ' A' ' 23' ' ' VAL . 41.7 Cg_endo -69.81 144.32 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.694 1.365 . . . . 0.0 110.846 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.4 p -160.75 -171.08 2.97 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.569 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.41 145.03 38.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 20' ' ' CYS . 15.5 t -84.96 56.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.23 -37.36 1.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 110.238 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 -79.03 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 111.155 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.2 pp -81.97 109.18 16.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.508 -0.745 . . . . 0.0 111.197 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -159.98 -12.64 0.05 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.116 -1.034 . . . . 0.0 113.068 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 50.3 t -173.19 111.98 0.21 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.678 -1.264 . . . . 0.0 110.287 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -56.29 -11.43 1.19 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.718 HG21 ' OXT' ' A' ' 26' ' ' TRP . 2.0 t -130.22 0.61 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.785 -1.197 . . . . 0.0 112.393 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -165.59 -152.5 7.17 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.364 -1.874 . . . . 0.0 112.012 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.68 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -97.28 -161.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.122 -0.634 . . . . 0.0 110.857 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 12.7 t -123.54 80.22 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 111.157 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.1 mp -88.83 55.12 3.24 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 103.75 -43.88 1.59 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.7 OUTLIER -160.86 140.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 5.3 t -41.15 98.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.7 mtt -76.15 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.725 -1.859 . . . . 0.0 107.43 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.718 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.899 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.72 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.237 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -142.29 143.89 33.02 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.162 -0.961 . . . . 0.0 109.432 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 2.8 mm-40 -79.18 142.05 36.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.25 127.85 1.36 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.752 -0.593 . . . . 0.0 111.063 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 83.44 19.61 0.2 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 61.8 mm-40 -107.88 154.43 41.04 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.224 -0.922 . . . . 0.0 109.283 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 41.7 Cg_endo -71.25 114.06 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.779 1.41 . . . . 0.0 109.736 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.695 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.0 p -132.65 172.16 12.89 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.707 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 12.3 m-20 -91.24 126.25 36.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 109.975 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 10' ' ' VAL . 14.2 p -88.93 61.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 110.074 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 0.8 OUTLIER -149.16 -35.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.025 -1.047 . . . . 0.0 110.56 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 13' ' ' LEU . 29.1 t -132.32 -86.79 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -113.73 136.87 52.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.547 -0.721 . . . . 0.0 109.087 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.695 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -162.03 -21.4 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.423 -1.311 . . . . 0.0 113.031 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.737 ' SG ' HG22 ' A' ' 17' ' ' THR . 20.7 t -141.23 108.66 5.56 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.359 -1.463 . . . . 0.0 111.106 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.93 -19.08 0.35 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.803 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.844 HG21 ' C ' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -108.88 -26.13 10.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.062 . . . . 0.0 112.312 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.424 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -160.57 -104.85 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 117.953 -2.07 . . . . 0.0 112.959 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.529 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.51 -164.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -1.076 . . . . 0.0 111.74 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 8.0 t -129.0 73.39 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.502 -0.749 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.731 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -88.15 51.71 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.793 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.32 -44.73 1.25 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 22' ' ' GLY . 1.8 m -162.91 171.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 49.7 t -45.45 121.05 2.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.95 -1.094 . . . . 0.0 108.399 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -82.83 171.7 13.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.843 -1.161 . . . . 0.0 110.71 -178.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.844 ' C ' HG21 ' A' ' 17' ' ' THR . 17.4 p90 . . . . . 0 N--CA 1.502 2.156 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.137 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.029 0.442 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -111.66 136.19 51.21 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.7 mm100 -73.09 133.06 44.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.622 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 137.87 0.46 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.698 -0.626 . . . . 0.0 110.635 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.0 t70 87.76 4.84 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.992 0.425 . . . . 0.0 110.127 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -100.22 143.84 27.28 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.28 143.67 35.69 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.313 1.691 . . . . 0.0 109.679 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' CB ' ' HA ' ' A' ' 14' ' ' ASP . 1.7 p -161.2 179.95 7.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.383 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.7 OUTLIER -102.9 144.87 30.65 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 10' ' ' VAL . 23.2 m -83.83 54.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.472 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -127.81 -32.86 2.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.109 -0.995 . . . . 0.0 109.806 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.6 t -161.05 -83.49 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pt? -79.06 120.17 23.23 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.54 0.686 . . . . 0.0 110.812 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.709 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -38.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.828 -1.17 . . . . 0.0 111.938 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 17' ' ' THR . 44.3 t -151.03 117.23 5.62 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.35 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -8.83 0.53 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 111.411 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -134.22 -0.15 3.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.727 -1.233 . . . . 0.0 113.25 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.08 -110.13 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 116.98 -2.533 . . . . 0.0 113.999 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.635 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -135.07 -152.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.567 -0.96 . . . . 0.0 111.742 -175.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -145.19 77.63 1.53 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.975 -1.078 . . . . 0.0 111.957 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 21' ' ' LEU . 4.8 mt -90.81 52.52 2.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.709 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 114.04 -47.67 1.02 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.604 -2.598 . . . . 0.0 106.604 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -161.04 147.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.856 -0.79 . . . . 0.0 108.915 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.449 ' SG ' ' HA ' ' A' ' 4' ' ' ALA . 3.9 t -52.14 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.812 -1.18 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.575 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 5.8 mtp -82.87 52.03 2.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.968 -1.083 . . . . 0.0 111.823 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.635 ' CH2' HG13 ' A' ' 19' ' ' ILE . 8.5 m-90 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.998 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 29.2 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.071 0.462 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -146.24 144.71 30.06 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.155 -0.966 . . . . 0.0 109.923 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 36.7 mm-40 -75.22 142.32 43.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.674 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.52 139.43 0.4 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.653 -0.654 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.0 m-20 84.21 4.97 0.7 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 120.963 0.411 . . . . 0.0 110.247 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 mm-40 -96.84 137.38 21.37 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 121.037 -1.039 . . . . 0.0 110.059 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.11 140.31 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.155 1.608 . . . . 0.0 110.11 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.1 p -161.12 -174.66 4.46 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.727 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -106.52 148.01 28.71 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 10' ' ' VAL . 24.5 m -85.36 56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.085 -1.009 . . . . 0.0 109.453 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.6 -38.36 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.158 -0.964 . . . . 0.0 110.694 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.36 -73.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 111.636 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 pp -86.12 107.81 18.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.306 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.7 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -160.78 -18.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.743 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' ' HE3' ' A' ' 26' ' ' TRP . 35.8 t -173.03 114.53 0.25 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.672 -1.268 . . . . 0.0 110.23 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -57.7 -6.82 0.56 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 112.064 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -135.69 3.89 3.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.515 -1.366 . . . . 0.0 112.993 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.76 -132.92 1.43 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 117.321 -2.371 . . . . 0.0 113.025 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.594 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.68 -150.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 122.058 -0.672 . . . . 0.0 110.902 -177.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 32.1 t -148.09 76.94 1.39 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.587 -1.321 . . . . 0.0 111.482 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.0 mm? -88.47 51.53 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.75 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.44 -45.28 1.31 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.3 m -161.8 158.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.998 -0.707 . . . . 0.0 109.459 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.559 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 12.4 t -61.37 101.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 108.658 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.63 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -95.36 50.58 1.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.716 -1.24 . . . . 0.0 113.673 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.855 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.4 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.969 0.414 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -144.23 147.19 33.27 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 5.8 mm-40 -76.27 137.92 40.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.186 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -38.74 121.57 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 111.138 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 11.3 t0 89.2 23.25 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.078 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mt-10 -112.51 157.63 39.66 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.389 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.6 Cg_endo -69.66 141.86 46.81 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.778 1.41 . . . . 0.0 109.513 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.6 p -155.83 174.85 14.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.88 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 1.1 m-20 -102.91 137.63 40.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 20' ' ' CYS . 29.4 m -83.65 55.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.295 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -141.57 -34.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.864 -1.148 . . . . 0.0 110.971 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.83 -80.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.079 . . . . 0.0 110.735 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -79.53 116.15 19.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 109.88 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.11 -23.61 0.06 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.771 -1.172 . . . . 0.0 112.618 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 17' ' ' THR . 46.5 t -164.21 117.16 1.38 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.056 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -54.32 -10.38 0.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 111.331 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.4 t -132.2 2.49 3.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.739 -1.225 . . . . 0.0 112.315 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 26' ' ' TRP . . . -166.49 -146.36 4.81 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 117.943 -2.075 . . . . 0.0 112.772 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.643 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -103.39 -156.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 122.222 -0.576 . . . . 0.0 110.745 -178.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.891 ' O ' HG12 ' A' ' 10' ' ' VAL . 49.5 t -132.1 75.01 1.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.634 -1.291 . . . . 0.0 110.833 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 21' ' ' LEU . 6.5 mt -88.48 51.77 2.27 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.791 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.78 -49.63 0.85 Allowed Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.0 m -161.96 150.05 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.866 -0.785 . . . . 0.0 109.048 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 4.8 t -43.49 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.761 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 3.1 mmm -78.05 -161.76 0.28 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 119.818 -1.802 . . . . 0.0 107.087 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.903 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.574 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.0 0.428 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -140.25 158.05 44.63 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.952 -1.093 . . . . 0.0 110.133 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.3 mm-40 -88.28 139.86 30.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.626 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.99 120.49 0.86 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.647 . . . . 0.0 111.015 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t70 92.01 19.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.74 0.416 . . . . 0.0 111.755 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 1.4 mp0 -110.67 152.08 43.23 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 120.747 -1.221 . . . . 0.0 109.359 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.78 141.85 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.757 1.398 . . . . 0.0 110.465 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 6.1 p -158.22 178.66 9.94 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.238 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -103.52 145.74 29.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.211 0.529 . . . . 0.0 109.662 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 20' ' ' CYS . 3.5 t -86.15 54.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.78 -41.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.773 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.61 -76.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 111.557 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -78.94 105.77 10.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.733 -0.605 . . . . 0.0 110.703 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 2.9 p30 -161.04 -24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.874 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.8 t -161.28 109.79 1.54 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.872 -1.143 . . . . 0.0 110.211 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.44 -11.81 2.18 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.665 -0.647 . . . . 0.0 110.855 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.758 HG21 ' OXT' ' A' ' 26' ' ' TRP . 3.4 t -120.98 -7.66 9.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 112.128 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.88 -139.27 2.59 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.525 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.627 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -105.64 -149.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.123 -0.634 . . . . 0.0 110.669 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 49.2 t -139.65 77.06 1.59 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.426 -1.421 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.719 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.6 mm? -86.89 48.57 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.59 -43.89 1.56 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -161.67 146.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.811 -0.817 . . . . 0.0 109.482 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 39.1 t -41.54 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.684 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 4.8 mmm -78.42 -164.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 119.969 -1.707 . . . . 0.0 107.39 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.758 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.619 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.757 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.042 0.448 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -134.58 145.16 48.41 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.961 -1.087 . . . . 0.0 110.531 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.7 mm100 -81.27 135.47 35.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 109.653 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.75 128.04 1.54 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 111.341 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t0 83.76 15.2 0.29 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.252 0.549 . . . . 0.0 110.397 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 60.9 mm-40 -104.37 145.23 30.28 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.537 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 39.9 Cg_endo -67.32 133.9 31.87 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.555 1.818 . . . . 0.0 109.417 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -160.59 169.86 22.05 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.241 -178.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 7.7 m-20 -96.06 142.25 28.48 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.9 p -85.66 59.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 0.0 109.385 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -24.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.203 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 31.2 t -161.0 -87.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.65 -1.281 . . . . 0.0 110.25 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -79.61 93.4 5.48 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.723 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -135.99 -17.83 1.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.584 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.717 ' SG ' HG22 ' A' ' 17' ' ' THR . 40.9 t -176.69 106.64 0.07 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.921 -1.112 . . . . 0.0 109.809 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -40.83 -21.17 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.889 -0.507 . . . . 0.0 111.935 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.717 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -111.04 -24.41 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.742 -1.224 . . . . 0.0 112.98 -178.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.7 -111.03 0.45 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 117.98 -2.057 . . . . 0.0 113.176 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.572 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -124.59 -152.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.81 -0.818 . . . . 0.0 110.904 -176.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.8 t -157.7 88.39 0.98 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.089 -1.007 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -88.17 51.99 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.661 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 123.01 -42.75 1.55 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.263 -2.735 . . . . 0.0 106.263 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 22' ' ' GLY . 21.4 m -160.72 158.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 1.7 t -63.94 94.63 0.1 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.952 -1.093 . . . . 0.0 109.368 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.3 mtp -86.47 52.8 2.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.76 -1.212 . . . . 0.0 110.719 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 15.0 m-90 . . . . . 0 C--N 1.295 -1.783 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.407 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 19.6 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' ASP . 22.2 mmtt -149.27 161.2 42.51 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.804 -1.185 . . . . 0.0 109.951 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -97.25 142.13 29.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.389 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.09 121.48 0.8 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 111.467 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 85.59 26.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.122 -0.361 . . . . 0.0 111.771 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -114.65 162.04 25.69 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.695 -1.253 . . . . 0.0 109.956 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 40.3 Cg_endo -69.22 117.22 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.818 1.431 . . . . 0.0 109.606 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.9 p -124.42 168.47 12.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 111.96 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.23 119.33 27.36 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' CZ ' ' A' ' 11' ' ' PHE . 11.2 m -86.08 52.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.591 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.6 -36.06 0.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.774 -1.204 . . . . 0.0 110.929 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.18 -82.94 0.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.123 -0.986 . . . . 0.0 110.605 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.3 pt? -106.02 152.56 23.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.5 -0.75 . . . . 0.0 110.386 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.719 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -161.99 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.131 -0.98 . . . . 0.0 111.37 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 1.1 t -81.31 134.28 35.56 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.743 0.782 . . . . 0.0 110.333 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 60.0 m -51.74 -12.96 0.22 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.701 -0.625 . . . . 0.0 112.201 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.666 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -134.07 -1.57 2.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.437 -1.414 . . . . 0.0 113.234 -178.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.31 -109.59 0.31 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 116.748 -2.644 . . . . 0.0 114.105 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.682 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.64 -161.82 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.752 0.786 . . . . 0.0 111.831 -175.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 44.4 t -135.55 80.27 1.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.663 . . . . 0.0 110.379 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 6.1 mp -88.75 52.27 2.38 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.748 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.27 -43.75 1.6 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.21 157.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.731 -0.864 . . . . 0.0 109.858 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 2' ' ' LYS . 37.8 t -39.83 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.7 . . . . 0.0 109.564 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.626 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -78.2 -162.46 0.34 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.296 -1.503 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.682 ' CH2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.389 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.05 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.9 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.282 0.563 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 12.8 mmtm -155.37 166.83 32.35 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.286 -0.884 . . . . 0.0 109.234 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -102.21 143.8 31.54 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.01 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.608 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.54 119.46 0.62 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.83 -0.544 . . . . 0.0 110.891 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.7 t0 88.15 27.26 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -112.93 159.87 32.95 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.429 -1.419 . . . . 0.0 110.632 178.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 43.3 Cg_endo -70.63 109.33 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.545 1.287 . . . . 0.0 109.942 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.1 p -128.24 170.0 13.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.38 124.62 34.62 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.293 0.568 . . . . 0.0 109.66 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -90.45 58.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.871 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -147.76 -34.08 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.187 . . . . 0.0 110.994 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.62 -76.81 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.9 pt? -122.48 153.59 38.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.645 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -161.6 -85.51 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.349 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -76.19 134.97 39.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.563 0.697 . . . . 0.0 109.464 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -49.24 -12.75 0.06 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.662 -0.649 . . . . 0.0 112.106 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 17' ' ' THR . 1.2 t -145.83 40.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.457 -1.402 . . . . 0.0 113.007 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . 171.24 -110.06 0.34 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 117.357 -2.354 . . . . 0.0 113.671 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -137.31 -164.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.128 -1.219 . . . . 0.0 112.33 -175.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.668 ' H ' HG22 ' A' ' 19' ' ' ILE . 23.2 t -131.67 76.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 109.793 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.725 HD22 ' HE3' ' A' ' 25' ' ' MET . 6.4 mp -86.97 63.32 7.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.706 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 108.84 -43.75 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 106.876 -2.489 . . . . 0.0 106.876 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 22' ' ' GLY . 13.7 m -161.49 -176.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 4' ' ' ALA . 4.7 t -47.48 120.35 3.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.725 ' HE3' HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -78.31 -169.09 1.51 Allowed 'General case' 0 C--N 1.288 -2.079 0 O-C-N 119.976 -1.702 . . . . 0.0 108.903 -178.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 19' ' ' ILE . 1.4 m95 . . . . . 0 C--N 1.283 -2.295 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.3 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.908 0.385 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -147.91 154.24 40.12 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.995 -1.066 . . . . 0.0 110.092 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -86.25 139.51 30.96 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.728 179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -37.63 119.94 0.77 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.381 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 23.0 t0 90.87 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 122.782 0.433 . . . . 0.0 111.416 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -117.57 156.23 49.57 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.977 -1.077 . . . . 0.0 109.151 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 42.8 Cg_endo -70.49 123.41 9.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.769 1.405 . . . . 0.0 110.43 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.8 p -134.96 172.56 12.83 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.11 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 20.1 t0 -79.41 124.72 28.71 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.499 0.666 . . . . 0.0 110.215 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 20' ' ' CYS . 3.9 m -90.53 57.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -158.1 -28.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.779 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.96 -83.48 0.31 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.914 -1.116 . . . . 0.0 110.033 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.3 pt? -110.65 148.39 32.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.972 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.702 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.27 -86.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.004 -1.06 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 17' ' ' THR . 49.5 t -77.49 125.35 29.19 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.425 0.631 . . . . 0.0 111.015 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.85 -10.75 1.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.536 -0.728 . . . . 0.0 110.846 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -127.93 -5.42 5.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.0 112.219 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.5 -142.72 3.47 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.203 -1.951 . . . . 0.0 112.123 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -102.21 -149.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.224 -0.574 . . . . 0.0 109.765 -179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.855 ' O ' HG12 ' A' ' 10' ' ' VAL . 46.4 t -153.83 81.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.295 -1.503 . . . . 0.0 111.688 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.734 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.3 mm? -89.85 43.74 1.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 130.25 -46.43 1.08 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -160.7 146.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.5 -1.0 . . . . 0.0 109.734 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 2.0 t -45.61 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 110.482 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 2.7 mmt -78.01 -162.97 0.37 Allowed 'General case' 0 C--N 1.292 -1.907 0 O-C-N 120.172 -1.58 . . . . 0.0 106.88 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.673 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.662 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.3 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.188 0.518 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -160.22 143.21 13.56 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.8 143.18 49.61 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.525 0.679 . . . . 0.0 111.052 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.13 134.88 1.02 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.576 -0.703 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.4 m-20 84.77 4.77 0.62 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.021 -0.424 . . . . 0.0 110.844 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.552 ' CG ' ' HG2' ' A' ' 2' ' ' LYS . 13.1 tp10 -96.16 143.07 25.48 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 120.901 -1.124 . . . . 0.0 109.076 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 38.8 Cg_endo -68.25 141.57 52.44 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.651 1.342 . . . . 0.0 110.014 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 p -160.81 -168.92 2.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.334 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.16 133.94 52.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' VAL . 6.3 p -85.81 60.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.123 -0.986 . . . . 0.0 110.202 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -139.0 -40.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.89 -77.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.327 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -119.21 132.35 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 110.121 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.679 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.84 -34.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.5 t -144.63 114.43 7.28 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.247 -0.908 . . . . 0.0 109.285 -178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -50.75 -13.0 0.12 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.518 -0.738 . . . . 0.0 111.874 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -135.95 11.61 3.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.442 -1.411 . . . . 0.0 112.53 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.554 ' HA3' ' CZ3' ' A' ' 26' ' ' TRP . . . -171.03 -164.11 26.19 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.266 -1.921 . . . . 0.0 111.996 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.728 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -84.68 -160.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 122.108 -0.642 . . . . 0.0 111.125 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 42.7 t -135.33 82.32 1.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.013 -1.055 . . . . 0.0 110.656 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -88.35 48.07 1.59 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.764 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.72 -41.25 2.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.4 143.4 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.855 . . . . 0.0 109.796 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 12.9 t -39.79 108.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.726 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 2.8 mmt -83.4 -166.69 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.232 -1.543 . . . . 0.0 108.223 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.728 ' CH2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.836 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 25.4 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 14' ' ' ASP . 18.0 mmtt -153.87 154.91 34.75 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.992 -1.067 . . . . 0.0 110.006 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 8.9 mm-40 -86.49 144.92 27.02 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.155 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.556 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.23 129.35 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.735 -0.603 . . . . 0.0 110.718 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.1 t70 79.97 26.05 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.736 -0.603 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 1.7 mm-40 -107.03 143.35 26.92 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.01 112.1 3.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.611 1.322 . . . . 0.0 109.943 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -124.74 168.19 13.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 15.6 m-20 -97.62 134.03 41.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.6 -0.688 . . . . 0.0 110.026 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 20' ' ' CYS . 33.8 m -85.42 57.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 10' ' ' VAL . 13.9 m-85 -133.66 -24.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 111.105 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.16 -73.17 0.07 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.925 -1.109 . . . . 0.0 110.998 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.855 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.9 pt? -110.35 147.36 34.1 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.802 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.743 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.96 -85.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 111.161 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 2.8 t -86.29 126.2 34.14 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.924 0.868 . . . . 0.0 110.529 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 61.6 m -47.6 -14.56 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.687 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -131.7 -11.6 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.33 -1.482 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.766 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -148.13 -128.41 1.77 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.575 -2.25 . . . . 0.0 113.109 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -110.37 -166.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.603 0.716 . . . . 0.0 111.6 -176.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.743 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.9 t -131.75 75.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.643 -0.661 . . . . 0.0 110.575 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.0 mt -88.29 62.43 6.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.746 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 111.82 -45.01 1.38 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 22' ' ' GLY . 6.1 m -161.22 179.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 50.9 t -65.21 103.74 0.82 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 108.772 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.634 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.5 -163.29 0.31 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 120.339 -1.476 . . . . 0.0 108.593 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.687 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.369 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.702 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 29.7 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.864 0.364 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtp -153.21 144.12 22.87 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.088 -1.007 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 18.8 mm100 -69.92 140.64 53.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 5' ' ' ASP . . . -38.93 143.15 0.17 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.44 -0.787 . . . . 0.0 111.619 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER 72.93 9.52 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.044 0.45 . . . . 0.0 110.582 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 10.8 tt0 -106.2 146.74 33.56 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.77 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 37.4 Cg_endo -64.04 132.38 34.19 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.375 1.197 . . . . 0.0 110.52 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.7 p -144.2 177.63 8.46 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.264 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -79.4 121.84 25.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.499 -0.751 . . . . 0.0 110.671 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 20' ' ' CYS . 11.7 m -90.98 62.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.605 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.69 -32.42 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.296 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.0 -86.32 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -110.72 142.34 42.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.141 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -62.27 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.439 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 19.8 t -87.19 113.02 22.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.643 0.735 . . . . 0.0 111.064 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 2' ' ' LYS . 67.7 m -44.53 -19.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.841 -0.537 . . . . 0.0 111.442 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -129.99 -12.22 4.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.764 -1.21 . . . . 0.0 112.922 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.78 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -149.51 -122.14 1.14 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.009 -2.043 . . . . 0.0 112.276 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.78 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.75 -176.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.895 . . . . 0.0 110.751 -178.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.916 ' O ' HG12 ' A' ' 10' ' ' VAL . 22.6 t -129.7 76.04 1.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.293 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.569 ' HB2' ' CE ' ' A' ' 25' ' ' MET . 4.2 mm? -92.19 45.2 1.2 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.808 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 136.01 -44.72 1.14 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.05 163.17 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.985 -0.715 . . . . 0.0 109.393 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 42.6 t -47.94 121.28 4.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.869 -1.145 . . . . 0.0 108.441 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -87.13 135.7 33.2 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 111.009 -178.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.614 ' CE3' ' HB3' ' A' ' 25' ' ' MET . 4.8 p90 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.001 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' CA ' ' A' ' 16' ' ' CYS . 27.5 p . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.141 0.496 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -150.96 132.86 15.08 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.219 -0.926 . . . . 0.0 110.227 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.87 137.89 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.28 140.12 0.46 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.539 -0.726 . . . . 0.0 111.547 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 5.1 m-20 81.65 5.3 1.27 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.042 0.449 . . . . 0.0 110.756 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mm-40 -107.55 149.44 38.87 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.1 Cg_endo -69.43 130.56 19.97 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.94 1.495 . . . . 0.0 110.651 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -139.5 177.37 7.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.702 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.96 114.57 22.97 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.672 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 10' ' ' VAL . 10.6 p -85.11 56.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -143.84 -37.47 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -75.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.968 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -123.44 153.03 41.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.673 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.85 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.308 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 6.4 t -73.66 118.1 16.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.866 -0.521 . . . . 0.0 109.875 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -38.76 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.674 -0.641 . . . . 0.0 111.336 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.74 HG23 ' HE1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.66 -13.6 2.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.845 -1.159 . . . . 0.0 111.808 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.944 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -121.3 -127.13 3.37 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.431 -1.842 . . . . 0.0 112.654 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.944 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -137.33 -175.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.747 -0.854 . . . . 0.0 110.447 -177.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.1 t -117.44 59.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.057 -1.027 . . . . 0.0 110.793 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 4.8 mp -88.71 49.6 1.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 131.48 -54.81 0.78 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 106.384 -2.686 . . . . 0.0 106.384 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.1 m -161.73 165.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 8.6 t -46.51 116.48 1.31 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.994 -1.066 . . . . 0.0 108.294 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TRP . 3.7 mtp -81.95 139.25 34.7 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.446 -0.784 . . . . 0.0 110.203 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.74 ' HE1' HG23 ' A' ' 17' ' ' THR . 4.9 p90 . . . . . 0 C--N 1.291 -1.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.6 p . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 1.6 mmtp -146.14 142.99 29.02 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 120.802 -1.186 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.2 mp0 -81.04 148.85 29.5 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.416 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.86 133.83 0.56 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.052 0.453 . . . . 0.0 111.121 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.7 t0 82.04 18.38 0.37 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.241 0.544 . . . . 0.0 110.027 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 52.7 mm-40 -106.76 136.88 19.37 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.02 137.92 27.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 111.005 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 1.2 p -160.36 177.37 10.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 110.882 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.41 131.5 34.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 109.566 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.6 p -89.55 59.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -141.18 -36.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 110.637 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.64 -74.57 0.45 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.663 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.758 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.7 pt? -114.39 147.8 38.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 111.218 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.657 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -162.6 -86.52 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.145 178.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.1 t -93.84 140.56 29.53 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.571 0.701 . . . . 0.0 110.67 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.71 -2.4 0.14 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.645 HG22 ' HD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -131.52 -8.1 3.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.289 -1.507 . . . . 0.0 113.343 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.511 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -162.67 -110.9 0.25 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 116.832 -2.604 . . . . 0.0 114.002 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG12 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -127.55 -150.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.625 -0.927 . . . . 0.0 111.874 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 t -148.83 76.09 1.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 111.537 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.5 mp -88.32 64.33 7.54 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.766 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 105.82 -52.08 0.72 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 106.023 -2.831 . . . . 0.0 106.023 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -162.11 159.28 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 26.1 t -43.78 115.0 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.949 -1.094 . . . . 0.0 109.917 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.576 ' O ' ' CE3' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -95.05 38.33 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 110.646 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.645 ' HD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.99 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.3 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 19.1 mmtt -144.06 144.3 31.56 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.183 -0.948 . . . . 0.0 110.069 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 12.2 mm-40 -72.11 140.97 49.16 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.02 127.8 1.64 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.611 -0.68 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 8.5 t70 88.49 17.91 0.06 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 120.979 0.419 . . . . 0.0 110.869 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.659 ' C ' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -106.83 147.56 35.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.023 -1.048 . . . . 0.0 109.719 179.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.28 137.03 38.99 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 124.463 1.77 . . . . 0.0 109.727 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.722 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 5.8 p -161.79 -178.56 6.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.361 -1.335 . . . . 0.0 112.677 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -110.67 145.27 38.26 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.476 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 10' ' ' VAL . 74.7 t -85.88 57.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 109.447 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -130.45 -38.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.117 -0.989 . . . . 0.0 109.963 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.81 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -82.9 102.62 11.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.701 -0.624 . . . . 0.0 111.084 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.754 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 23.3 p30 -160.18 -3.5 0.06 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.243 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.5 t 178.14 106.33 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.632 -1.292 . . . . 0.0 109.63 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -59.22 -3.09 0.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 112.352 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.596 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.1 t -128.48 1.76 5.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 112.841 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.47 -125.07 0.83 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 117.687 -2.197 . . . . 0.0 112.645 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.565 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -111.32 -143.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.805 -0.82 . . . . 0.0 110.6 -177.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 37.1 t -159.81 70.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.84 -1.163 . . . . 0.0 111.332 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.796 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.2 mm? -85.81 62.47 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 110.24 -48.77 0.9 Allowed Glycine 0 N--CA 1.483 1.821 0 N-CA-C 106.471 -2.651 . . . . 0.0 106.471 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.08 159.86 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.933 -0.745 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 42.8 t -56.73 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.094 -1.004 . . . . 0.0 109.061 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.583 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 7.1 mtp -84.9 52.97 2.56 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.026 -1.046 . . . . 0.0 112.962 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.0 m-90 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.099 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 11.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.957 0.408 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.603 ' HG3' ' HA ' ' A' ' 14' ' ' ASP . 12.4 mmtt -137.34 167.17 22.14 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 120.832 -1.168 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.1 mm-40 -95.49 137.53 34.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.059 -1.025 . . . . 0.0 109.616 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 116.64 0.52 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.649 -0.657 . . . . 0.0 110.79 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 18.4 t70 92.24 20.83 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 122.744 0.417 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.6 mt-10 -107.02 161.77 21.83 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.58 138.04 37.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.805 1.424 . . . . 0.0 109.416 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 11.7 p -150.86 177.82 9.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.161 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -120.82 146.33 46.65 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.999 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.48 56.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.913 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -136.46 -42.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 110.811 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -76.16 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.005 -1.059 . . . . 0.0 111.044 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.8 pp -78.68 111.28 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.685 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.675 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -160.7 -17.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.691 -1.203 . . . . 0.0 113.298 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 12.4 t -172.5 119.23 0.38 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.773 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 40.4 m -60.69 -6.78 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 111.1 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.956 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.6 t -133.07 0.94 3.49 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.856 -1.152 . . . . 0.0 112.266 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.96 -140.17 2.81 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.747 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.633 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -107.38 -147.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 122.341 -0.505 . . . . 0.0 110.304 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 51.5 t -135.31 83.14 2.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.349 -1.469 . . . . 0.0 111.12 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.597 HD23 ' HZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -87.8 51.2 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.756 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 107.28 -41.04 2.3 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.5 m -161.04 148.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.949 -0.736 . . . . 0.0 109.142 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 15.3 t -41.11 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 5.4 mmt -79.49 -165.2 0.75 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 119.896 -1.752 . . . . 0.0 107.826 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.956 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.503 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.768 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 31.5 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.103 0.477 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 14' ' ' ASP . 7.9 mmtt -153.13 158.24 41.55 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.441 -0.787 . . . . 0.0 108.924 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 26.3 mm-40 -91.89 145.84 24.23 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.01 120.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.838 -0.539 . . . . 0.0 110.428 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.1 t0 86.94 30.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.08 0.467 . . . . 0.0 110.871 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 6.9 mm-40 -114.67 154.61 46.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.081 -1.012 . . . . 0.0 110.069 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.85 120.39 6.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.643 1.339 . . . . 0.0 110.041 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.3 p -140.05 171.56 14.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.077 -1.015 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.58 124.59 48.4 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 10' ' ' VAL . 9.2 p -85.16 54.19 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.041 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 54.3 m-85 -132.0 -17.62 2.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.175 -0.953 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.05 -54.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.929 -1.107 . . . . 0.0 110.875 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.813 HD23 ' H ' ' A' ' 13' ' ' LEU . 2.3 pt? -136.82 144.38 43.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.81 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.94 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' MET . 0.8 OUTLIER -78.72 123.68 27.41 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.681 0.753 . . . . 0.0 109.755 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.69 -20.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.599 -0.688 . . . . 0.0 112.107 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -143.27 14.22 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.488 -1.382 . . . . 0.0 112.226 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.599 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -149.81 -126.44 1.43 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.624 -2.227 . . . . 0.0 113.027 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.658 HD11 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -130.2 178.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.491 0.662 . . . . 0.0 110.838 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -116.65 65.36 0.71 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 109.557 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 21' ' ' LEU . 1.9 mt -87.39 62.69 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.765 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.26 -50.81 0.76 Allowed Glycine 0 N--CA 1.481 1.658 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.7 m -162.86 -175.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 12.1 t -49.85 125.35 11.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.555 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 36.4 mmm -77.16 -174.91 3.4 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 120.242 -1.536 . . . . 0.0 109.301 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.658 ' CH2' HD11 ' A' ' 19' ' ' ILE . 1.1 m95 . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.237 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.7 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.015 0.436 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -145.25 156.06 43.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.013 -1.054 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.0 mm100 -88.25 138.35 31.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 109.406 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.56 128.0 1.1 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.452 -0.78 . . . . 0.0 111.184 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 3.3 t0 83.3 19.53 0.21 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.041 -0.412 . . . . 0.0 111.143 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -109.13 165.49 12.54 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 120.866 -1.146 . . . . 0.0 109.697 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.462 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 40.1 Cg_endo -70.04 136.75 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.913 1.481 . . . . 0.0 109.618 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 19.2 p -148.81 -170.55 3.65 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.784 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 1.8 m-20 -122.34 131.03 53.7 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 20' ' ' CYS . 24.8 m -84.22 55.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.121 -0.987 . . . . 0.0 110.838 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -144.5 -27.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 0.0 111.088 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.557 ' N ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -161.55 -86.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.936 -1.102 . . . . 0.0 110.811 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pp -82.36 117.67 22.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.688 0.756 . . . . 0.0 110.779 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -161.84 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.761 -1.212 . . . . 0.0 111.889 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -149.51 110.24 4.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.802 -1.186 . . . . 0.0 109.477 -179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -43.99 -17.44 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.662 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -121.52 -21.74 6.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.36 -1.463 . . . . 0.0 112.681 -178.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -151.15 -141.16 3.3 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.144 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.771 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -95.63 -154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 122.086 -0.655 . . . . 0.0 110.479 -179.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -154.88 97.47 1.96 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 111.147 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.824 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.9 mm? -90.83 59.81 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.119 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 113.69 -38.0 3.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -160.57 149.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.964 . . . . 0.0 109.047 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 48.9 t -39.34 107.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.694 0.759 . . . . 0.0 109.97 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.624 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.5 mmt -77.71 -164.08 0.47 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.506 -1.371 . . . . 0.0 108.758 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.662 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.37 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.406 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.076 0.465 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 4.3 mmtt -146.09 139.5 26.06 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.249 -0.907 . . . . 0.0 109.981 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.531 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 27.3 mm100 -72.17 141.47 49.07 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.283 -0.886 . . . . 0.0 110.016 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.31 136.88 0.61 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.687 -0.633 . . . . 0.0 111.439 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.5 m-20 80.91 10.22 0.99 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.309 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.626 ' C ' HG12 ' A' ' 23' ' ' VAL . 5.7 mm-40 -103.95 143.37 26.51 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.708 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 39.0 Cg_endo -67.07 140.95 55.93 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 124.73 1.911 . . . . 0.0 109.657 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.3 p -160.82 178.06 9.8 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.831 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 95.9 m-20 -101.22 137.87 38.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 0.0 109.872 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.7 p -85.49 58.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.511 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.49 -35.07 0.91 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.199 -0.938 . . . . 0.0 110.43 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -161.05 -80.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -178.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -87.53 104.02 16.1 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.813 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.718 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 p30 -160.63 10.62 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.571 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 7.4 t 175.13 106.96 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.967 -1.083 . . . . 0.0 109.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -60.46 -4.26 0.84 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 112.054 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -133.77 15.02 3.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.576 -1.327 . . . . 0.0 112.692 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.497 ' N ' ' SG ' ' A' ' 15' ' ' CYS . . . 179.09 -130.95 1.61 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 117.915 -2.088 . . . . 0.0 112.296 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.602 HG13 ' CZ2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.18 -149.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.827 -0.807 . . . . 0.0 110.106 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.9 t -158.74 78.2 0.77 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.349 -1.469 . . . . 0.0 111.958 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -89.22 47.45 1.49 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.784 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.76 -44.81 1.23 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -161.9 154.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.82 . . . . 0.0 109.982 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 41.9 t -61.05 99.62 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.033 -1.042 . . . . 0.0 108.862 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.619 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 8.4 mtp -94.33 53.52 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.576 -1.327 . . . . 0.0 113.447 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.619 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.686 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.0 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.051 0.453 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 13.4 mmtt -145.84 144.5 30.28 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.224 -0.922 . . . . 0.0 109.806 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 4' ' ' ALA . 29.2 mm100 -75.07 142.37 43.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.84 128.47 1.2 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.732 -0.605 . . . . 0.0 110.382 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.606 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t0 87.81 19.15 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.139 0.495 . . . . 0.0 110.536 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' C ' HG12 ' A' ' 23' ' ' VAL . 23.5 mm-40 -111.41 137.36 21.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.184 -0.947 . . . . 0.0 109.603 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' N ' HG12 ' A' ' 23' ' ' VAL . 41.7 Cg_endo -69.81 144.32 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.694 1.365 . . . . 0.0 110.846 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.4 p -160.75 -171.08 2.97 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.569 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.41 145.03 38.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 20' ' ' CYS . 15.5 t -84.96 56.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.23 -37.36 1.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 110.238 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 -79.03 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 111.155 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 1.2 pp -81.97 109.18 16.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.508 -0.745 . . . . 0.0 111.197 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -159.98 -12.64 0.05 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.116 -1.034 . . . . 0.0 113.068 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 50.3 t -173.19 111.98 0.21 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.678 -1.264 . . . . 0.0 110.287 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -56.29 -11.43 1.19 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.718 HG21 ' OXT' ' A' ' 26' ' ' TRP . 2.0 t -130.22 0.61 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.785 -1.197 . . . . 0.0 112.393 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -165.59 -152.5 7.17 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.364 -1.874 . . . . 0.0 112.012 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.68 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -97.28 -161.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.122 -0.634 . . . . 0.0 110.857 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 12.7 t -123.54 80.22 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 111.157 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.1 mp -88.83 55.12 3.24 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 103.75 -43.88 1.59 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 22' ' ' GLY . 0.7 OUTLIER -160.86 140.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 5.3 t -41.15 98.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 1.7 mtt -76.15 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.725 -1.859 . . . . 0.0 107.43 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.718 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.899 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.72 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.237 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -142.29 143.89 33.02 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.162 -0.961 . . . . 0.0 109.432 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 2.8 mm-40 -79.18 142.05 36.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.25 127.85 1.36 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.752 -0.593 . . . . 0.0 111.063 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 83.44 19.61 0.2 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 61.8 mm-40 -107.88 154.43 41.04 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.224 -0.922 . . . . 0.0 109.283 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 41.7 Cg_endo -71.25 114.06 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.779 1.41 . . . . 0.0 109.736 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.695 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 4.0 p -132.65 172.16 12.89 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.707 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 12.3 m-20 -91.24 126.25 36.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 109.975 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 10' ' ' VAL . 14.2 p -88.93 61.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 110.074 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 0.8 OUTLIER -149.16 -35.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.025 -1.047 . . . . 0.0 110.56 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 13' ' ' LEU . 29.1 t -132.32 -86.79 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -113.73 136.87 52.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.547 -0.721 . . . . 0.0 109.087 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.695 ' CB ' ' HB2' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -162.03 -21.4 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.423 -1.311 . . . . 0.0 113.031 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.737 ' SG ' HG22 ' A' ' 17' ' ' THR . 20.7 t -141.23 108.66 5.56 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.359 -1.463 . . . . 0.0 111.106 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.93 -19.08 0.35 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.803 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.844 HG21 ' C ' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -108.88 -26.13 10.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.062 . . . . 0.0 112.312 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.424 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . -160.57 -104.85 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 117.953 -2.07 . . . . 0.0 112.959 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.529 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.51 -164.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -1.076 . . . . 0.0 111.74 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 8.0 t -129.0 73.39 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.502 -0.749 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.731 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -88.15 51.71 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.793 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 124.32 -44.73 1.25 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 22' ' ' GLY . 1.8 m -162.91 171.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 49.7 t -45.45 121.05 2.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.95 -1.094 . . . . 0.0 108.399 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -82.83 171.7 13.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.843 -1.161 . . . . 0.0 110.71 -178.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.844 ' C ' HG21 ' A' ' 17' ' ' THR . 17.4 p90 . . . . . 0 N--CA 1.502 2.156 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.137 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.029 0.442 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -111.66 136.19 51.21 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.7 mm100 -73.09 133.06 44.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.622 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.94 137.87 0.46 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.698 -0.626 . . . . 0.0 110.635 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.0 t70 87.76 4.84 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.992 0.425 . . . . 0.0 110.127 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -100.22 143.84 27.28 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.28 143.67 35.69 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.313 1.691 . . . . 0.0 109.679 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' CB ' ' HA ' ' A' ' 14' ' ' ASP . 1.7 p -161.2 179.95 7.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.383 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.7 OUTLIER -102.9 144.87 30.65 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 10' ' ' VAL . 23.2 m -83.83 54.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.472 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -127.81 -32.86 2.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.109 -0.995 . . . . 0.0 109.806 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.6 t -161.05 -83.49 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 2.0 pt? -79.06 120.17 23.23 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.54 0.686 . . . . 0.0 110.812 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.709 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -38.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.828 -1.17 . . . . 0.0 111.938 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 17' ' ' THR . 44.3 t -151.03 117.23 5.62 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.35 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -8.83 0.53 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 111.411 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -134.22 -0.15 3.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.727 -1.233 . . . . 0.0 113.25 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.08 -110.13 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 116.98 -2.533 . . . . 0.0 113.999 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.635 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -135.07 -152.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.567 -0.96 . . . . 0.0 111.742 -175.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 16.5 t -145.19 77.63 1.53 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.975 -1.078 . . . . 0.0 111.957 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 21' ' ' LEU . 4.8 mt -90.81 52.52 2.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.709 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 114.04 -47.67 1.02 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.604 -2.598 . . . . 0.0 106.604 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -161.04 147.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.856 -0.79 . . . . 0.0 108.915 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.449 ' SG ' ' HA ' ' A' ' 4' ' ' ALA . 3.9 t -52.14 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.812 -1.18 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.575 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 5.8 mtp -82.87 52.03 2.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.968 -1.083 . . . . 0.0 111.823 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.635 ' CH2' HG13 ' A' ' 19' ' ' ILE . 8.5 m-90 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.998 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 29.2 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.071 0.462 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -146.24 144.71 30.06 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.155 -0.966 . . . . 0.0 109.923 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 36.7 mm-40 -75.22 142.32 43.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.674 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.52 139.43 0.4 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.653 -0.654 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.0 m-20 84.21 4.97 0.7 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 120.963 0.411 . . . . 0.0 110.247 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 mm-40 -96.84 137.38 21.37 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 121.037 -1.039 . . . . 0.0 110.059 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.11 140.31 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.155 1.608 . . . . 0.0 110.11 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.1 p -161.12 -174.66 4.46 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.727 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -106.52 148.01 28.71 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 10' ' ' VAL . 24.5 m -85.36 56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.085 -1.009 . . . . 0.0 109.453 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.6 -38.36 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.158 -0.964 . . . . 0.0 110.694 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.36 -73.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 111.636 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 pp -86.12 107.81 18.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.306 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.7 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -160.78 -18.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.743 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' ' HE3' ' A' ' 26' ' ' TRP . 35.8 t -173.03 114.53 0.25 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.672 -1.268 . . . . 0.0 110.23 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -57.7 -6.82 0.56 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 112.064 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' HB2' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -135.69 3.89 3.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.515 -1.366 . . . . 0.0 112.993 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.76 -132.92 1.43 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 117.321 -2.371 . . . . 0.0 113.025 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.594 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -114.68 -150.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 122.058 -0.672 . . . . 0.0 110.902 -177.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 32.1 t -148.09 76.94 1.39 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.587 -1.321 . . . . 0.0 111.482 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.0 mm? -88.47 51.53 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.75 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.44 -45.28 1.31 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.3 m -161.8 158.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.998 -0.707 . . . . 0.0 109.459 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.559 ' HA ' ' CZ3' ' A' ' 26' ' ' TRP . 12.4 t -61.37 101.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 108.658 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.63 ' C ' ' CG ' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -95.36 50.58 1.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.716 -1.24 . . . . 0.0 113.673 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' CG ' ' C ' ' A' ' 25' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.855 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 16.4 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.969 0.414 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -144.23 147.19 33.27 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 5.8 mm-40 -76.27 137.92 40.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.186 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -38.74 121.57 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 111.138 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 11.3 t0 89.2 23.25 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.078 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mt-10 -112.51 157.63 39.66 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.389 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.6 Cg_endo -69.66 141.86 46.81 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.778 1.41 . . . . 0.0 109.513 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.6 p -155.83 174.85 14.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.88 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 1.1 m-20 -102.91 137.63 40.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 20' ' ' CYS . 29.4 m -83.65 55.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.295 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -141.57 -34.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.864 -1.148 . . . . 0.0 110.971 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.83 -80.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.079 . . . . 0.0 110.735 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -79.53 116.15 19.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 109.88 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.11 -23.61 0.06 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.771 -1.172 . . . . 0.0 112.618 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 17' ' ' THR . 46.5 t -164.21 117.16 1.38 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.056 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -54.32 -10.38 0.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 111.331 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 26' ' ' TRP . 1.4 t -132.2 2.49 3.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.739 -1.225 . . . . 0.0 112.315 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 26' ' ' TRP . . . -166.49 -146.36 4.81 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 117.943 -2.075 . . . . 0.0 112.772 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.643 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -103.39 -156.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 122.222 -0.576 . . . . 0.0 110.745 -178.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.891 ' O ' HG12 ' A' ' 10' ' ' VAL . 49.5 t -132.1 75.01 1.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.634 -1.291 . . . . 0.0 110.833 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 21' ' ' LEU . 6.5 mt -88.48 51.77 2.27 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.791 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.78 -49.63 0.85 Allowed Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.0 m -161.96 150.05 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.866 -0.785 . . . . 0.0 109.048 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 4.8 t -43.49 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.761 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 3.1 mmm -78.05 -161.76 0.28 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 119.818 -1.802 . . . . 0.0 107.087 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.903 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.574 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.0 0.428 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -140.25 158.05 44.63 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.952 -1.093 . . . . 0.0 110.133 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.3 mm-40 -88.28 139.86 30.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.626 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.99 120.49 0.86 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.647 . . . . 0.0 111.015 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.2 t70 92.01 19.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.74 0.416 . . . . 0.0 111.755 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 1.4 mp0 -110.67 152.08 43.23 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 120.747 -1.221 . . . . 0.0 109.359 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.78 141.85 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.757 1.398 . . . . 0.0 110.465 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 6.1 p -158.22 178.66 9.94 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.238 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -103.52 145.74 29.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.211 0.529 . . . . 0.0 109.662 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 20' ' ' CYS . 3.5 t -86.15 54.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.78 -41.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.773 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.61 -76.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 111.557 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -78.94 105.77 10.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.733 -0.605 . . . . 0.0 110.703 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 2.9 p30 -161.04 -24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.874 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 17' ' ' THR . 11.8 t -161.28 109.79 1.54 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.872 -1.143 . . . . 0.0 110.211 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.44 -11.81 2.18 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.665 -0.647 . . . . 0.0 110.855 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.758 HG21 ' OXT' ' A' ' 26' ' ' TRP . 3.4 t -120.98 -7.66 9.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 112.128 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.88 -139.27 2.59 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.525 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.627 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -105.64 -149.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 122.123 -0.634 . . . . 0.0 110.669 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 49.2 t -139.65 77.06 1.59 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.426 -1.421 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.719 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.6 mm? -86.89 48.57 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.59 -43.89 1.56 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.3 m -161.67 146.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.811 -0.817 . . . . 0.0 109.482 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 39.1 t -41.54 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.684 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 4.8 mmm -78.42 -164.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 119.969 -1.707 . . . . 0.0 107.39 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.758 ' OXT' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.619 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.757 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 17.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.042 0.448 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -134.58 145.16 48.41 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.961 -1.087 . . . . 0.0 110.531 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.7 mm100 -81.27 135.47 35.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 109.653 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -38.75 128.04 1.54 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 111.341 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t0 83.76 15.2 0.29 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.252 0.549 . . . . 0.0 110.397 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 60.9 mm-40 -104.37 145.23 30.28 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.537 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' OE1' ' A' ' 6' ' ' GLU . 39.9 Cg_endo -67.32 133.9 31.87 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.555 1.818 . . . . 0.0 109.417 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -160.59 169.86 22.05 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.241 -178.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 7.7 m-20 -96.06 142.25 28.48 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.9 p -85.66 59.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 0.0 109.385 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -24.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.203 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 31.2 t -161.0 -87.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.65 -1.281 . . . . 0.0 110.25 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -79.61 93.4 5.48 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.723 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -135.99 -17.83 1.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.584 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.717 ' SG ' HG22 ' A' ' 17' ' ' THR . 40.9 t -176.69 106.64 0.07 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.921 -1.112 . . . . 0.0 109.809 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -40.83 -21.17 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.889 -0.507 . . . . 0.0 111.935 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.717 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -111.04 -24.41 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.742 -1.224 . . . . 0.0 112.98 -178.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.7 -111.03 0.45 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 117.98 -2.057 . . . . 0.0 113.176 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.572 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -124.59 -152.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.81 -0.818 . . . . 0.0 110.904 -176.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 35.8 t -157.7 88.39 0.98 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.089 -1.007 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -88.17 51.99 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.661 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 123.01 -42.75 1.55 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.263 -2.735 . . . . 0.0 106.263 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 22' ' ' GLY . 21.4 m -160.72 158.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 1.7 t -63.94 94.63 0.1 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.952 -1.093 . . . . 0.0 109.368 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.3 mtp -86.47 52.8 2.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.76 -1.212 . . . . 0.0 110.719 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 15.0 m-90 . . . . . 0 C--N 1.295 -1.783 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.407 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 19.6 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' ASP . 22.2 mmtt -149.27 161.2 42.51 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.804 -1.185 . . . . 0.0 109.951 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -97.25 142.13 29.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.389 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -37.09 121.48 0.8 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 111.467 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.2 t70 85.59 26.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.122 -0.361 . . . . 0.0 111.771 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -114.65 162.04 25.69 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.695 -1.253 . . . . 0.0 109.956 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 40.3 Cg_endo -69.22 117.22 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.818 1.431 . . . . 0.0 109.606 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.9 p -124.42 168.47 12.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 111.96 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.23 119.33 27.36 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' CZ ' ' A' ' 11' ' ' PHE . 11.2 m -86.08 52.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.591 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.6 -36.06 0.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.774 -1.204 . . . . 0.0 110.929 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.18 -82.94 0.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.123 -0.986 . . . . 0.0 110.605 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.3 pt? -106.02 152.56 23.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.5 -0.75 . . . . 0.0 110.386 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.719 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -161.99 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.131 -0.98 . . . . 0.0 111.37 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 1.1 t -81.31 134.28 35.56 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.743 0.782 . . . . 0.0 110.333 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 60.0 m -51.74 -12.96 0.22 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.701 -0.625 . . . . 0.0 112.201 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.666 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -134.07 -1.57 2.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.437 -1.414 . . . . 0.0 113.234 -178.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.31 -109.59 0.31 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 116.748 -2.644 . . . . 0.0 114.105 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.682 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -131.64 -161.82 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.752 0.786 . . . . 0.0 111.831 -175.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 44.4 t -135.55 80.27 1.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.663 . . . . 0.0 110.379 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 6.1 mp -88.75 52.27 2.38 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.748 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 116.27 -43.75 1.6 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.21 157.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.731 -0.864 . . . . 0.0 109.858 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 2' ' ' LYS . 37.8 t -39.83 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.7 . . . . 0.0 109.564 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.626 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -78.2 -162.46 0.34 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.296 -1.503 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.682 ' CH2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.389 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.05 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 27.9 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.282 0.563 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 8' ' ' CYS . 12.8 mmtm -155.37 166.83 32.35 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.286 -0.884 . . . . 0.0 109.234 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -102.21 143.8 31.54 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.01 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.608 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.54 119.46 0.62 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.83 -0.544 . . . . 0.0 110.891 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 4.7 t0 88.15 27.26 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -112.93 159.87 32.95 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.429 -1.419 . . . . 0.0 110.632 178.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 43.3 Cg_endo -70.63 109.33 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.545 1.287 . . . . 0.0 109.942 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 2.1 p -128.24 170.0 13.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.38 124.62 34.62 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.293 0.568 . . . . 0.0 109.66 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -90.45 58.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.871 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -147.76 -34.08 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.187 . . . . 0.0 110.994 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.62 -76.81 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.9 pt? -122.48 153.59 38.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.645 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -161.6 -85.51 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.349 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -76.19 134.97 39.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.563 0.697 . . . . 0.0 109.464 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -49.24 -12.75 0.06 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.662 -0.649 . . . . 0.0 112.106 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 17' ' ' THR . 1.2 t -145.83 40.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.457 -1.402 . . . . 0.0 113.007 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' NE1' ' A' ' 26' ' ' TRP . . . 171.24 -110.06 0.34 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 117.357 -2.354 . . . . 0.0 113.671 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -137.31 -164.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.128 -1.219 . . . . 0.0 112.33 -175.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.668 ' H ' HG22 ' A' ' 19' ' ' ILE . 23.2 t -131.67 76.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 109.793 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.725 HD22 ' HE3' ' A' ' 25' ' ' MET . 6.4 mp -86.97 63.32 7.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.706 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 108.84 -43.75 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 106.876 -2.489 . . . . 0.0 106.876 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 22' ' ' GLY . 13.7 m -161.49 -176.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 4' ' ' ALA . 4.7 t -47.48 120.35 3.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.725 ' HE3' HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -78.31 -169.09 1.51 Allowed 'General case' 0 C--N 1.288 -2.079 0 O-C-N 119.976 -1.702 . . . . 0.0 108.903 -178.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 19' ' ' ILE . 1.4 m95 . . . . . 0 C--N 1.283 -2.295 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 12.3 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.908 0.385 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -147.91 154.24 40.12 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.995 -1.066 . . . . 0.0 110.092 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -86.25 139.51 30.96 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.728 179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -37.63 119.94 0.77 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.381 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 23.0 t0 90.87 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 122.782 0.433 . . . . 0.0 111.416 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -117.57 156.23 49.57 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.977 -1.077 . . . . 0.0 109.151 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 42.8 Cg_endo -70.49 123.41 9.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.769 1.405 . . . . 0.0 110.43 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.8 p -134.96 172.56 12.83 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.11 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 20.1 t0 -79.41 124.72 28.71 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.499 0.666 . . . . 0.0 110.215 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 20' ' ' CYS . 3.9 m -90.53 57.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -158.1 -28.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.779 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.96 -83.48 0.31 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.914 -1.116 . . . . 0.0 110.033 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.3 pt? -110.65 148.39 32.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.972 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.702 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.27 -86.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.004 -1.06 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 17' ' ' THR . 49.5 t -77.49 125.35 29.19 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.425 0.631 . . . . 0.0 111.015 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -57.85 -10.75 1.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.536 -0.728 . . . . 0.0 110.846 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -127.93 -5.42 5.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.0 112.219 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.5 -142.72 3.47 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.203 -1.951 . . . . 0.0 112.123 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG13 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -102.21 -149.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.224 -0.574 . . . . 0.0 109.765 -179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.855 ' O ' HG12 ' A' ' 10' ' ' VAL . 46.4 t -153.83 81.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.295 -1.503 . . . . 0.0 111.688 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.3 mm? -89.85 43.74 1.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 130.25 -46.43 1.08 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 22' ' ' GLY . 2.8 m -160.7 146.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.5 -1.0 . . . . 0.0 109.734 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 2.0 t -45.61 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 110.482 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' TRP . 2.7 mmt -78.01 -162.97 0.37 Allowed 'General case' 0 C--N 1.292 -1.907 0 O-C-N 120.172 -1.58 . . . . 0.0 106.88 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.673 ' CE2' ' HB2' ' A' ' 25' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.662 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 13.3 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.188 0.518 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -160.22 143.21 13.56 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.8 143.18 49.61 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.525 0.679 . . . . 0.0 111.052 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.13 134.88 1.02 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.576 -0.703 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 6.4 m-20 84.77 4.77 0.62 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.021 -0.424 . . . . 0.0 110.844 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.552 ' CG ' ' HG2' ' A' ' 2' ' ' LYS . 13.1 tp10 -96.16 143.07 25.48 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 120.901 -1.124 . . . . 0.0 109.076 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 38.8 Cg_endo -68.25 141.57 52.44 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.651 1.342 . . . . 0.0 110.014 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 7.5 p -160.81 -168.92 2.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.334 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.16 133.94 52.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' VAL . 6.3 p -85.81 60.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.123 -0.986 . . . . 0.0 110.202 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -139.0 -40.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.89 -77.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.327 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -119.21 132.35 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 110.121 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.679 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.84 -34.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.5 t -144.63 114.43 7.28 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.247 -0.908 . . . . 0.0 109.285 -178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -50.75 -13.0 0.12 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.518 -0.738 . . . . 0.0 111.874 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -135.95 11.61 3.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.442 -1.411 . . . . 0.0 112.53 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.554 ' HA3' ' CZ3' ' A' ' 26' ' ' TRP . . . -171.03 -164.11 26.19 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.266 -1.921 . . . . 0.0 111.996 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.728 HG12 ' CH2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -84.68 -160.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 122.108 -0.642 . . . . 0.0 111.125 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 42.7 t -135.33 82.32 1.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.013 -1.055 . . . . 0.0 110.656 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -88.35 48.07 1.59 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.764 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 117.72 -41.25 2.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.6 m -161.4 143.4 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.855 . . . . 0.0 109.796 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 12.9 t -39.79 108.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.726 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 2.8 mmt -83.4 -166.69 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.232 -1.543 . . . . 0.0 108.223 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.728 ' CH2' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.836 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB2' ' N ' ' A' ' 16' ' ' CYS . 25.4 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 14' ' ' ASP . 18.0 mmtt -153.87 154.91 34.75 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.992 -1.067 . . . . 0.0 110.006 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 8.9 mm-40 -86.49 144.92 27.02 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.155 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.556 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -36.23 129.35 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.735 -0.603 . . . . 0.0 110.718 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 1.1 t70 79.97 26.05 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.736 -0.603 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 1.7 mm-40 -107.03 143.35 26.92 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.01 112.1 3.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.611 1.322 . . . . 0.0 109.943 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -124.74 168.19 13.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 15.6 m-20 -97.62 134.03 41.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.6 -0.688 . . . . 0.0 110.026 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 20' ' ' CYS . 33.8 m -85.42 57.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 10' ' ' VAL . 13.9 m-85 -133.66 -24.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 111.105 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.16 -73.17 0.07 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.925 -1.109 . . . . 0.0 110.998 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.855 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.9 pt? -110.35 147.36 34.1 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.802 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.743 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -161.96 -85.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 111.161 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' SG ' ' CD1' ' A' ' 26' ' ' TRP . 2.8 t -86.29 126.2 34.14 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.924 0.868 . . . . 0.0 110.529 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 1' ' ' CYS . 61.6 m -47.6 -14.56 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.687 HG22 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -131.7 -11.6 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.33 -1.482 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.766 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -148.13 -128.41 1.77 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.575 -2.25 . . . . 0.0 113.109 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -110.37 -166.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.603 0.716 . . . . 0.0 111.6 -176.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.743 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 49.9 t -131.75 75.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.643 -0.661 . . . . 0.0 110.575 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.0 mt -88.29 62.43 6.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.746 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 111.82 -45.01 1.38 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 22' ' ' GLY . 6.1 m -161.22 179.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 50.9 t -65.21 103.74 0.82 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 108.772 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.634 ' HB3' ' CD2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.5 -163.29 0.31 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 120.339 -1.476 . . . . 0.0 108.593 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.687 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.369 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.702 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 29.7 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.864 0.364 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' ASP . 12.4 mmtp -153.21 144.12 22.87 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.088 -1.007 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 18.8 mm100 -69.92 140.64 53.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 5' ' ' ASP . . . -38.93 143.15 0.17 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.44 -0.787 . . . . 0.0 111.619 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER 72.93 9.52 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.044 0.45 . . . . 0.0 110.582 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 10.8 tt0 -106.2 146.74 33.56 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.77 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD2' ' HG3' ' A' ' 6' ' ' GLU . 37.4 Cg_endo -64.04 132.38 34.19 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.375 1.197 . . . . 0.0 110.52 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 1.7 p -144.2 177.63 8.46 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.264 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -79.4 121.84 25.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.499 -0.751 . . . . 0.0 110.671 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 20' ' ' CYS . 11.7 m -90.98 62.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.605 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.69 -32.42 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.296 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.0 -86.32 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -110.72 142.34 42.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.141 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -164.24 -62.27 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.439 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 19.8 t -87.19 113.02 22.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.643 0.735 . . . . 0.0 111.064 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 2' ' ' LYS . 67.7 m -44.53 -19.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.841 -0.537 . . . . 0.0 111.442 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 ' CD1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -129.99 -12.22 4.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.764 -1.21 . . . . 0.0 112.922 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.78 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -149.51 -122.14 1.14 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.009 -2.043 . . . . 0.0 112.276 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.78 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.75 -176.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.895 . . . . 0.0 110.751 -178.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.916 ' O ' HG12 ' A' ' 10' ' ' VAL . 22.6 t -129.7 76.04 1.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.293 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.569 ' HB2' ' CE ' ' A' ' 25' ' ' MET . 4.2 mm? -92.19 45.2 1.2 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.808 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 136.01 -44.72 1.14 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 22' ' ' GLY . 3.1 m -162.05 163.17 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.985 -0.715 . . . . 0.0 109.393 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 42.6 t -47.94 121.28 4.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.869 -1.145 . . . . 0.0 108.441 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' ' CE3' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -87.13 135.7 33.2 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 111.009 -178.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.614 ' CE3' ' HB3' ' A' ' 25' ' ' MET . 4.8 p90 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.001 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' CA ' ' A' ' 16' ' ' CYS . 27.5 p . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.141 0.496 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -150.96 132.86 15.08 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.219 -0.926 . . . . 0.0 110.227 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -71.87 137.89 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 5' ' ' ASP . . . -39.28 140.12 0.46 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.539 -0.726 . . . . 0.0 111.547 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 5.1 m-20 81.65 5.3 1.27 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.042 0.449 . . . . 0.0 110.756 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.7 mm-40 -107.55 149.44 38.87 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 41.1 Cg_endo -69.43 130.56 19.97 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.94 1.495 . . . . 0.0 110.651 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 1.6 p -139.5 177.37 7.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.702 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.96 114.57 22.97 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.672 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 10' ' ' VAL . 10.6 p -85.11 56.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -143.84 -37.47 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -75.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.968 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -123.44 153.03 41.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.673 ' CB ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -161.85 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.308 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 24' ' ' CYS . 6.4 t -73.66 118.1 16.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.866 -0.521 . . . . 0.0 109.875 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -38.76 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.674 -0.641 . . . . 0.0 111.336 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.74 HG23 ' HE1' ' A' ' 26' ' ' TRP . 0.6 OUTLIER -133.66 -13.6 2.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.845 -1.159 . . . . 0.0 111.808 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.944 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -121.3 -127.13 3.37 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.431 -1.842 . . . . 0.0 112.654 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.944 HD13 ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -137.33 -175.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.747 -0.854 . . . . 0.0 110.447 -177.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 3.1 t -117.44 59.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.057 -1.027 . . . . 0.0 110.793 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 4.8 mp -88.71 49.6 1.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 23' ' ' VAL . . . 131.48 -54.81 0.78 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 106.384 -2.686 . . . . 0.0 106.384 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.1 m -161.73 165.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 8.6 t -46.51 116.48 1.31 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.994 -1.066 . . . . 0.0 108.294 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TRP . 3.7 mtp -81.95 139.25 34.7 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.446 -0.784 . . . . 0.0 110.203 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.74 ' HE1' HG23 ' A' ' 17' ' ' THR . 4.9 p90 . . . . . 0 C--N 1.291 -1.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 stop_ save_